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Human pluripotent stem cells are increasingly used for cell-based regenerative therapies worldwide, with 
the use of embryonic and induced pluripotent stem cells as potential treatments for a range of debilitating 
and chronic conditions. However, with the level of chromosomal aneuploidies the cells may generate in 
culture, their safety for therapeutic use could be in question. This study aimed to develop sensitive and 
high-throughput assays for the detection and quantification of human pluripotent stem cell aneuploidies, 
to assess any changes in their positioning in nuclei, as well as investigate the possible roles of lamins in the 
accumulation of aneuploidies.  
Using Droplet Digital PCR™, we optimised the detection of aneuploid cells in a predominantly diploid 
background. An assay was established for the sensitive detection of up to 1% of mosaicism and was used 
for the monitoring of low-level chromosome copy number changes across different cell lines, conditions 
and passages in the human pluripotent stem cells.  
In addition, fluorescence in-situ hybridisation was used to map genes ALB and AMELX on chromosomes 4 
and X, respectively, in karyotype-stable chromosome X aneuploid lymphoblastoid cell lines. Our results 
demonstrated significant alternations in the gene loci positioning in the chromosome X aneuploid cell lines. 
Using the same established method, the positioning of ALB and AMELX was monitored, alongside the 
genomic instability with ddPCR™, in the different human pluripotent stem cell lines, conditions and 
passage. We demonstrated a highly plastic nuclear organisation in the pluripotent stem cells with many 
changes occurring within a single passage. Furthermore, these results were not exclusive to a single cell 
line or condition, regardless of the presence or absence of feeder cells and of passage number, and the 
flexibility of the chromatin organisation remained throughout the duration of the study. We demonstrated 
high levels of genomic instability with recurrent gains and losses in the AMELX copy number in the human 
embryonic stem cells during the course of our study, however no significant changes in their gene loci 
positioning from these abnormalities were observed. 
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Additionally, we observed reduced levels of lamin B2 in the aneuploid lymphoblastoid cell lines and 
complete loss in some hPSC samples. Our results support recent findings that suggest a link between lamin 
B2 loss and the formation of chromosome aneuploidies in cell culture. 
In conclusion, our data demonstrates several key novel findings. Firstly, we have established a sensitive 
technique for the detection of up to 1% mosaicism, which to our knowledge is the most sensitive assay 
currently available. Secondly, we showed significant changes in the gene loci positioning between 
aneuploid and diploid cell lines. Thirdly, utilising our novel ddPCR™ assay, we demonstrated the 
karyotypical instability of hPCSs with consistent gains and/or loses of gene copy numbers in a short period 
of time in culture. When studying the effects of different growth conditions, we showed that the 
karyotypical instability was not exclusive to a single condition or a combination of conditions, and what is 
more, the karyotypical abnormalities detected were not observed to change the gene positioning of hPSCs 
significantly, with the genome organisation remaining plastic. Finally, our results support a potential 
association of lamin B2 loss and karyotypical instability. We conclude that more sensitive and robust 
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1.1. General Introduction 
 
1.1.1. Definition of Stem Cells 
 
Stem cells are unspecialised cells that can give rise to a range of different cell types through self-renewal. 
Adult stem cells are unspecialised cells that can be found throughout the body in various niches, such as 
the small intestine, colon or bone marrow (Barker et al., 2007; Hérault et al., 2017). Embryonic stem cells 
(ESCs) are derived from the cells of the inner cell mass (ICM) in an early preimplantation embryo or 
blastocyst and can differentiate to form all three germ cell layers – the ectoderm, the endoderm and the 
mesoderm (Figure 1.1). Such cells are known as pluripotent cells, since they give rise to every cell type of 
the body, but not the extra-embryonic membrane or placental tissue. Induced pluripotent stem cells (iPSCs) 
are pluripotent cells made from the reprogramming of differentiated (usually adult) cells and can likewise 
give rise to a range of different cell types (Takahashi et al., 2007).  
 
  
Figure 1.1. Multiple Origins of Human Stem Cells 
Pluripotent stem cells may be derived from several sources and have the ability to differentiate into any 
cell type, with high therapeutic potential. 
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1.1.2. A Brief History of Stem Cells 
 
 The term “stem cells” can be traced back to the late nineteenth century, when a number of notable 
scientists were working on theories to explain the role stem cells played in the human body and 
evolutionarily where they came from (Timeline shown in Figure 1.2). Amongst them was Ernest Haeckel, a 
German biology professor. Haeckel believed that unicellular organisms or protozoa gave rise to 
multicellular organisms and he referred to these cells as “Stammzellen”. He believed that the 
“Stammzellen” formed the evolutionary basis of all plants and animals (all cells “stemming” from one 
source) and compared this theory to the development of an embryo from a single cell to complex 
multicellular organism. Ultimately, in 1877 he proposed that the fertilised egg cell is the origin of all cells in 
the body (reviewed in Maehle, 2011). 
Around the same time August Weismann worked on the theory of the continuity of the “germ plasm”, 
which involved the belief that the nucleus carried hereditary characteristics of the cells. Weissman had an 
assistant Valentin Haecker, who in 1892 published a paper stating stem cells as the common precursor of 
all other cells. The researchers were interested in the “nuclear substance” carrying hereditary information 
and described the distribution and doubling of chromosomes during cell division. Weissman proposed that 
stem cells passed on only a part of the nuclear chromatin to somatic cells (chromatin diminution), thus 
leading to cell differentiation (reviewed in Maehle, 2011). 
In 1909, a Russian scientist Alexander Maksimov declared at the Berlin Haematological Society the presence 
of haematopoietic stem cells or “polyblasts” and that all cells were derived from one common precursor 
cell. Interestingly, Maksimov also mentioned “Stammzellen” in the paper he published with this theory 
(reviewed in Maehle, 2011). 
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Almost fifty years later Frank J. Dixon and Robert A. Moore, together with Leroy Stevens and Clarence Cook 
Little found that 96.5% of testicular tumours had a germinal cell origin (Dixon and Moore, 1953) and in 1% 
of mice, spontaneous testicular teratoma was “undifferentiated, rapidly dividing embryonic-type cells” 
(Stevens and Little, 1954). This indicated that stem cells had a potential to develop into a cancer that could 
form into different types of tissues.  
Throughout the twentieth century, the concept of stem cells gradually became more and more accepted. 
A significant number of studies were being performed with the injection of bone marrow stem cells into 
irradiated mice to successfully treat the destroyed bone marrow in the mice. Finally, in 1958 Georges 
Mathe injected human bone marrow from healthy donors into four patients suffering from radiation 
damage. What was remarkable about this incident was that despite the lack of donor-to-recipient matching 
at the time, all of the patients survived. This was because of the surge of healthy cells from the donors that 
helped the patients overcome their illness, rather than the cells being accepted by the donors. Although 
subsequently the patients did reject the cells, none suffered from graft-versus-host disease (GVHD), where 
the recipient’s immune system attacks the donor’s cells. Unfortunately, four years later when treating a 
leukaemia patient, the results were not as successful, and the patients died of encephalitis, probably due 
to a severe immune response to the foreign tissue (MATHE et al., 1959).  Despite the unsuccessful outcome 
Figure 1.2 Overview of Stem Cell Discovery Throughout History 
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in Mathe’s later patient, this did prompt research to match tissue types between the donors and recipients 
and by 1969, E. Donnall Thomas could successfully treat leukaemia via a matched sibling bone marrow 
transplantation. Eight years later, an unrelated donor was used, and the national registry of bone marrow 
was formed (Thomas and Ferrebee, 1962). This was a ground-breaking development that allowed the 
treatment of many diseases that were previously thought fatal. 
However, it was only in 1998 when John Gearhart and James Thomson both reported the successful 
isolation and on-going culture of human embryonic stem cells from aborted embryos (Shamblott et al., 
1998) and in vitro fertilised embryos (Thomson et al., 1998), respectively. While this phenomenon was a 
huge breakthrough for researchers interested in the potential of embryonic stem cells to cure a wide range 
of difference diseases, some argued that their use was ethically immoral and had a “dark side”, due to 
potential negative outcome from their risk of tumour formation (Kraft, 2011). By 2006, Shinya Yamanaka 
had discovered a way to reprogramme differentiated cells into naïve cells and referred to them as induced 
pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006). This discovery was revolutionary to the 
field, as it removed the ethical concerns associated with the use of human embryonic stem cells by avoiding 
embryo destruction, and also lessened the risk of GVHD if the cells were to ever be used as treatment 
options, as the patient’s own cells could potentially be reprogrammed for therapeutic use. 
Stem cell research in the twenty-first century had not only a colossal impact on the molecular research 
associated with stem cell therapies, but also on the therapies themselves. In 2010, the first trial using 
human embryonic stem cells was conducted on patients suffering from spinal cord injuries (Lebkowski, 
2011) and in 2012 -age-associated macular degeneration, a disease causing blindness (ClinicalTrials.gov, 
2012). Throughout the clinical trials, advancements in the reprogramming of cells, specifically 
transdifferentiation was developed by Marius Wenig’s group (Wernig et al., 2008; Vierbuchen et al., 2010). 
This is where one somatic cell can be transformed into another one by bypassing a step for the 
reprogramming into iPSCs. Similarly, more recently CRISPR-Cas9 has been implemented for chromatin 
modifications to generate pluripotency (Kim, Kang and Ju, 2017). Considering that embryonic stem cells 
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were only successfully isolated twenty years ago, these recent studies are a huge leap forward in the stem 
cell world and hold great promise for the development of future therapies. With such immense therapeutic 
potential, stem cells could be used for tissue engineering of whole organs, negating the lack of present 
organ donors and permitting the development of personalised medicine (Badylak, Taylor and Uygun, 2011). 
Due to their pluripotent properties the stem cell-based treatment of many diseases, such as age-related 
macular degeneration (AMD) (Song et al., 2015), spinal cord injuries (SCI) (Deshpande et al., 2006)  and 
Parkinson’s disease (Bjorklund et al., 2002; Takagi et al., 2005; Grealish et al., 2014; Barker et al., 2016) may 
soon be permitted. 
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1.1.3. Stem Cell Culture Systems 
 
For the cells to be used in the clinic, their culture in the laboratory must be carefully documented and 
moreover, regulated. Human pluripotent stem cells are widely regarded as difficult to culture, due to their 
frequent spontaneous differentiation, user-to-user and/or culture condition-dependent growth i.e. media 
composition and dissociation methods, as well as their extreme sensitivity to other environmental factors, 
such as CO2, O2 and toxin levels (Mohyeldin, Garzón-Muvdi and Quiñones-Hinojosa, 2010; Burgess, 
Agathocleous and Morrison, 2014; Chen et al., 2014; Ito and Suda, 2014). 
Originally, inactivated mouse embryonic fibroblasts (MEFs), bovine serum albumin (BSA), glutamine, amino 
acids and growth factors were used as the feeder layer and supplements during the derivation of the first 
mouse embryonic stem cells (mESCs) (Evans and Kaufman, 1981) and human embryonic stem cells (hESCs) 
(Reubinoff et al., 2000; Zhang et al., 2006). Unfortunately, due the animal derivatives used in the original 
cell culturing methods, today this would not be acceptable for the expansion of potential therapies in 
humans. For example, the animal derivatives carry risk of contamination by mouse retroviruses, 
transmissible spongiform encephalopathies, or can express immunogenic non-human proteins (Martin et 
al., 2005; Wang et al., 2011). All components must fall within stringent regulations of Good Manufacturing 
Practice (GMP) and cell lines must be classified as European Union Tissues and Cells Directive (EUTCD) 
clinical grade lines; with the use of chemically-defined and xeno-free reagents. Nevertheless, MEFs have 
been used extensively in the culture of stem cells, due to their secretion of growth factors that help support 
and maintain them; these include fibroblast growth factors (FGFs), activin A and transforming growth factor 
beta (TGF-β) (Unger et al., 2008; Yoon et al., 2010). Alternative media and matrices must be used that are 
chemically-defined, xeno-free and comply with current regulations and standards, as well as maintain 
pluripotency. With the development of commercial human serum, and later serum-free media, the 
opportunity to generate clinical grade embryonic cell lines for therapeutic application has greatly improved 
(Inzunza et al., 2005; Skottman and Hovatta, 2006). 
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Another issue that requires addressing is the standardisation of the media and/or matrices used in 
embryonic cell culturing systems. Considering only the use of human feeders a variety of different sources 
have proven effective in the maintenance of “stemness” i.e. differentiation potential and pluripotency, 
including foetal muscle (Richards et al., 2002), foetal skin (Richards et al., 2003), adult fallopian tube 
epithelial cells, foreskin fibroblasts (Hovatta et al., 2003), adult marrow cells (Cheng et al., 2003), and adult 
endometrial cells (Lee et al., 2005), many of which have shown to be as capable as MEFs (Eiselleova et al., 
2008) and can additionally successfully support induced pluripotent stem cells (iPSCs) (Unger et al., 2009) 
without altering their gene expression (Stephenson and Braude, 2010). 
A frequently used basement membrane for the growth of pluripotent stem cells is the soluble basement 
membrane extract from Engelbreth-Holm-Swarm mouse tumour, known as matrigel  (Kibbey, 1994). 
Matrigel is a feeder-free matrix and forms a continuous sheet of extra-cellular matrix for the cells, whilst 
maintaining them in their native state over prolonged periods of time (Ludwig et al., 2006). This 
demonstrates the successful use of xeno-free conditions with synthetic matrices for cell culture conditions 
and promotes its use in the future (Klim et al., 2010). Despite the success of using synthetic biomaterials, 
the cost of reagents tends to be too high for most laboratories and compels the ongoing use of MEFs as 
the gold standard basement feeder layer for the growth of research-grade hPSCs (Khadun, 2013).  
Other culture conditions, such as the passaging method, can also have a major impact on the quality of 
cells cultured. Originally, hESC lines were manually cut passage-to-passage by the selection of colonies 
(Thomson et al., 1998; Reubinoff et al., 2000). This method is very labour-intensive and user-dependent. 
Newer methods, such as enzymatic passaging allow much faster cell culture procedures to occur by the 
uniform production of stem cell colonies in larger quantities (Ellerström et al., 2007). Although this method 
would be much more practical for large-scale expansion for potential therapeutic use, the issue of more 
spontaneous differentiation occurring using this method has been raised (Draper et al., 2004; Hasegawa et 
al., 2006; Khadun, 2013), and more importantly, the use of enzymes, such as trypsin and accutase, for 
passaging has found more selective pressure for an increased level of chromosome aberrations 
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accumulating in the hPSCs (Brimble et al., 2004; Buzzard et al., 2004; Draper et al., 2004; Schwartz et al., 
2011; Garitaonandia et al., 2015). This has led to the drive to find more suitable enzymes for the large-scale 
production of hPSCs, but unfortunately has also increased the number of different enzymes available to 
scientists and decreased the level of uniformity in the stem cell community. 
Furthermore, newer methods for the bulk production of hPSCs have been used increasingly in recent years. 
These methods include the use of support matrices in bioreactors , also known as microcarrier suspension 
cultures  (Oh et al., 2009; Gupta et al., 2016), bioreactors (Kehoe et al., 2010; Abraham et al., 2017) and 
likewise CRISPR-Cas9 for disease modelling using hESCs and iPSCs (Budde et al., 2017; Jacobs et al., 2017; 
Kim, Kang and Ju, 2017). The development of such methods increases the potential of treatment for a wide 
range of different diseases and has given rise to a large number of research-grade cell lines, including cell 
lines carrying mutations for neurofibrillin (Hewitson et al., 2016) and cystic fibrosis (Miere et al., 2016).  
With large scale automation becoming a widely accepted next step for downstream processes, the 
characterisation of these cells is vital. Newer methods need to be developed for the sensitive 
characterisation of hPSCs intended for therapeutic use. 
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1.1.4. The Problem with Using Stem Cells 
1.1.4.1. Ethical and Political Issues 
 
 
There are many ethical and political issues surrounding the use of human embryonic stem cells for research. 
The main problem associated with their use is the derivation of pluripotent stem cell lines from embryos, 
which causes the destruction of embryos (Lo and Parham, 2009). For this reason, the use of hESCs in 
potential therapies has been both limited and controversial. Previously, some countries, such as France, 
Germany and Australia have had stringent laws in place that either discourage or completely ban hESC 
research (Holm, 2006; Levine, 2008; Elstner et al., 2009) with Ireland notably banning the use of embryos 
for research completely (EuroStemCell, 2018) 
Similarly, in 2001 the Bush administration in the USA stopped federal funding for embryonic stem cell work 
that left the USA underperforming in hESC research (Seelye, 2001). However, in light of the Obama 
administration, in 2009, new regulations allowed research with previously derived stem cell lines to be 
considered for federal funding (Holm, 2006; Dhar and Hsi-En Ho, 2009; Nasaw, 2009). In addition, James 
Thomson’s (Servick, 2014; Fikes, 2015; Jensen, 2015) patents on the derivation of hESCs has slowed down 
industrial development of hESC use. Although these patents are only valid in the USA, this combined with 
federal funding problems has delayed researchers globally in the development of hESC therapies. 
In the UK, a Steering Committee was established in 2002 to oversee the activities within the UK Stem Cell 
Bank (UKSCB) and any research involved with established hESCs (Medical Research Council, 2018) . The 
committee functions to make sure all proposed research uses cells ethically sourced with appropriate 
donor consent. 
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1.1.4.2. Genomic Instability 
 
 
Both ESCs and iPSCs often accumulate whole chromosome gains and/or losses, also known as aneuploidies. 
These chromosomal abnormalities typically include chromosomes 8, 12, 17, 20 and X, as shown in Figure 
1.3 (Draper et al., 2004; Maitra et al., 2005; Baker et al., 2007; Taapken et al., 2011) and are often recurrent 
after prolonged culturing (Amps et al., 2011).  
 
Figure 1.3. Common Chromosome Gains and/or Losses in hPSCs 
Ideogram demonstrating the common gains and/or losses found in human pluripotent stem cells (Amps 
et al., 2011).  125 human embryonic stem cells and 11 induced pluripotent stem cells from most major 
ethnic groups were analysed across 28 different laboratories worldwide using both cytological and 
sequence-based karyotyping techniques.  
 
This is unlike in live human births, where the most common aneuploidies are the chromosomes containing 
fewer genes i.e. human chromosomes 13, 18 and 21 (Caine et al., 2005), and in spontaneous abortions, 
where the common aneuploidies include human chromosomes 4, 7, 13, 15, 16, 21  and 22 (Fritz et al., 
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2001) (Table 1. 1). Seemingly the aneuploidies accumulating in the hiPSCs in culture are not viable for life 
and are strikingly similar to the aneuploidies that are found in human embryonal carcinoma cells  (hECC), 
with respect to the types of karyotypic changes observed (Summersgill et al., 2001; Reuter, 2005; Harrison, 
Baker and Andrews, 2007) and in gene expression profiles (Sperger et al., 2003), suggesting a tumorigenic 
potential. Furthermore, stem cells with these recurrent gains/losses display growth advantage in culture 
(Peterson and Loring, 2014), signifying that these chromosomes contain critical genes needed for cell 
growth, pluripotency and possibly tumorigenesis. This poses a serious threat to the therapeutic use of ESCs 
and/or iPSCs, as the effects of using genomically unstable stem cells in patients is unknown  (Brimble et al., 
2004; Draper et al., 2004; Peterson and Loring, 2014). 
 
 Cell Type Chromosomal Abnormalities 
Embryonic Stem Cells 1, 12, 17, 20, X 
Induced Pluripotent Stem Cells 1, 9, 12, 20, X 
Human Embryonal Carcinoma Cells 1, 12,17,20, X 
Live Births 13, 18, 21, X, Y 
Abortions 4, 7, 13, 15, 16, 21 and 22 
Table 1. 1 Chromosomal Aneploidies in Specific Cell Types or in Live Births and Abortions 
The table shows in specific chromosome gains and/or losses that occur most commonly in the different cell 
types and in live births and abortions (Fritz et al., 2001; Summersgill et al., 2001; Caine, et al., 2005; Reuter, 
2005; Harrison, et al., 2007). 
 
Currently, it is unknown what effects these aneuploidies may have if cells containing them are administered 
to human patients. It has been proposed that the possibility of a malignant transformation of the cells and 
then unregulated proliferation could limit their use for future therapies (Herberts, Kwa and Hermsen, 
2011). An issue that is particularly important to address is the risk of transplanting hPSCs into individuals 
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without being able to control their self-renewal capacity (Kanemura et al., 2014).  It has already been 
demonstrated when using murine mesenchymal stem cells (MSCs) that aneuploidy from prolonged cell 
culture can lead to malignant transformation in vivo (Miura et al., 2006). This could, in turn, lead to 
devastating consequences if patients were injected with unstable differentiated cells derived from hPSCs. 
Tumour development from non-host origin has been reported after the injection of karyotypically normal 
neural stem cells into an ataxia telangiectasia patient (Amariglio et al., 2009), however many details of the 
procedure had not been disclosed and  it was thought that an extensive enough characterisation of the 
transplanted cells did not occur (Baker, 2009). Additionally the DNA integrity of iPSCs potentially used for 
patients is of concern (Yang et al., 2008; Bai et al., 2013). This is due to the reprogramming methods used 
for iPSC, particularly the use of the oncogene, C-MYC, where the chances of insertional mutagenesis and 
the inhibition of proto-oncogenes could lead to malignant transformation (Bai et al., 2013);  Furthermore, 
it has been reported that somatic cells with pre-existing chromosomal mutations limited the 
reprogramming of the cells to iPSCs (Yang et al., 2008). 
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1.1.5. Nuclear Architecture 
 
 
The nucleus is the organelle that protects the genetic material of the cell, as well as regulate several 
different functions, including DNA replication and repair, gene expression and apoptosis. Because of the 
range of different functions, the nucleus is organised in a highly-ordered way with a number of different 
compartments, such as the nucleolus, genome and nuclear envelope, which contains many different 
proteins that make up the nuclear architecture. Nuclear structure maintains the integrity and genomic 
health of nuclei and allows them to function efficiently. Disruption to any of these nuclear components has 
been associated with many different diseases or nucleopathies (Gruenbaum et al., 2003; Bridger et al., 
2014). 
The eukaryotic cell nucleus is separated from the cytoplasm by a complex barrier, known as the nuclear 
envelope, which is made up from a number of different parts, including the nuclear membrane, the nuclear 
lamina and finally, the nuclear pore complexes. The nuclear membrane is a double-layered membrane, 
where the outer membrane is a continuation of the endoplasmic reticulum, whereas the inner membrane 
faces the interior of the nuclei. The nuclear membrane contains a collection of over sixty-seven integral 
membrane proteins (IMPs), such as emerin, lamin B receptor, MAN1, nesprins, barrier to autoinegration 
factor (BAF) and SUN proteins (Schirmer et al., 2003). These proteins, in turn, help tether the nuclear lamina 
to the nuclear envelope and support the interaction of IMPS, chromatin-binding proteins and chromatin or 
DNA to each other (Bridger and Bickmore, 1998; Gruenbaum et al., 2003; Zastrow, Vlcek and Wilson, 2004; 
Bridger et al., 2007). 
The inner nuclear membrane has a role in the maintenance of nuclear morphology (Bridger et al., 2007) 
and is scattered with multiple nuclear pore complexes, which allow the selective movement of molecules 
in and out of the nucleus  (Goldberg, 2004). The nuclear membrane also has functions in the regulation of 
gene expression in different tissues and in chromatin organisation (Dechat et al., 2008). The nuclear lamina 
is a meshwork of type V intermediate filament proteins or “nuclear lamins” (Fisher, Chaudhary and Blobel, 
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1986; Gerace and Burke, 1988). The lamins contain an α-helical rod domain with a globular N-terminal head 
at one end and a C-terminal tail domain on the other (Strelkov et al., 2004); this shape helps the lamins 
form polymers that arrange the lamin meshwork (Figure 1.4). For lamins to form a layer between chromatin 
and the inner membrane of the nuclear envelope, a basic structure is assembled using the lamin 
monomers. The lamins, first, dimerise via their α-helical rod domain (Strelkov et al., 2004; Dechat et al., 
2010; Dittmer and Misteli, 2011) and then, with these dimers form head-to-tail interactions with multiple 





Figure 1.4. The Formation of Lamin Filaments 
Cartoon representation of two parallel lamin monomers that can dimerise through coiled-coil interactions 
in their rod domains. The dimers then form head-to tail interactions to assemble polymers, which further 
associate side-by-side with other polymers to form lamin filaments (Dittmer and Misteli,2011; Gruenbaum, 
et al., 2003). 
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1.1.6. Lamin Genes, Expression and Disruption 
 
Humans have three lamin genes, LMNA, LMNB1 and LMNB2, which code for seven different lamin proteins. 
LMNA encodes the A-type lamins, lamin A, AΔ10, C and C2 (Fisher, Chaudhary and Blobel, 1986; McKeon, 
Kirschner and Caput, 1986; Lin and Worman, 1993; Furukawa, Inagaki and Hotta, 1994; Machiels et al., 
1996). Lamins A and C are alternate splicing forms of the LMNA gene with the former having ninety-eight 
additional amino acids (Berrios and Fihser, 1986) and the latter, six unique amino acids at its C-terminal 
end (Fisher, Chaudhary and Blobel, 1986; McKeon, Kirschner and Caput, 1986). Lamin AΔ10 is identical to 
Lamin A, however it has exon 10 completely spliced out (Machiels et al., 1996; Broers et al., 2006), and 
Lamin C2 is a form of lamin A that lacks in the head and coil regions of lamin A and is found only in germ 
line cells (Furukawa, Inagaki and Hotta, 1994; Peter and Stick, 2012). Lamin B1 is a product of the LMNB1 
gene, whereas lamins B2 and B3 are splice variants of LMNB2 (Pollard et al., 1990; Biamonti et al., 1992; 
Stuurman, Sasse and Fisher, 1996).  
A-type lamin expression is developmentally regulated, therefore changes with differentiation (Lehner et 
al., 1987; Rober et al., 1989; Riemer et al., 1995). Lamin AΔ10 is expressed in very low levels in all cell types, 
whereas lamins A and C are expressed in both early and late embryos (Schatten et al., 1985; Stewart and 
Burke, 1987; Houliston et al., 1988; Foster et al., 2007; Malhas et al., 2007), however not in blastocytes 
(Schatten et al., 1985; Stewart and Burke, 1987). B-type lamins, however, are expressed in most somatic 
cells in both adults and embryos (Vergnes et al., 2004). Lamin C2 is expressed in the testis and during 
meiosis (Furukawa, Inagaki and Hotta, 1994; Alsheimer and Benavente, 1996), whereas lamin B3 is 
expressed only in sperm cells and oocytes  (Furukawa, Inagaki and Hotta, 1994). 
All of the lamin precursor mRNAs, except lamin C, contain a CaaX motif at the C-terminal end that allows 
farnesylation to occur via the enzyme farnesyltransferase. Lamin C does not undergo any post-translational 
modifications. Following this, both A-type and B-type lamins have been observed both at the nuclear 
periphery and as foci in the nucleoplasm. The distribution of lamin proteins in the nucleus can differ with 
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the cell cycle. For example, during the early G1 phase A-type lamins appear as foci, however with the S-
phase the lamin foci disappear (Bridger et al., 1993).  
In human and mouse ES cells, the presence of lamins B1 and B2 was observed, an essential part of all cell 
types, however lamin A/C was absent in the nuclear periphery of ES cells (Constantinescu et al., 2006) 
(Constantinescu et al., 2006) and has been observed to completely disappear with successful 
reprogramming of iPSCs (Mattout, Biran and Meshorer, 2011). In addition, lamin A/C was found to 
accumulate with the downregulation of OCT4, a hallmark of cells differentiating (Constantinescu et al., 
2006) The absence of lamins A/C has been suggested to contribute to the ESC genome plasticity compared 
to the more rigid state of somatic cell chromatin (Meshorer and Misteli, 2006). Lamins A/C associate with 
the nuclear envelope, heterochromatin and histones. As heterochromatin is often found at the nuclear 
periphery and can associate with lamins A/C, it is possible that with differentiation the accumulation of 
lamins A/C causes more association with chromatin and therefore more binding with lamin- associated 
proteins. This complex interaction of chromatin and the "nuclear wall", compromised of lamins and lamin-
associated proteins, may compromise how "rigid" the chromatin within differentiated cell nuclei is. 
Moreover, in ESC nuclei because there is less of this interaction, the chromatin would be less restricted in 
movement (Meshorer and Misteli, 2006; Meshorer et al., 2006; Morris, Kelly, Chotalia and Pombo, 2010). 
Furthermore, increase in lamin A has been linked to higher stability against nuclear rupture and increase in 
nuclear “stiffness”. Such findings suggest that cell types with low levels of lamin A are more prone to nuclear 
stress and therefore more likely to have disruptions in chromosome territory arrangements (Swift, et al., 
2014).  
Lamin A directly regulates the binding of lamina-associated domains (LADs), associating the nuclear 
membrane to heterochromatic regions of the nucleus. This implies a role of lamin A in epigenetic 
regulation. Physical regulation of LADs is linked to tissue stiffness in different cell types. Additionally, lamin 
A knockdown affects the SRF pathway that promotes expression of abundant actin-myosin cytoskeletal 
components involved in the differentiation of cells (Swift and Discher, 2014). The SRF pathway is partially 
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regulated by nuclear actin (Olson and Nordheim, 2010; Baarlink, Wang and Grosse, 2013), which binds to 
lamin A (Simon, Zastrow and Wilson, 2010) and other proteins associated with lamin A, such as emerin 
(Simon, Zastrow and Wilson, 2010). This would suggest a functional role of lamin A in the indirect regulation 
of the differentiation of cells via an inhibitory effect on nuclear actin and myosins. 
A-type lamins have been observed to associate with chromatin histone, DNA replication sites and RNA 
splicing speckles (Muralikrishna et al., 2001; Zastrow, Vlcek and Wilson, 2004; Broers et al., 2006). In 
addition, A-type lamins binds to nuclear proteins, such as emerin, lamina-associated protein 1 (LAP1), 
lamina-associated protein 2 (LAP2), lamin B receptor (LBR), nesprins, MAN1 and telomeres (Worman et al., 
1988; Shoeman and Traub, 1990; Dechat et al., 2000; Sakaki et al., 2001; Mansharamani and Wilson, 2005). 
Although it has not been clearly identified whether A-type and B-type lamins interact with each other, it 
has been suggested that B-type lamins are important for the structural organisation and maintenance of 
A-type lamins within interphase nuclei (Shimi et al., 2008). As lamins are involved a number of functions 
within cells, potential mutation or disruption to the lamin protein expression could lead to the 
misregulation of many different activities and thus, also contribute or causes disease. 
The abnormal expression of A-type lamins has been associated with increased tumour progression in 
diseases, such as small cell lung cancer, testicular germ cell tumours, Hodgkin’s disease, skin cancers and 
in leukaemia (Kaufmann et al., 1991; Kaufmann, 1992; Machiels et al., 1997; Oguchi et al., 2002; Burke and 
Stewart, 2006). Mutations in exon 11 of the LMNA gene can cause the most common form of Hutchinson-
Gilford Progeria Syndrome (HGPS), a disease causing premature aging, disrupted heterochromatin 
formation, increased apoptosis and abnormally-shaped nuclei (De Sandre-Giovannoli et al., 2003; Bridger 
and Kill, 2004; Scaffidi and Misteli, 2005; Capell and Collins, 2006).   
Conversely, B-type lamin expression is thought to be essential for survival in-vivo (Vergnes et al., 2004), 
although a study had found that in ESCs it is not required for the maintenance of pluripotency and self-
renewal (Kim et al., 2011). B-type lamins’ differential expression has been linked to nuclear rotation, mitotic 
spindle defects (Tsai et al., 2006), gene silencing (Peric-Hupkes and van Steensel, 2010) and senescence 
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(Shimi et al., 2011). More recently Lamin B2 disruption has been linked to aneuploidy formation and 
changes to chromatin organisation (Ranade et al., 2017). 
Nuclear lamin disruption has often been linked to abnormal nuclear morphology and genomic instability. 
In breast cancer cells, A-type lamins are often lost completely or may be expressed heterogeneously with 
many cells experiencing mitotic arrest, enlarged nuclei and chromosome aneuploidies, such as 
chromosome X gains (Capo-chichi et al., 2011). Ovarian cancer cell lines had shown similar results with 
lamin A/C loss leading to aneuploidy; these cells shown increased p53 and p21 protein levels, however the 
authors were not able to conclude whether the aneuploid cells with loss in both A-type lamins and p53 
would permit cell survival (Capo-chichi et al., 2011).  
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1.1.7. Genome Organisation 
 
 
Chromosomes are organised into discrete compartments, known as chromosome territories (Cremer and 
Cremer, 2001) within interphase nuclei and are conserved throughout different species (Marshall et al., 
1996; Bridger and Bickmore, 1998; Parada and Misteli, 2002; Tanabe et al., 2002; Foster, Griffin and 
Bridger, 2012). This organisation is influenced by the chromosome  gene density and the guanine-cytosine 
(GC)content (Dietzel et al., 1998; Visser and Aten, 1999; Bridger et al., 2000; Boyle et al., 2001; Cremer and 
Cremer, 2001; Federico et al., 2006; Meaburn and Misteli, 2007), transcription (Volpi et al., 2000; Mahy et 
al., 2002; Mahy, Perry and Bickmore, 2002), differentiation (Cremer and Cremer, 2001; Parada, McQueen 
and Misteli, 2004; Wiblin et al., 2005; Meshorer and Misteli, 2006; Szczerbal, Foster and Bridger, 2009; 
Fraser, Ferrai, et al., 2015) and, in addition, can be altered  due to disease (Cremer et al., 2003; Meaburn 
et al., 2007; Mehta et al., 2011), upon  infection (Knight et al., 2011; Arican-Goktas et al., 2014), and serum 
removal (Mehta et al., 2010). In addition, the organisation of specific genes can change with gene 
expression, with genes able to loop out from their chromosome territories (Volpi et al., 2000; Christova et 
al., 2007). 
Conversely, mESC nuclear architecture and positioning of the chromosomal territories is suggested to have 
a certain flexibility in specific location (Meshorer and Misteli, 2006), presumably in order to allow global 
gene activity to function whilst remaining pluripotent and maintaining self-renewal capacity. This has been 
supported by findings of an accumulation of heterochromatin concomitantly with differentiation 
(Francastel et al., 2000), which implies that chromosome location is at least partially controlled through 
epigenetic regulation of chromatin modelling. Indeed, as shown in Figure 1.5, differentiation-dependent 
chromatin modifications occur in cells with an increase in silenced chromatin markers and a decrease in 
active chromatin markers (Keohane et al., 1996; Lee, Hart and Skalnik, 2004; Meshorer et al., 2006), 
suggesting ESC chromatin to be more open or plastic (Lee, Hart and Skalnik, 2004; Meshorer and Misteli, 
2006).  
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However, a gene-density radial distribution of chromosome territories has also been observed in hESCs 
(Wiblin et al., 2005; Bártová et al., 2008) and in human blastomeres (Finch et al., 2008), although gene-rich 
chromosomes 17 and 19 were positioned more centrally in granulocytes when compared to ESC (Bártová 
et al., 2001).  Despite this, after differentiation, chromosome 17 positioning in pluripotent and somatic cells 
was the observed to be similar (Wiblin et al., 2005; Bártová et al., 2008). However, a variation in centromere 
positioning (Wiblin et al., 2005; Bártová et al., 2008) and in the pluripotency gene, NANOG (Wiblin et al., 
2005) was observed. In normal somatic cells centromeres are mostly, but not exclusively, found nearer to 
the nuclear periphery (Shelby et al., 1996) or around the nucleoli (Bridger et al., 1998; Carvalho et al., 2001; 
Weierich et al., 2003; Gilchrist et al., 2004), although changes to their spatial arrangement may relate to 
Figure 1.5. Nuclear Architecture and Genome Organisation in Somatic Versus Naïve Cells 
The inner blue circle represents A type lamins, whereas the outer circle represents B type lamins. 
Histone modification markers associated with silenced chromatin, such as H3K9me3 and H3K29me3 
are shown as purple and blue cylinders throughout the chromatin. The pluripotent cell in A depicts the 
lack of these histone markers in comparison to the differentiated cell shown in B. The image was 
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the stage of cell cycle and gene expression (Ferguson, Ward and Manueiidis, 1992; Weimer et al., 1992; 
Hulspas et al., 1994; Janevski, Park and De Boni, 1995). Unlike somatic cells ES centromere clusters are 
usually positioned towards the nuclear interior, however after differentiation the centromeres arrange 
themselves towards the nuclear periphery (Bártová et al., 2008; Butler et al., 2009) or around the nucleoli 
(Bártová et al., 2008). Similar centromere arrangements have been demonstrated in human B and T 
lymphocytes (Skalníková et al., 2000). This rearrangement may be due to heterochromatic regions 
containing more inactive genes and therefore being anchored to the nuclear periphery. 
Embryo genome activation (EGA) occurs during embryonic development at a time when maternal 
transcripts and proteins are being degraded and embryonic transcripts start synthesis. This period in 
development is known as the maternal-to-embryonic transition (MET) is initiated at different times 
dependent on species (Braude, Bolton and Moore, 1988; Sirard, 2012). In humans this occurs at the four-
to-eight-cell stage (Braude, et al., 1988). As development proceeds, different genes become activated at 
specific time points and chromatin can rearrange itself to aid this process (Graf et al., 2014). In bovine cells, 
the gene-dense Bos taurus autosome (BTA) 19 and gene-poor BTA 20 chromosome territories positions 
change after EGA. Prior to EGA a peripheral, radial distribution of both chromosomes was present (Graf et 
al., 2014). However, post-EGA the organisation of chromosome territories shifted to a more gene-density-
related radial distribution (Koehler, et al., 2009). This suggests that EGA could also affect hESC chromosome 
territory positioning. Additionally, a factor that may contribute to the different chromatin organisation 
patterns is the different transcription patterns between ESC and somatic cells. This is supported by the 
findings from Koehler, 2009, where ESCs splicing factors were distributed through the nuclei and after 
differentiation became more concentrated into distinct areas and is consistent with data suggesting that 
hESC nuclei are more plastic than somatic cells (Koehler et al., 2009). 
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1.1.8. Mechanism of Aneuploidy Formation in Human Pluripotent Stem Cells 
 
To maintain genomic integrity, it is essential that with each cell division the distribution of DNA in each 
daughter cell is equal. Unfortunately, how exactly aneuploidies come about in human pluripotent stem 
cells is still unknown. I discuss several different mechanisms that could lead to the formation of the gain or 
loss of whole chromosomes and discuss the genomic abnormalities that could contribute to aneuploidy 
formation. 
1.1.8.1. Mitotic Segregation Defects 
 
Telomeres are repetitive nucleotide sequences found at the end of chromosomes to prevent chromosome 
end-to-end fusions that can result in chromosome instability (CI). In hESCs, the telomerase enzyme is active 
to maintain the length of telomeres length and in iPSCs, telomerase is re-activated after reprogramming 
and the process of telomere lengthening begins (Marion et al., 2009; Takahashi et al., 2007; Takahashi and 
Yamanaka, 2006). Anaphase bridges or chromatin bridges occur when two end-to-end fused chromosomes 
are being pulled apart by opposing mitotic spindle fibres, attached by the kinetochores during anaphase 
and a chromatin bridge still links the two daughter cells. Although the formation of anaphase bridges does 
occur in healthy cells (Baumann et al., 2007; Chan, North and Hickson, 2007), it is strongly associated with 
the erosion of telomeres (Tusell et al., 2010), as end-to-end fusions of chromosomes causes breakage-
fusion-bridge (BRB) cycles, resulting in CI (DePinho, 2000; Gisselsson et al., 2001; Hackett, Feldser and 
Greider, 2001). 
Normally, telomeres shorten as a result of each cell division and in stem cells telomerase is active to ensure 
the maintenance of telomere length, however, telomerase activity has been implicated in tumorigenesis 
(Shay and Wright, 2010). Telomeric sequences are associated with a group of proteins- TRF1, TRF2, RAP1, 
POT1, TIN1, and TIN2, collectively known as the shelterin complex (Liu et al., 2004). The disruption of these 
proteins can cause fragile sites, contributing to DNA replication defects (Sfeir et al., 2009), anaphase bridges 
(Bunch et al., 2005; Nera et al., 2015) , fusions (Pardo and Marcand, 2005) and the activation of DNA 
damage responses (Palm and de Lange, 2008). A recent study has shown that overexpression of telomeric 
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protein TRF1 in mouse embryonic stem cells can cause anaphase bridges to form (Lisaingo, Uringa and 
Lansdorp, 2014), and thus highlights the importance of telomere protection via telomeric proteins in 
embryonic stem cells.  
On occasion, not all parts of the chromatid sisters are resolved together, due to segregation issues from 
the lack of a kinetochore attachment to the mitotic spindle and one daughter cell can end up with the other 
daughter cell’s chromosome, resulting in an aneuploidy in both new cells. How the mitotic spindles 
assemble in hPSCs in relatively unknown, however spindle defects, such as asymmetric orientation, have 
been linked with carcinogenesis in Drosophila (Caussinus and Gonzalez, 2005; Castellanos, Dominguez and 
Gonzalez, 2008) and in gut epithelial stem cells (Quyn et al., 2010). A balance of symmetric or asymmetric 
cell divisions are necessary for normal development and tissue homeostasis, however abnormal 
proliferation can occur and  the cells may become tumourigenic (Noatynska, Gotta and Meraldi, 2012). 
Alternatively, lagging chromosomes from the mitotic spindle detachment or the bipolar orientation of 
chromatids (Cimini et al., 2002) could instead form a separate compartment of chromatin from the nucleus. 
Atelometric and acentric, whole or fragment chromosomes can become micronuclei (Cimini, Tanzarella 
and Degrassi, 1999; Minissi et al., 1999; Norppa and Falck, 2003) or double-minute (DM) chromatin, where 
small fragments of amplified genes occur extra-chromosomally during tumorigenesis (Haaf and Schmid, 
1988; Itoh and Shimizu, 1998). Although nuclear contents may be lost in this manner, they can also be 
engulfed or taken back into the nucleus that lost them (Minissi et al., 1999). Micronuclei or DMs can appear 
as a result of replicative stress and sometimes still remain transcriptionally active, albeit reduced (Hoffelder 
et al., 2004; Utani, Kawamoto and Shimizu, 2007), with occasional nuclear lamin expression (Tanaka and 
Shimizu, 2000), that coincides with upregulated transcription (Utani, Kawamoto and Shimizu, 2007) . 
Interestingly, the micronuclei that did form a  nuclear lamina were also able to start DNA replication (Tanaka 
and Shimizu, 2000), implicating a function of lamins in DNA replication. It is currently unknown how exactly 
micronuclei can contribute to the overall phenotype of the cell, especially due to their lack of nuclear 
trafficking and reduced transcription (Hoffelder et al., 2004), but the reduction of amplified genes found in 
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micronuclei increased the radiation sensitivity of cancer cells (Sanchez, Barrett and Schoenlein, 1998; 
Schoenlein et al., 2003). Cells with micronuclei often underwent abnormal mitosis and had elevated levels 
of apoptosis (Utani et al., 2010). In mouse embryonic stem cells, an increase in micronuclei formation and 
apoptosis  was observed with the downregulation of the pluripotency marker Oct4 (Zhao et al., 2014), 
suggesting that compromised cell culture techniques could, in fact, directly affect the genomic instability 
of stem cells. Since stem cells have an increased rate of proliferation for the maintenance of their self-
renewal capacity (White and Dalton, 2005; Neganova and Lako, 2008), this could be a factor contributing 
to their genomic instability via the formation of micronuclei (Stopper et al., 2003). For example 
differentiation of embryonic stem cell to neural progenitor cells causes nearly a two-fold increase in 
micronuclei formation and an increase in CI (Sartore et al., 2011).  
1.1.8.2. DNA Damage 
 
As double-stranded breaks (DSBs) are considered the first causative damage associated with chromosome 
abnormalities, which can further lead to formation of tumours (Pandita and Richardson, 2009), the 
chromosomal instability of hPSCs are of high concern. Despite elevated rates of apoptosis and 
hypersensitivity to apoptosis in ESCs (Dravid et al., 2005; Lin et al., 2005; Nagaria et al., 2016), the apoptosis 
inhibitor protein, survivin, often associated with polyploidy development (Li et al., 1999) and increased 
expression in cancerous cells (Altieri, 2003), is also expressed in high levels in ESCs (Mull, et al., 2014). This 
suggests that apoptosis alone is not enough to stop the accumulation of aneuploidies in hPSCs. However, 
it is well known that during development, blastocysts must go through many cell divisions very quickly, 
suggesting that perhaps the cells have to compromise on their DNA proof-reading machinery in order to 
achieve this. This is supported by the shortened G1 phase of ESCs (Becker et al., 2006; Ghule, et al., 2008), 
exposing them to higher replicative errors. Furthermore, studies in hESC p53-p21 pathways have shown 
that during stress stimuli, the cell cycle regulator, p21, mRNA is upregulated in hESCs, however no p21 
protein is detected (Dolezalova, et al., 2012). During DNA damage in ESCs, p53 binds directly to NANOG’s 
promoter, supressing it and promoting ESC differentiation (Bradner, 2010). If the p53 levels are reduced, 
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the levels of spontaneous differentiations are also reduced. (Qin, et al., 2007). It seems that in hiPSCs DNA 
damage does not give rise to single-stranded DNA regions, with the cells, thus not activating checkpoints 
and not permitting DNA repair to occur (Desmarais et al., 2012), despite there being elevated gene 
expression levels of DNA repair genes (Momcilovic et al., 2010).  
Furthermore, hiPSCs have been found to be deficient in intra-S checkpoints and also in G2/M decatenation 
or chromatin dis-entanglement preventing delayed entry of inappropriately condensed chromosomes into 
mitosis and permitting the formation of anaphase bridges (reviewed in Lamm, et al., 2016). Topoisomerase 
II allows the chromatin decatenation to occur in G2 to delay mitosis and to allow smooth sister chromatid 
segregation (Uemura et al., 1987; Holm, Stearns and Botstein, 1989). When the decatenation checkpoint 
is disrupted entangled chromosomes segregate and can form aneuploidies (Gorbsky, 1994; Andoh and 
Ishida, 1998). Chromosome decatenation deficiency has been reported in mouse ESCs and human 
multipotent progenitor cells, however improved decatenation was observed with cell differentiation 
(Damelin et al., 2005).  The reason behind such entanglement of ESC chromatin may be due to the lack of 
higher chromatin organisation in nuclei. ESC nuclei lack chromatin silencing markers, such as H3K9, H3K27. 
Open chromatin in hPSCs with the dispersed presence of the DNA damage marker, gamma-H2AX (γ-H2AX) 
in hESCs (Meshorer et al., 2006), suggests a more exposed, and therefore more vulnerable chromatin. The 
plasticity of the chromatin state may be one of the reasons for the increased genomic instability of hPSCs 
when grown in vitro. This is, however, debatable as no additional protection of heterochromatin in 
comparison to euchromatin has been observed from the reactive oxygen species (ROS) induction of double-
stranded breaks (DSBs) (Woodbine et al., 2011), since lower levels of Ataxia-telangiectasia mutated 
kinase (ATM) phosphorylation in iPSCs have been previously reported in cells treated with low levels of 
radiation, alongside hypersensitivity to apoptosis (Nagaria et al., 2016). The exact role of ATM in DNA 
damage  is still unknown, but it has been suggested to be preferentially required in the DNA damage repair 
of heterochromatin (Goodarzi et al., 2008). As hPSCs lack the presence of heterochromatin (Francastel et 
al., 2000; Meshorer and Misteli, 2006), the reduced levels of ATM phosphorylation (Nagaria et al., 2016) 
would suggest to not have a significant effect on the genomic integrity of the cell. However, ATM-deficient 
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iPSCs were less efficient in reprogramming and influenced the appearance of genomic variation (Marión et 
al., 2009; Kinoshita et al., 2011; Lu et al., 2016). 
It should be highlighted that ATM phosphorylates a number of proteins, related to apoptosis, cell cycle 
checkpoints and DNA repair (Lee and Paull, 2007), therefore its potentially reduced role in hPSCs should be 
carefully considered.  Similarly, Artemis, an endonuclease associated with non-homologous end-joining 
(NHEJ) is required for the maintenance of genomic stability (Woodbine et al., 2011), but its absence from 
cells did not impair myeloid differentiation, reprogramming  or show significant of genomic instability 
(Felgentreff et al., 2014). 
Human pluripotent stem cells are known to accumulate gains and/or losses of whole chromosomes (Draper 
et al., 2004; Maitra et al., 2005; Baker et al., 2007; Taapken et al., 2011), often showing signs of growth 
advantage (Enver et al., 2005; Baker et al., 2007), making them similar to cancerous cells (Baker et al., 
2007). This cultural adaptation can occur, due to specific gene amplifications and a candidate driver 
mutation suggested in hPSCs is found in BCL2L1, located on chromosome 20. BCL2L1 is associated with 
anti-apoptotic properties (Boise et al., 1993; Amps et al., 2011; Avery et al., 2013; Na et al., 2014), which is 
a hallmark of cancer (Herszfeld et al., 2006; Yang et al., 2008; Avery et al., 2013). The knock-down of BCL2L1 
did diminish the growth advantage effect (Avery et al., 2013). Other candidate genes suggested include 
genes found on chromosome 12, such as pluripotency –related genes NANOG, DPPA3 and GDF3, oncogene 
KRAS and cell cycle regulator CCND2 (Na et al., 2014), on chromosome 17, such as BIRC5(SURVIVIN) (Na et 
al., 2014), which is associated with ploidy development (Li et al., 1999). Another candidate mutation could 
be with the oncogene PTEN, which is found on chromosome 10, associated with many different cancers 
(Jemal et al., 2004; Takei et al., 2008).  
1.1.8.3. Bystander Effect 
 
Another possible mechanism of the process of aneuploidy accumulation is not well understood. Cells could 
accumulate an aneuploidy and then via a bystander effect the aneuploidies start accumulating in 
neighbouring cells. Such mechanisms have been observed with radiation-treated cells causing cell 
  Chapter I: General Introduction
  
 
27 | P a g e  
 
senescence in neighbouring cells (Nelson et al., 2012), increased sister chromatid exchange (Nagasawa and 
Little, 1992; Deshpande et al., 1996), increased p53 expression (Hickman et al., 1994; Azzam et al., 1998), 
and most importantly chromosomal instability (Lorimore et al., 1998; Sawant et al., 2001). This instability 
is probably observed due to the reactive oxygen species (ROS) produced from the radiation (Yamamori et 
al., 2012) causing DNA damage to occur (Yermilov et al., 1996; Balasubramanian, Pogozelski and Tullius, 
1998).  
A similar effect has been observed with Enterococcus faecalis, an intestinal bacterium, where the 
production of ROS molecules can induce CI in human cells with defects in mismatch repair (Huycke et al., 
2001; Huycke, Abrams and Moore, 2002; Wang et al., 2008). Although this theory needs to be investigated 
further, it is well established that ROS and nitrogen species from both radiation and metabolism can cause 
oxidative stress that can lead to DNA damage and senescence in cells (Lindahl, 1993; Suh et al., 1999; Geiszt 
et al., 2000). Moreover, it may be the case with hPSCs that if one event triggers an aneuploidy to occur, a 
bystander effect could then cause neighbouring cells to also acquire aneuploidies.  Alternatively, this may 
due to stem cells often being grown on a layer of inactivated feeders; the feeders would be under stress 
and could potentially cause a stressful environment to the stem cells. Mitomycin C (MMC) is used to treat 
the feeder cells that hESCs are grown on. This treatment can affect the neighbouring stem cells and 
potentially cause or promote the generation of aneuploidies in culture. This is supported by the increased 
levels of micronuclei observed (Asur, Thomas and Tucker, 2009), alongside increased homologous 
recombination (Rugo et al., 2005) and changes in the expression of mitogen-activated protein kinase 
(MAPK) target genes (Asur et al., 2010).  
It has been previously proposed that the increased age of cells and the amount of ROS are linked (Finkel 
and Holbrook, 2000). As human pluripotent stem cells are metabolically very active and can be maintained 
in cultures for long periods of time, the increased age and the fast metabolism required in these cells could 
also be an aspect that factors in the genomic instability often observed. In contrast, it has been reported 
that both high levels and low levels of ROS can impair the reprogramming ability of cells into iPSCs (Zhou 
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et al., 2016) and elevated levels can impair their differentiation ability as well (Rönn et al., 2017). These 
studies suggest that optimal levels of ROS may be required for the cells to grow stably in culture.  
1.1.8.4. Nuclear Lamin Depletion 
 
LMNA mutations cause impaired differentiation of adult stem cells (Gotzmann and Foisner, 2006; Pekovic 
and Hutchison, 2008; Scaffidi and Misteli, 2008), altered signalling pathways in mesenchymal stem cells 
(MSCs; Espada et al., 2008; Meshorer and Gruenbaum, 2008; Scaffidi and Misteli, 2008; Hernandez et al., 
2010) and MSC death (Halaschek-Wiener and Brooks-Wilson, 2007; Meshorer and Gruenbaum, 2008; 
Prokocimer et al., 2009).  
In contrast, Lamin B1 and B2 knock-out does not affect the differentiation of blastocysts, but does affect 
organogenesis in mice (Coffinier et al., 2010; Kim et al., 2011) and mitotic spindle orientation and formation 
(Tsai et al., 2006; Ma et al., 2009; Kim et al., 2011). This suggests that B-type lamins would have a functional 
role in making sure chromosomes are efficiently segregated during mitosis. This correlates with findings of 
Lamin B2 depletion being associated with aneuploidy formation, prolonged mitosis and formation of 
anaphase bridges (Kuga et al., 2014; Ranade et al., 2017).  
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1.1.9. Aneuploidy Detection Methods 
 
 
For human pluripotent stem cells to become a common available therapy, scientists must be able to screen 
the cells intended for therapeutic use. One of the criteria for this screen is the ability to sensitively and 
accurately assess their karyotype. Currently, G-banding is a common technique used by clinical 
cytogenetics for the prenatal diagnosis of aneuploidies and structural rearrangements in foetuses and 
many different assays are currently on the market for aneuploidy detection. However, each platform, 
whether cytological or sequence-based, has its advantages and disadvantages with regards to sensitivity, 
resolution, turnover time, cost and staff requirement. 
 
1.1.9.1. Quantitative Fluorescence Polymerase Chain Reaction 
 
Quantitative fluorescence polymerase chain reaction (QF-PCR) is a technique that utilises multiple short 
tandem repeats (STRs) of the common aneuploidies, such as trisomy 13, 18 and 21 and sex chromosome 
aneuploidies to amplify the regions of interest. The method allows the multiplexing of different 
fluorescence intensities produced from the PCR, resulting in a fast method for chromosome copy number 
detection. The method can use different samples of origin, such as amniotic fluid, chorionic villus, foetal 
blood, postnatal blood and foetal tissue and had been demonstrated to be 99.2% accurate for whole 
chromosome aneuploidy (Cirigliano et al., 2004; Ogilvie et al., 2005) and 20-30% mosaicism detection 
(Donaghue et al., 2005). QF-PCR has been reported to be a much cheaper and faster alternative to other 
assays and many laboratories have now replaced traditional fluorescence in-situ hybridisation with QF-PCR 
(Shaffer, 2007).  Unfortunately, like many assays the limitation of QF-PCR is the inability to detect balanced 
chromosomal translocations. 
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1.1.9.2. Multiplex Ligation-Dependent Probe Amplification  
 
Multiplex Ligation-Dependent Probe Amplification (MLPA) is an assay designed to detect gene dosage 
abnormalities by utilising up to 45 different DNA sequences. Rather than amplify the nucleic acids in the 
sample, the technique amplifies the probes that are added to the sample; the amplification depends on 
the presence of specific sequences in the sample. The probe intensities are quantified and the whole 
experiment typically takes 2-3 days (Sellner and Taylor, 2004; Shaffer, 2007). Like QF-PCR, MLPA cannot 
detect structural aberrations.   
1.1.9.3. DNA Microarrays 
 
DNA microarrays use a panel of DNA sequences that compare the copy number of each area of interest to 
a control; this, then calculates the gene copy number of the sample (Shaffer, 2007). The advantage of DNA 
microarray is the ability to construct the target molecules, although most commonly the pre-designed, 
commercially- available Agilent microarray platforms for Array Comparative Genomic Hybridisation (aCGH) 
are used. The technique can detection DNA dosage imbalances, such as aneuploidies, deletions and 
duplications with a high resolution, dependent on the target of interest and is a much faster approach than 
methods, such as FISH, due to the high-throughput data produced. Typically, DNA microarrays can only 
detect 10-25% of mosaicism (Lu et al., 2007; Manning et al., 2010; Novik et al., 2014; WiCell, 2017; Xiang 
et al., 2008). 
Similarly, another commonly used kit, albeit with less DNA targets, bacterial artificial chromosomes-on-
beads (BoBs™) is a novel easy to use method for the detection of aneuploidies utilising sequences attached 
to beads from bacterial artificial chromosomes (Choy et al., 2014). The limit of all the microarray assays, 
however, is the inability to detect chromosomal rearrangements. In addition, for the detection of low level 
aneuploidies approximately 25% of cells must be aneuploid (Novik et al., 2014). 
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1.1.9.4. Fluorescence in-situ Hybridisation 
 
Fluorescence in-situ Hybridisation (FISH) is a technique that uses target-specific probes that are 
fluorescently labelled for the copy number identification of whole chromosomes or genes (Bridger and 
Volpi, 2010). FISH can be used in cells that are in both metaphase and interphase and be multiplexed i.e. 
multicolour FISH (mFISH) or spectral karyotyping (SKY FISH) to look at the whole genome karyotype. The 
limitation of FISH is that it is labour-intensive and has a lower resolution in comparison to novel methods 
that utilise hundreds or thousands of target molecules, however unlike those methods FISH can detect 
structural rearrangements of the genome and mosaicism (Hultén, Dhanjal and Pertl, 2003).  
1.1.9.5. G-banding 
 
An older method and one that is still used as the gold standard in clinics today is traditional karyotyping by 
G-banding. G-banding uses the staining of dark and light bands in metaphase spreads to distinguish 
between the different chromosomes (Hultén, Dhanjal and Pertl, 2003). Unfortunately, despite its common 
use in clinics, this method is highly labour-intensive and time-consuming, due to the difficulty in sample 
analysis; trained cytogenetics are required. In addition, a small number of metaphase spreads are usually 
analysed, which does not pose a problem during the presence of whole population chromosomal gains and 
losses, however for mosaicism it may not be an appropriate method of analysis, as it is not an accurate 
representation of the whole cell population in the sample. G-banding has been estimated to detect 5-10 % 
of mosaicism in cell culture (Baker, et al., 2007). 
To summarise, currently there are a limited number of methods that are regularly used for the monitoring 
of genomic instability of human pluripotent stem cells. However, current methods are either labour-
intensive, require specialist training or expensive, as well as not sensitive for the detection of low-level 
mosaicism that is common occurrence in hPSCs. New methods need to be developed and optimised for 
the detection of genomic instability in cells intended for therapeutic use. 
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The aim of this project is to develop a rapid and sensitive assay for the detection of chromosomal 
aneuploidies utilising ddPCR™. To characterise the impact of chromosomal abnormalities in the nuclei, 
fluorescence in-situ hybridisation will be used to map and compare the gene loci positioning in diploid and 
aneuploid nuclei of karyotypically stable lymphoblastoid cell lines. 
Lamin pattern analysis, as well as gene and protein expression levels will be monitored in the diploid and 
aneuploid nuclei of the karyotypically stable lymphoblastoid cell lines. Lamins A, C, B1 and B2 levels will be 
assessed and compared in the different cell lines to detect any significant differences. 
In addition, human pluripotent stem cells will be used to monitor the genomic stability, to map gene loci 
positioning in the nuclei to assess the significance of different media and matrices, as well as the effect of 
passage number. Pluripotency and lamin gene expression levels will be measured to observe any deviations 
with the different cell culture conditions. Finally, RNA-Seq will be used to investigate the global gene 
expression changes and the different up- and down-regulated pathways in the different cell lines and 
conditions. 
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2.1.1. Digital Polymerase Chain Reaction 
 
Digital polymerase chain reaction (dPCR) is a sensitive assay for the absolute quantification of target nucleic 
acids in a sample (Vogelstein and Kinzler, 1999). Digital PCR works by the separation of a sample into a large 
number of partitions and in principle, each partition would contain either one or zero copies of the target 
molecule allowing the increased sensitivity in the detection of the target molecule. In droplet digital PCR 
(BioRad ddPCR™), after the sample partitioning with all necessary PCR components, such as primers, 
probe(s), and mastermix, PCR is performed in the optimal conditions for each specific amplicon and the 
amplicons are either hybridised with fluorescent TaqMan™ probes or labelled by the incorporation of a 
DNA-binding dye, EvaGreen®, to allow the detection of specific sequences. The droplets are then 
individually passed through a fluorescence detector in a ddPCR™ droplet reader and scored as either 
positive or negative for each fluorescence channel. For the TaqMan™ method two different fluorophores 
can be used to tag the probes, allowing a duplex reaction (Figure 2.1). However, to increase the number of 
detectable targets in a PCR reaction, Taqman™ probes can be manipulated in different concentrations to 
label more than two different target molecules; this allows researchers to multiplex for more than 2 targets. 
Using Poisson statistics, ddPCR™ is then able to determine the initial concentration of the input sample. 
For example, the human diploid genome is typically 6.6pg and thus for a 40ng genomic DNA (gDNA) input, 
approximately 6060.6 diploid genomes or 12,121.2 gene copies are found in a 20μl reaction volume 
(assuming 2 gene copies/genome). This, in turn, would mean that for a wild-type sample, two copies of 
genes in 40ng of a 20µl reaction, the expected concentration output from ddPCR™ is 606.6 gene copies/μl, 
whereas for one copy of a gene, 303.3 copies/μl would be expected. If the 20µl reaction was partitioned 
into 20,000 droplets, the gene copies per droplet (CPD) is calculated as (12,121.2 gene copies/20,000 
droplets) 0.606 CPD. However, in reality, the random partitioning of ddPCR™ leads to the uneven 
distribution of gene copies and the droplet occupancy is not uniform with some droplets containing more 
than one gene copy, alongside those with either zero or one copies. To solve this problem in the absolute 
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quantification of target molecules, Poisson statistics are used. Poisson statistics utilises the number of 
negative droplets and makes a correction for droplets that contain more than or less than 1 target copy. 
As a result, the absolute quantification of the original amount of target genes is possible.  
Even when the number of copies per droplet is equal to 1 gene copy, the fraction of positive droplets (p) is 
still 0.606. For this reason, loading too much DNA, or in some cases where the abundance of the target is 


















Figure 2.1. Schematic Representation of ddPCR™ 
The formation of droplets, the enrichment of target molecules following thermocycling conditions, 
droplet reading, and finally, ddPCR™ analysis (BioRad, 2018). 
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The sensitivity of dPCR™ is up to 0.001% of mutation detection, this puts dPCR sensitivity to 1000 times 
higher than quantitate PCR, qPCR; (Hindson et al., 2011). It is also more accurate at low template copy 
number measurement (Hindson et al., 2011), does not require external standard optimisation between 
laboratories or standard curves generated relative to reference samples (Bhat et al., 2010), has reduced 
sensitivity to PCR inhibitors (Dingle et al., 2013) and the quantification is absolute. Unlike qPCR, dPCR does 
not measure target presence via cycle threshold, but through end-point quantification (Strain et al., 2013), 
therefore making it a much more suitable assay for the detection of rare mutations. 
A number of mutation detection assays have been developed by measuring the fluorescence intensity of a 
mutant sequence in parallel with a wild-type sequence (Pohl and Shih, 2004).  dPCR can be used to detect 
mutations, copy number variations in specific genes with amplifications or deletions and quantify specific 
nucleic acid sequences (Miotke et al., 2014), however it is unable to detect balanced translocations. 
With the purpose of being able to readily identify chromosomal aneuploidies in ESC culture, it was 
necessary to develop and optimise a sensitive molecular technique. dPCR is a novel technique that due to 
its ability to provide absolute quantification of a sample may be able to deliver accurate results for the 
detection of aneuploidies. The advantage of dPCR is its ability to detect a rare DNA sequence or mutant 
gene in a large background of wildtype DNA, or alternatively, the ability to detect small changed in the gene 
copy numbers. However, for this to occur a “normal” or stable/control gene needs to be used in 
conjunction with the mutant gene (or the gene being quantified) to see whether their relationship changes 
compared with normal cells or tissues. Firstly, the normal tissue or cells need to be monitored and their 
ratio described (Hindson et al., 2011; Heredia et al., 2013). This could allow the development of a more 
sensitive method for the detection of stem cell aneuploidies in culture. 
The detection of rare events, such as single nucleotide polymorphisms (SNPs), opens up the opportunity to 
allow clinicians fast and sensitive diagnosis of many diseases. For example, most tumours, including small 
ones, have a common characteristic of allelic instability (AI), which has been found very early during 
colorectal neoplasia (Pohl and Shih, 2004). The earlier the detection of such diseases occurs, the better the 
outcome of treated patients. Similarly, this could perhaps occur in stem cells, where instead of spontaneous 
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accumulation or loss of chromosomes in culture, stem cells in vitro always have some degree of genomic 
instability, but it was not possible to detect it due to the absence of high sensitivity detection assays. 
Since the development of personalised medicine for treating patients with specific drugs for their 
disease/disorder type, the need for sensitive high-throughput tests to monitor mutation levels in the 
patient has become increasingly necessary. For example, in the treatment of leukaemia patients with 
Imatinib, BCR-ABL mutation levels are regularly monitored (Zagaria et al., 2015). Routine screening in 
colorectal and non-small-cell lung cancer patients is now performed for EGFR, PIK3CA and KRAS with the 
choice of chemotherapeutic drug dependent on the test outcome (Eberhard, Giaccone and Johnson, 2008; 
Normanno et al., 2009; van Eijk et al., 2011).  So far a number of assays have been developed to detect 
gene mutations, such as BRAF (Reid et al., 2014), BAT26 (Traverso et al., 2002), and EGFR (Zhu et al., 2015) 
for a range of different diseases.  
Digital PCR suggests encouraging new alternatives to many current invasive diagnostic methods, including 
the ability to analyse foetal DNA in the mother’s blood and DNA from apoptosing or necrosing tumour cells  
in circulating blood (Hindson et al., 2011; Reid et al., 2014). Although dPCR sounds like an ideal monitoring 
assay for patients that require sensitive screenings for common cancer-associated genomic variants, the 
disadvantage of dPCR is that it would require a very large sample size from cell-free DNA (cfDNA). This is 
because you would need 50000 gene copies to reach a 99% probability that the sample will contain at least 
1 mutant copy (1 SNP in 10000 wild-type sequences). In a healthy individual there are approximately 1000 
copies per milliliter (mL) of cell-free DNA in the plasma. For it to be possible to find 1 SNP in 1000 wild-type 
sequences (or in 50000 gene copies) it would require 50mL of patient blood (Huggett, Cowen and Foy, 
2014), possibly an impractical method for clinical use. However, the potential of dPCR remains, as its 
applications for the monitoring of donor DNA in recipient patients for organ/tissue transplants. Shotgun 
Next Generation Sequencing (NGS) has already been performed to try and predict cellular rejection of the 
graft by observing the amount of donor specific DNA in the patients receiving heart transplants (Snyder et 
al., 2011), an area where dPCR may be more suitable. Similarly, trisomies in circulating foetal DNA in 
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maternal blood or specific SNPs that affect drug metabolism can be detected by dPCR and used by clinicians 
(Ouahchi, Lindeman and Lee, 2006; Wang, McLeod and Weinshilboum, 2011).  
As chromosome abnormalities, such as trisomies, account for a significant number of miscarriages and 
stillbirths (reviewed in Fan et al., 2009) and current diagnostic methods, including karyotyping cells derived 
from the chorionic villus and/or amniotic fluid take 1-2 weeks, this prompts the need for more rapid, 
sensitive, diagnostic methods. ddPCR™ has already been applied in the detection of aneuploidies from 
chorionic villi or amniotic fluid samples. A dPCR screening for common aneuploidies, specifically for 
trisomies 13 (Patau Syndrome), 18 (Edwards Syndrome), 21 (Down Syndrome), X and Y aneuploidies (XXY 
(Klinefelter Syndrome), XYY, and X0 (Turner Syndrome) was performed (Fan and Quake, 2007; Lo et al., 
2007; Fan et al., 2009) and chromosome 1 was chosen as a reference target, due to its lack of aneuploidy 
in ongoing pregnancies. This particular study, however had used traditional karyotyping to find 
chromosome 1 as a stable chromosome, which is not likely to be sensitive enough (Lathi, Westphal and 
Milki, 2008).  
ddPCR™ is a much more powerful tool for the detection of chromosome aneuploidies because of the speed 
results can be obtained (within approximately six hours) compared with other current techniques. It does 
not require trained cytogeneticists, unlike for the analysis of FISH cell karyotypes, and is not as labour-
intensive (Hultén, Dhanjal and Pertl, 2003; Dudarewicz et al., 2005). Additionally the sensitivity of the 
ddPCR™ is much higher compared with current methods used for aneuploidy detection, such as array-
based comparative genomic hybridisation (aCGH), traditional karyotyping, FISH and qPCR (Baker et al., 
2007).  
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The aim of this chapter was to investigate the sensitivity of the ddPCR™ platform in the detection of 
aneuploidies in a background of wild-type DNA. The study was designed to optimise the ddPCR™ system 
via different DNA treatment methods, assessing different fluorophore intensities and finally the limit of 
detection for aneuploidies.  
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2.3 Methods and Materials 
2.3.1. Cell Culture and Methodology 
 
Eight human cell lines were used: four diploid lymphoblastoid cell lines (two male and two female) and 
three aneuploid lymphoblastoid cell lines (Table 2.1). Lymphoblastoid cells were cultured in RPMI-1640 
medium (Sigma, UK) supplemented with 10% (v/v) Foetal Calf Serum (FCS; Sigma) and 5% (v/v) L-glutamine 
(Sigma) in a 5% CO2 atmosphere at 37⁰C. Medium was changed approximately every four days and the cells 
were split once a week. To freeze the lymphoblastoid cells for different cell banks, a freezing solution was 
made comprised of 10% Di-Methyl Sulfoxide (DMSO; Sigma-Aldrich) and 20% FCS in RPMI-1640 (Sigma). 
Cells were counted using a manual haemocytometer, pelleted and then the freezing solution was used to 
re-suspend 5 million cells in 1mL in each cryo-vial. The cryo-vials were then placed in a “Mr Frosty” freezing 
container (ThermoFisher Scientific, UK) with iso-propanol and transferred to a -80⁰C freezer for 1-2 days 
before storage in liquid nitrogen. 
Additionally, all cell culture samples were routinely tested for Mycoplasma (testing performed by Julia 
Sung, NIBSC) and sterility testing of cell cultures using tryptone soya broth, thioglycolate medium and 
sabouraud dextrose broth was carefully monitored for any contamination (testing was performed by the 
Microbiology Service Laboratory, NIBSC). 
2.3.2. DNA Extraction 
 
The lymphoblastoid cell lines were grown in large quantities to create single DNA stocks. Cells were cultured 
to approximately 70% confluency, harvested, washed in PBS and a cell count performed to produce cell 
pellets of a minimum of 2-5 x 106 cells that were stored at -80⁰C. Pellets were then thawed in a 37⁰C 
waterbath and vortexed briefly to resuspend the cells in the residual supernatant. 10ml of Cell Lysis Solution 
(Qiagen, UK) was added to the cell pellet and dispersed by pipetting. This was followed by the addition of 
50μl RNase A Solution (Qiagen) and mixing by inverting the tube. The pellet was then incubated at 37⁰C for 
30 minutes. Next, 3.5ml Protein Precipitation Solution (Qiagen) was added, the tube was vortexed 
vigorously and the sample was then centrifuged at 2500 x g for 10min. The supernatant containing the DNA 
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was decanted into a new tube containing 10ml 100% iso-propanol (Sigma) and gently inverted. The sample 
was centrifuged again at 2000 x g for 3min to form a pellet, the supernatant discarded, and the tube drained 
on a clean absorbent tissue. This was followed by the addition of 10ml 70% (v/v) ethanol (Sigma) and tube 
inversion to wash the DNA pellet. The sample was centrifuged again at 2000 x g for 1min, the ethanol was 
removed carefully and the tube was inverted and placed on a clean absorbent tissue to allow the pellet to 
air-dry for up to 6h. DNA Hydration Solution (Qiagen) was added to the tube and then the tubes were 
placed on a low speed blood wheel overnight at room temperature (RT) to allow good mixing of the DNA 
and DNA Hydration Solution. DNA at 1000μg/μl or more was stored at 4⁰C, whereas lower concentrations 
of DNA were stored at -20⁰C.  
For DNA extraction from blood samples from MCWES01 and MCWES02 donors, a Blood and Cell Culture 
Mini Kit (Qiagen) was used; the blood was from normal healthy donors. To start the QIAGEN Genomic-tip 
20/G was equilibrated with 1ml Buffer QBR and allowed to flow through the column by gravity. The blood 
samples were vortexed, thoroughly applied to the column and once more allowed to flow through by 
gravity. The column was washed three times with 1ml Buffer QC and then eluted with 1ml Buffer QF. Buffer 
QF, 1ml, was added a second time to the column to collect a maximum yield of DNA from the blood 
samples. 1.4ml of RT iso-propanol was then added to the eluted DNA, the tube was inverted and then 
centrifuged at 5,000 x g for a minimum of 15min at 4⁰C. The supernatant was carefully removed, and the 
pellet allowed to air-dry for 5-10min. The DNA was then re-suspended in TE, usually 30μl, and then allowed 
to mix overnight on a blood wheel and subsequently stored at -20⁰C. 
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2.3.3. DNA Quantification and Quality Monitoring  
 
For DNA quantification a Qubit 2.0 Fluorometer (Thermo Fisher Scientific, UK) was used, a Nanodrop ND-
1000 (Thermo Fisher Scientific) was used to check the purity of the sample, and a TapeStation bioanalyser 
(Agilent Technologies, UK) or agarose gel was used determine the DNA integrity. The Qubit was chosen for 
the DNA quantification, due to increasing amount of literature suggesting the Qubit is a more accurate DNA 
quantification instrument than the Nanodrop, as the latter overestimates the amount of DNA  present in a 
sample (O’Neill et al., 2011; Sironen, Uimari and Vilkki, 2011; Simbolo et al., 2013). 
For agarose gel electrophoresis, 1-2% (m/v) agar was dissolved completely in TAE (40 mM Tris at pH 7.6, 
20 mM acetic acid and 1 mM EDTA) buffer by heating. The mixture was allowed to cool, 1:10000 SybrSafe® 
(ThermoFisher Scientific) was added, the mixture was poured into a gel tank and allowed to set. TAE buffer 
was then added to the gel tank, the samples were added to the gel wells and were resolved at 100V until 




Lymphoblastoid cultures were grown until approximately 60-70% confluency. Fresh media was added and 
the cells in the flask were sent for karyotyping (The Doctors Laboratory, UK). FCWES01, FCWES02, 
MCWES01 and MCWES02 were sent at passages 14, 11, 13 and 11, respectively.  
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2.3.5. DNA Fragmentation 
 
In order to improve the droplet segregation and distribution on the 2-D plot of the ddPCR™, DNA was 
fragmented using different treatments. This would potentially improve the efficiency of the assay by 
making sure the ddPCR™ experiment was working optimally. 
2.3.5.1. Enzyme Treatment 
 
Restriction enzyme digestion was considered in order to break down any clumps in the chromatin that may 
hinder the formation of droplets for ddPCR™ and furthermore prevent the binding of primers and probe to 
our gene of interest.  
For enzymatic treatment of DNA before ddPCR™, restriction enzymes EcoRI, BstYI and BtgI (NEB, UK) were 
used with the CutSmart Buffer (NEB) for varying amounts of time. The mixtures were incubated at each 
enzyme’s optimal temperature according to the manufacturer’s guidelines. The size of the DNA fragments 
produced by the BstYI and BstgI digestion are shown in Table 2.2. 
For pre-digested DNA i.e. DNA digestion before use in ddPCR™, typically, 1000μg of DNA was digested with 
5 Units (U) of enzyme in a total volume of 50μl. For “in-tube digestion” of the DNA, x0.25 units (U) of BstYI 
was used with x0.025 of the CutSmart Buffer in the ddPCR™ mix, which included the primers, probes and 
mastermix.   To the check the efficiency of the restriction enzyme digestion, the DNA was initially run on a 
1% (g/v) agarose gel  
2.3.5.2. DNA Sonication 
 
DNA was sonicated for varying periods of times and at different amplitudes using the Branson 450D 
sonicator (BRANDSON Ultrasonics Corporation, USA). Sonication fragments DNA randomly, as unlike in 
restriction enzyme digestion, sonication does not target specific DNA sequences and therefore, there will 
be a great distribution of fragment sizes. The sonication, however, also allows droplets in the ddPCR™ to 
form more readily around the DNA fragments. 
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The DNA samples were then resolved on an agarose gel to visualise the fragments produced from the 
sonication. For this both the ProMega-Markers® Lambda Ladder (Promega) and the GelPilot 500Bp Ladder 
(Qiagen) were used. Additionally, to quantify the DNA fragments a TapeStation (Agilent Technologies, UK) 
was used with either a Genomic DNA Analysis ScreenTape and, correspondingly, the Genomic DNA 
Reagents, or the High Sensitivity DNA ScreenTape with the High Sensitivity DNA Reagents.  
 
Figure 2.2. Schematic Representation of the Different restriction digestion Sites and resulting 
Fragment Sizes 
The different gene restriction sites and the fragments produced from the digestion with BstYI (purple) and 
BtgI (black) enzymes are shown for the four genes analysed in this study. All of the DNA fragments for genes 
AMELX (blue), AMELY (blue), ALB (red) and RPP30 (green) were 2000-4000bps long; the amplicons for these 
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Table 2.1 Characterisation of cell lines.  
The table describes the different cell lines used in this chapter, their genotypes and origin. The wild-type cell lines were provided by NIBSC, whereas the aneuploid cell 






Cell line  Species  Age at Sampling Origin  Karyotype Source  
FCWES01 Human  Unknown  Female lymphoblastoid cell line 46,XX[8]/46,XXad(12)(q24.3)[2](performed by TDL; see Appendix I) NIBSC 
FCWES02 Human  Unknown Female lymphoblastoid cell line 46, XX (Performed by TDL; see Appendix I) NIBSC  
MCWES01 Human  Unknown Male lymphoblastoid cell line 46,XY,?inv(6)q25.2q25.3)(Carried out by TDL; see Appendix I) NIBSC 
MCWES02 Human  Unknown Male lymphoblastoid cell line 46, XY ( Performed by TDL; see Appendix I) NIBSC 
DD0567 Human 1 Year and 11 Months Female lymphoblastoid cell line 47,XXX,t(8;10)(q22.1;24.1)de novo (provided by ECACC) ECACC 
DD0710  Human  19 Years and 10 Months Male lymphoblastoid cell line. Patient diagnosed with Klinefelter Syndrome 47,XXY (Provided by ECACC) ECACC 
DD1473  Human  18 Years and 17 Months Female lymphoblastoid cell line. Patient diagnosed with developmental delay 48,XXXX (Provided by ECACC) ECACC 
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2.3.6. Droplet Digital™ PCR (ddPCR™) 
 
The QX200 ddPCR™ system (BioRad, UK) was used for the ddPCR™ experiments according to the 
manufacturer’s guidelines. ddPCR™ can be used to monitor copy number variation (CNV) by selecting 
two genes from specific chromosomes segments and then observing the ratio between these two 
genes.  
All primers were HPLC-purified and “lab-ready” (Integrated Device Technology, USA), whereas probes 
were ordered from Thermo Fisher Scientific, with ddPCR™ Supermix for Probes or ddPCR™ Supermix 
for Probes (no UTPs) used as the master mix (BioRad). The exact concentration of reagents used in each 
ddPCR™ experiment is shown in Table 2.2 and the sequence of the primers and probes for AMELX, 
AMELY and ALB are shown in Table 2.3. The probes used are TaqMan® MGB (minor groove binder) 
probes incorporating a 5' reporter and a 3' non-fluorescent quencher (NFQ). The AMELX and AMELY 
primer and probe sequences, as well as the PCR conditions, were established by our collaborators at 
the Anne and Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg 
School of Medicine, Chicago (George et al., 2013). During this study, this group (Lawrence Jennings et 
al.) had kindly sent us a sonicated sample of male DNA and their primers and probes to test on our 
ddPCR™ machine. 
Firstly, a 20µl reaction mixture was added to each well in the droplet cartridge (reaction mixture details 
are shown in Table 2.2), followed by 70µl ddPCR™ droplet generator oil. A gasket was then used to seal 
the cartridge, which was placed in the droplet generator (BioRad). Once in the droplet generator the 
PCR mix, and oil are drawn to form approximately 20,000 droplets suspended in emulsion. This 
emulsion was transferred into a 96-well PCR plate (BioRad) and sealed with foil in a thermal plate sealer 
(BioRad). Latterly the manual generation of droplets was replaced with the QX200 AutoDG, an 
automated droplet generator which automatically places the droplets into a 96-well plate. This required 
an increase in reaction mixture from 20µl to 22µl. The sealed plates are then placed in a thermocycler 
(BioRad), and PCR performed according to Table 2.4, with the total volume set at 35μl and the lid 
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temperature at 105⁰C.  After the PCR amplification, the plate was transferred to a droplet reader 
(BioRad), which scanned each droplet and measured each droplet’s fluorescence to classify it as positive 
or negative accordingly.  
Additionally, the housekeeping gene Albumin (ALB) was selected as the reference gene in our duplex 
assay, due to being on a “stable chromosome” in hESCs i.e. Chromosome 4. In hPSCs, aberrations of all 
chromosomes, except chromosome 4 has been reported (Amps et al., 2011); the area of the gene that 
was amplified in the PCR was not found listed as a “micro-instability” in the Supplementary Data from 
the International Stem Cell Initiative, 2011. RPP30 or ribonuclease P/MRP 30kDa subunit, a BioRad 
recommended reference gene, located on chromosome 10, was also tested as a potential candidate 
reference/control gene. The primer/probe mix was ordered from BioRad. 
Before use all primers and probes for each gene and genes in combination with each other in duplex 
reactions were tested on a temperature gradient to make sure there was a clear discrepancy between 
a positive and a negative signal. For AMELX and AMELY, this was performed at 55-65⁰C by Dr Jennifer 
Boyle (NIBSC). For all other genes and their combinations, this was performed at 55-62⁰C. For all duplex 
reactions 59⁰C was selected as the temperature for DNA annealing and elongation. 
 





Forward (F) Primer 900μM 
Reverse (R) Primer 900μM 
Probe 250μM 
Master Mix (MM) 2X 
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Table 2.3. ddPCR™ Primer and Probe Design for Amelogenin  X and Y 
AMELX/Y Forward Primer CCCTGGGCTCTGTAAAGAATAGTG 
AMELX/Y Reverse Primer CAGGCTTGAGGCCAACCAT 
AMELX Probe ATCCCAGATGTTTCTCAA 
AMELY Probe CATCCCAAATAAAGTGGTT 
ALB Forward Primer GCTGTCATCTCTTGTGGGCTGT 
ALB Reverse Primer AAACTCATGGGAGCTGCTGGTT 




Table 2.4 ddPCR™ Thermocycler Set-up 
 Temperature (⁰C) Time (Minutes) Process 
Step 1 95 10 DNA Denaturation 
Step 2 95 0.2 DNA Denaturation 
Step 3 59 1 Annealing and DNA amplification 
No Extension 
Go to Step 2 X 39 
Step 4 98 10 Enzyme denaturation and droplet 
hardening 
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2.2.6.1. ddPCR™ Sensitivity vs qPCR Sensitivity 
 
To determine the sensitivity of the ddPCR™, several ddPCR™ experiments were performed. Firstly, female 
DNA, FCWES02, was titrated into male DNA, MCWES02, in 6.25% increments (Table 2.5) by the addition 
of two extra X chromosomes (female DNA) to the XY (male DNA).  The sample started with a normal male 
sample i.e. 50% X chromosome/AMELX and the female DNA (100% X chromosome/AMELX) was titrated 
in 6.25% increments for the range of titrated samples to finally reach a fully diploid 100% female.  
 
Table 2.5. Titration of Wild-type Female DNA in Wild-Type Male DNA in 6.25% Increments 
 
Sample 
% of gDNA Volume of gDNA (μl) 
Total X Total Y Female DNA Male DNA 
1 50 50 0 100 
2 56.25 43.75 12.5 87.5 
3 62.5 37.5 25 75 
4 68.75 31.25 37.5 62.5 
5 75 25 50 50 
6 81.25 18.75 62.5 37.5 
7 87.5 12.5 75 25 
8 93.75 6.25 87.5 12.5 
9 100 0 100 0 
 
 
2.3.7. Data Analysis and Bio-Informatics Tools 
 
NEBCutter Tool (NEB) was used to determine restriction enzyme cutting sites and fragment sizes. 
All ddPCR™ data were extrapolated from the Quantasoft software Version 1.7.4.0917 (BioRad); the 
thresholds for the ddPCR™ plots were set manually. Additionally, the ddPCR™ 2-D plots show the raw 
data of the positive and negative droplets, however the ratio and fractional abundances shown in the 
Quantasoft software are values derived from Poisson corrections. The qPCR data was extrapolated 
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using the MxPro – Mx3000P software Version 4.00 (Agilent Technologies).  For statistical analysis 
GraphPad Prism 5.0 was used. 
For the statistical analysis of significance from a single sample, assuming the data was of normal 
distribution, a one sample t-test was used. For the statistical analysis of significance from two samples, 
a two-sample t-test was used. If the aim was to find whether one sample was greater than the other, 
then a one-tailed t-test was performed. If the aim was to find whether any significant difference was 
observed between two samples, then a two-tailed t-test was performed, but the type of two-tailed t-
test was dependent on whether the two samples had equal or unequal variances.  To see whether the 
difference between the variances of two samples was significantly different, a two-tailed F-test was 
performed. The greater value of the standard variation from one sample is divided by the smaller value 
of the standard variation from the other sample to get an F value. Using the degrees of freedom, the F 
critical value from an F-table is then compared to the calculated F value. If the F value is greater than 
the F critical value, then the variances of the two samples are significantly different; the t-test would 
have to be adjusted accordingly.  
To test whether there is a significant difference between more than two groups a one-way analysis of 
variance (ANOVA) was performed.  To look at which groups specifically showed statistical significance 
between each other a follow-up Tukey’s Multiple Comparison Test was used.  Both tests assume a 
normal distribution of the data analysed.  
If the data was from two groups that tested samples analysed with two different methods, then a paired 
t-test was used, assuming the data had normal distribution.  A symbol, such as an asterisk (*) was 
assigned to depict statistical significance on a graph between two samples; Table 2.6 shows each 
symbol according to the P values for t-tests and ANOVAs. 
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Table 2.6. P Values and Symbols for Statistical Significance  
P value Wording Summary 
< 0.001 Extremely significant *** 
0.001 to 0.01 Very significant ** 
0.01 to 0.05 Significant * 
≥ 0.05 Not significant ns 
 
Additionally, linear regression was used to analyse whether a line indeed fit the data; Significance of F, 
residual plots and R2 values were also derived.  
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To investigate the sensitive detection of aneuploidies in a background of wild-type DNA, the model cell 
lines, lymphoblastoid cells were used for the optimisation. In a normal male diploid genome, there is 
one copy of chromosome X and one copy of chromosome Y, therefore one copy of AMELX and one 
copy of AMELY. When using primers and probes against these two genes a 50:50 ratio should 
theoretically exist, and we can see this in several different ways on the BioRad ddPCR™.  
Firstly, a temperature gradient experiment of 55-65°C was performed to observe the quality of droplet 
segregation in the ddPCR™ (Figure 2.3) and to be confident that the signals’ fluorescence is well-
separated from the background fluorescence. The data shows that for  AMELX and AMELY that the ideal 
droplet segregation was approximately 56-60°C; 59°C was selected as the optimal temperature, which 
coincided with out collaborator’s optimal temperature (George et al., 2013). 
The Quantasoft software allows us to view the data in a 1D (Figure 2.4) or 2D plot (Figure 2.5), where 
the blue or green scatters signify droplets positive for one particular gene target, whereas the orange 
scatter signifies droplets in the sample that were positive for both genes. The grey scatter displays the 
negative droplets (Figure 2.5). 
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Using Poisson statistics, the Quantasoft software can calculate the ratio of the positive droplets from 
the two channels or genes (Figure 2.6). The extrapolated data can then be converted as the fractional 
abundance of each gene. Fractional abundance for FAM or VIC is calculated by dividing the 
concentration of Channel1/Channel2 by the sum of concentration of Channel 1 and Channel 2, this is 
then multiplied by 100 (Figure 2.7). 
65         64.4       63.1      61.2       59        57.1      55.8       55 
A 
B 
Figure 2.3. Quantasoft 1-D Plot of AMELX/AMELY Temperature Gradient 
A temperature gradient from 55⁰C to 65⁰C for AMELX, shown in blue (A) and AMELY, shown in green 
(B), the negative droplets are shown in black. The arrows highlight 59⁰C on the Quantasoft 1-D plot. 
The pink link shows the manual threshold calling for the separation of positive and negative droplets. 
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To ensure the data derived are accurate, a 1-D plot may also be used; this demonstrates appropriate 
droplet segregation from the background fluorescence and avoids false negative or positives (Figure 
2.4).  
 
Figure 2.4. Quantasoft 1-D Plot Example 
A screenshot of the 1-D plot from the BioRad Quantasoft software. The DNA that was run was 
not treated with any enzymes or sonication. AMELX is labelled on FAM (Channel 1), whereas 
AMELY on VIC (Channel 2); the FAM and VIC signal are shown separately compared to the 
background fluorescence, the black line underneath the blue and green signals and the peaks for 
each of the signal’s fluorescence. The small peaks on the right are the positive droplets, whereas 
the left peaks are the negative droplets. The two left peaks in FAM signify potential bleed -
through from the VIC channel. The plot represents four replicates of a male sample. All thresholds  
were called manually. 
 
Figure 2.5. Establishment of AMELX and AMELY in the ddPCR™ Assay 
A screenshot of the 2D plot from the BioRad Quantasoft software. The DNA that was run was not 
treated with any enzymes or sonication. AMELX was labelled with FAM, whereas AMELY with VIC; 
the plot represents four replicates of a male sample, MCWES02. The black points on the plot 
represent negative droplets, the blue points are positive droplets on the FAM channel, the green 
– VIC channel and the orange points represent droplets that are positive for both the FAM and 
VIC channels. 
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Figure 2.6. Quantasoft Gene Ratio Example Screenshot 
The Quantasoft software graph depicts the ratio of the positive droplets between two channels in a 
sample. The example above shows the ratio of AMELX to AMELY in four wells of the ddPCR™ run. AMELX 
was in the FAM channel and AMELY was in the VIC channel. Male sample, MCWES02 was used; the 





Figure 2.7. Quantasoft Gene Fractional Abundance Example Screenshot 
The Quantasoft software graph depicts the fractional abundance of the positive droplets between two 
channels in a sample. The example above shows the fractional abundance of AMELX to AMELY in four 
wells of the ddPCR™ run. AMELX was in the FAM channel and AMELY was in the VIC channel. Male 
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2.3.1. Titration of Female DNA into Male DNA in 6.25% Increments 
 
To test the linearity of the ddPCR™ machine the change in fractional abundance was monitored (Figure 
2.8). We observed a statistically significant difference between all of the different samples from Figure 
2.8; a one-way ANOVA and Turkey’s Multiple Comparison Test were used. The R2 value was 0.999 
showing a strong linear regression. 
 
Figure 2.8. Quantasoft Gene Fractional Abundance Screenshot 
The Quantasoft software graph depicts the fractional abundance of the positive droplets between two 
channels in a sample. The example above shows the fractional abundance of AMELX to AMELY in four 
wells of the ddPCR run. AMELX was in the FAM channel and AMELY was in the VIC channel. A significant 
difference between each of the different samples was observed using an ANOVA and Tukey’s Multiple 
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2.3.2. Enzyme Digestion  
2.3.2.1. Use of Different Types of Enzymes 
 
As mentioned before the results obtained from the ddPCR™ can be shown in 2-D plots (Figure 2.5).  In 
an attempt to try and cluster droplets more closely together in the quadrant of the 2-D plot, the 
ddPCR™ DNA was digested with BstYI and EcoRI enzymes before being added to the ddPCR™ mix. Both 
BstYI and EcoRI enzymes produced similar fragments sizes on AMELX and AMELY (fragment sizes were 
determined using the NEBCutter tool (Figure 2.2). Difference in ratio and in droplet numbers produced 
between the control (undigested DNA) and digested DNA from MCWES02 with either EcoRI or BstYI 
would be observed. For these four replicates were used and then merged to produce a single average 
result.  
In Panel A, the double-positive droplets are scattered quite randomly without a specific central cluster 
of droplets making it difficult to distinguish between a negative and positive droplet. This becomes 
especially difficult when the double-positive droplets start “merging” or overlapping with the single-
positive droplets. In Panel B, the same male DNA was used for analysis on the ddPCR™, however it was 
first treated with an enzyme EcoRI. This resulted in the droplets being much more clustered together 
closely and created a more distinct difference between positive and negative droplets. Similarly, Panel 
C shows that by digesting a DNA sample first before adding it to the ddPCR™ mixture can improve the 
look of the 2-D plot by stopping the spreading of the droplets across the plot without substantially 
changing the ratios. 
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Figure 2.9. Quantasoft 2-D plot of Different Enzyme Digestions 
Male DNA from MCWES02 cells were run on the ddPCR™ in triplicates. In panel A the DNA was 
undigested, in panel B the DNA was digested with EcoRI for 1hr and in panel C the DNA was digested 
with BstYI for 1hr. AMELX is labelled with FAM and AMELY – in VIC. Results were obtained from the 
Quantasoft software. The black points on the plot represent negative droplets, the blue points are 
positive droplets on the FAM channel, the green- VIC channel and the orange points represent droplets 
that are positive for both the FAM and VIC channels. The results show four replicates. 
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To see whether there was a substantial difference between the ratios or the fractional abundance of 
each gene in a sample when a sample was treated in different ways, a scatter plot was created, and 
statistical tests were performed (Figure 2.9). From Table 2.7, we see the average ratios of AMELX to 
AMELY and a One-Way ANOVA and Tukey’s Multiple Comparisons Test was performed, no significant 
difference was observed (p = 0.5696). Although the digestion did not show any significant difference in 
the ratio of AMELX to AMELY (Figure 2.10), we can see that the digestion had improved the droplet 
segregation allowing the user to call positive and negative droplets more readily. This allowed the 
thresholds to be more easily. Additionally, the different enzymes did not show any significant difference 
to each other on the 2D plots (Figure 2.9 Panel B and C). 
Table 2.7 Average Ratio of AMELX to AMELY 
DNA was treated with different enzymes and then run on the ddPCR™. The average ratio of AMELX to 
AMELY is shown below from quadruplicates. One-Way ANOVA and Tukey’s Multiple Comparisons Test 
was performed to measure any potential significant differences between the control and digested 
samples. 
Sample Control EcoRI Digestion BstYI Digestion 
Average Ratio of AMELX to AMELY 1.031 1.067 1.03 
 
  
Using ddPCR™, we found there were two ways to digest the DNA. This included adding the enzyme and 
buffer mix directly with the PCR mix or by pre-digesting the DNA and then adding it to the PCR mixture. 
No significant difference was found in the two methods using a One-Way ANOVA (p = 0.0622) and 
Tukey’s Multiple Comparisons Test, however when adding the enzyme and buffer mixture directly into 
the PCR tube it was more difficult to control the time of the DNA digestion. Salt concentration 
inhibitions can cause this lack of control of too many units of enzyme in the in-tube digestions. For this 
reason, all further experiments with digested DNA used the “pre-digested DNA” method. 
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Figure 2.10. Scatter Plot of the Different Enzymatic Treatments 
DNA was treated with BstYI in different ways. The pre-digested sample was first digested, whereas the 
in-tube digestion included added the enzyme directly into the PCR mix before running it on the ddPCR™. 
The control was undigested DNA. The fractional abundance of AMELX to AMELY was obtained from the 
Quantasoft software for four replicates and was plotted on GraphPad Prism. One-Way ANOVA and 
Tukey’s Multiple Comparisons Test was performed to measure any potential significant differences 
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2.3.2.2. Time needed for DNA Digestion 
 
After BstYI was selected as a standard enzyme for the digestion of AMELX and AMELY due to its capacity 
to segregate droplets well on the 2-D plot, the amount of time needed for the digestion was monitored. 
From Figure 2.11, it is clear that digestion improves the droplet segregation by making the droplets 
“more positive” and also clustering them closer together. These results were obtained after allowing 
the DNA to digest for one hour, however in an aim to improve the speed and efficiency of the assay, 
the amount of time for digestion was altered to see how this would affect the results. 
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Figure 2.11. Quantasoft 2-D plot of Different Times of BstYI Digestions 
Male DNA from MCWES02 cells were run on the ddPCR™ in triplicates. In panel A the DNA was 
undigested, in panel B the DNA was digested with BstYI for 15min and in panel C the DNA was digested 
with BstYI for 1h. AMELX is labelled with FAM and AMELY – in VIC. Results were obtained from the 
Quantasoft software. The black points on the plot represent negative droplets, the blue points are 
positive droplets on the FAM channel, the green- VIC channel and the orange points represent droplets 
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Figure 2.11 shows that by pre-digesting the DNA for 15min the droplet segregation does improve the 
2-D plot and that there is no significant difference in digesting the DNA for 15 min or for 1 h.  A One-
Way ANOVA and Tukey’s Multiple Comparisons Test was used Figure 2.12.  
























Figure 2.12. Scatter Plot of Different Enzymatic Treatment Times 
DNA was treated with BstYI in different ways. One sample was digested for 15min, the other for 1h. 
The control was undigested DNA. The fractional abundance of AMELX to AMELY was obtained from the 
Quantasoft software and was plotted on GraphPad Prism. 
 
 
2.3.3. Fluorophore Signal Intensity Differences 
 
After performing a number of experiments it was observed the Channel 1 (FAM) signal, that was usually 
used to label AMELX, was constantly higher compared to the Channel 2 (VIC) signal or AMELY (Figure 
2.6, Figure 2.10, Figure 2.12). To explore this “heightened” amount of Channel 1, two separate 
assessments were used. In the first instance, the labelling of the fluorophores was switched, where 
AMELX would be labelled in VIC and AMELY- FAM. Secondly, we extracted DNA directly from the 
MCWES02 donor’s blood and tested it on the ddPCR™ to see if there was a cell culture artefact; the 
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blood was extracted in two separate lots to ensure accuracy (Figure 2.14). Figure 2.13 shows that there 
is a significant difference (One-Way ANOVA and Tukey’s Multiple Comparison Test) between the 
labelling of AMELX with FAM or VIC.   However, when the DNA was extracted from two different vials 
of blood and cell culture, there was no significant difference in the ratios of AMELX to AMELY (Figure 
2.14).  
 






















Figure 2.13 Scatter Plot of Switched Fluorophores 
The ratio of AMELX to AMELY was obtained from the Quantasoft software and was plotted on GraphPad 
Prism. AMELX FAM shows when AMELX was labelled with FAM, AMELX VIC – AMELX labelled with VIC 
and AMELY FAM, where AMELY was labelled with FAM. A One-Way ANOVA and Tukey’s Multiple 
Comparison Test was performed. The asterisk (*) symbolises statistically significant differences 
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Figure 2.14. Scatter Plot of Different DNA Sources 
DNA was extracted from two different sources- cell culture and blood. The blood was extracted from 
separate blood vials – 1 and 2. Both samples were from the same male donor, MCWES02 and taken on 
the same instance. The ratio of AMELX to AMELY was obtained from the Quantasoft software and was 
plotted on GraphPad Prism. A One-Way ANOVA and Tukey’s Multiple Comparison Test was performed. 
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2.3.4. Comparing Sonicated DNA with Digested DNA 
2.3.4.1. Using DNA from collaborator labs 
 
As we had derived our original ddPCR™ set-up from our collaborator Lawrence Jennings (from Ann & 
Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of 
Medicine), we wanted to make sure our results were comparable. To do this the Jennings group had 
kindly sent us a wild-type male DNA sample and their primers and probes to run on our machine. The 
DNA is sonicated in their lab, whereas their primers and probes were exactly the same sequence as 
ours (George et al., 2013).  
From the results it could be observed that the sonicated DNA produced a closer ratio to 1 (Figure 2.15), 
whether using the primers and probes from the Jennings group (Reagents 2) or ours (Reagents 1) 
compared to our digested DNA. Additionally, the sonicated DNA produced a higher concentration of 
AMELX and AMELY due to producing more positive droplets (Figure 2.16), regardless of the total 
number of droplets (Figure 2.17). This indicated that the differences in results are solely due to the 
sonicated DNA and not the primers and probes.  
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Figure 2.15. Scatter Plot of AMELX/AMELY Ratio in Sonicated and Digested Samples 
The graph shows the ratio of AMELX to AMELY for our and our collaborators’ samples. Our DNA 
sample was DNA enzymatically digested, whereas our collaborator’s sample was sonicated. 
“Reagents 1” refers to our in-house primers and probes, whereas “Reagents 2” refers to our 
collaborator’s in-house primers and probes. The ratio of AMELX to AMELY was obtained from the 
Quantasoft software and was plotted on GraphPad Prism. Four replicates were used. No 
significant difference was observed. 
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Figure 2.16. Scatter Plot of Channel 1 Number of Events in Sonicated and Digested Samples 
The graph shows the number of events for AMELX in Ch1 (FAM) for our and our collaborator ’s 
samples. Our DNA was enzymatically digested, whereas our collaborator’s sample was sonicated. 
“Reagents 1” refers to our in-house primers and probes, whereas “Reagents 2” refers to our 
collaborator’s in-house primers and probes. The number of events of AMELX was obtained from 
the Quantasoft software and was plotted on GraphPad Prism. Four replicates were used. No 




Additionally, it was observed that although sonicated DNA produced a higher number of positive 
droplets, it also caused the 2D plot to look “messier” by scattering the droplets across the plot (Figure 
2.18 Panel B). Fewer droplets showed distinct area of clustering compared to using restriction enzyme-
digested DNA (Panel A). This was again seen when switching the primers and probes (Panels C and D). 
Extremely significant differences were observed in the all of the different samples (Figure 2.16). 
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Figure 2.17. Scatter Plot of Total No. of Events in Sonicated and Digested Samples 
The graph shows the total number of events for AMELX and AMELY for our and our collaborator’s 
samples. Our DNA enzymatically digested, whereas our collaborator’s sample was sonicated. 
“Reagents 1” refers to our in-house primers and probes, whereas “Reagents 2” refers to our 
collaborator’s in-house primers and probes. Number of events of AMELX was obtained from the 
Quantasoft software and was plotted on GraphPad Prism. Four replicates were used. No 
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Figure 2.18. Quantasoft 2-D plot of Different Treatment Methods of DNA 
Male DNA from MCWES02 cells were run on the ddPCR™ in quadruplicates. In panel A our wild-type male, digested DNA is shown in combination with our in-house 
primers and probes, in panel B our collaborator’s sonicated DNA with their primers and probes, in panel C- our digested DNA in combination with our collaborator’s 
primers and probes and in panel D- our collaborator’s sonicated DNA with our in-house primers and probes. AMELX is labelled with FAM and AMELY – VIC. Results were 
obtained from the Quantasoft software. The black points on the plot represent negative droplets, the blue points are positive droplets on the FAM channel, the green- 
VIC channel and the orange points represent droplets that are positive for both the FAM and VIC channels. The results are shown in triplicate. 
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Figure 2.19 shows the sonication of MCWES01 at 200ng/μl in a 100μl total volume for 10s at amplitude 
of 20% (Amplitude 2 on the Branson 450 D). This condition was chosen, due to the ease of replicability 
of fragment sizes, consistent fragmentation of the DNA and lastly, the increased number of positive 
droplets we see in Figure 2.19 and Figure 2.20. Previously, we had tested a 10% amplitude on the DNA, 
however no noticeable effect had been observed. Different concentrations of DNA were also tested, 
where lower concentrations were very difficult to observe on the gel and higher concentrations did not 
fragment easily. Similarly, when sonicating the DNA for short periods of time, the DNA did not fragment 
efficiently and for longer periods of time it was difficult to observe on the gel. From Figure 2.19, we 
observe the segregation of the droplets much closer following the digestion, whereas after sonication 
the appearance of “rain” increased. On average, a significantly increased percentage of positive 
droplets were observed with both the digestion and sonication; a 1.6% and 3.4% increase, respectively 
(Figure 2.20). 
As proof of concept dictated, it was easier and more reliable to sonicate the control DNA, rather than 
digest it with different enzymes, dependent on the amplicon size and location in the human genome. 
We, therefore, decided that within each ddPCR™ experiment, the same stock of sonicated DNA would 
be used as a positive control. This would eliminate any possible differences in the comparison of control 
DNA to the DNA being tested in the experiment. 
  
  Chapter II: Optimisation of Droplet Digital PCR 




















Figure 2.19. Quantasoft 2-D plot of Different Treatment Methods of DNA 
 Male DNA from MCWES01 cells were run on the ddPCR™ in quadruplicates. In panel A, our wild-type 
male is untreated, in panel B, the DNA is digested with BstYI, in panel C, the DNA is sonicated for 10s 
at amplitude 2. AMELX is labelled with FAM and AMELY – VIC. Results were obtained from the 
Quantasoft software. The black points on the plot represent negative droplets, the blue points are 
positive droplets on the FAM channel, the green- VIC channel and the orange points represent 
droplets that are positive for both the FAM and VIC channels. The results are shown in triplicate. 
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Figure 2.20. Scatter Plot of the Percentage of Positive Droplets in ddPCR™ 
The graph shows the percentage of positive droplets in comparison to the total number of 
droplets generated in the ddPCR™ experiment. The control DNA was the untreated, wild-type 
MCWES01, the digested DNA was the MCWES01 digested with BstYI and the sonicated DNA was 
MCWES01 sonicated for 10s on amplitude 2 at 200ng/μl in a 100μl volume. Results were obtained 
from the Quantasoft software, where AMELX was labelled with FAM and AMELY – VIC. One-Way 
ANOVA was calculated with Tukey’s Multiple Comparison Test; significant differences are shown 
with asterisk(s).  
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2.3.5. Using Reference Genes in ddPCR™ 
 
Previously, we had always used our ddPCR™ set-up template from the Jennings lab, however from 
BioRad’s guidelines for ddPCR™ it was recommended we use a stable reference gene for copy number 
variation.  In an attempt to reference our gene of interest to a stable gene, a literature search for stable 
gene in human pluripotent stem cells was performed. Due to the huge amount of genomic instability 
present in the hPSCs, all apart from one chromosome commonly accumulate as aneuploidies in 
recurrent gains and /or losses; chromosome 4 was reported as a stable chromosome in hPSCs, despite 
the structural variants that were observed (Amps et al., 2011). In a female sample, where there are two 
copies of our gene of interest i.e. AMELX and two copies of the housekeeping genes ALB and /or RPP30, 
we expect a ratio of 1:1.  Additionally, as a control, we also tested RPP30 labelled on FAM and VIC 
together to make sure none of the positive droplets were positive for a single Ch1. If the results showed 
any droplets positive for the blue (Ch1/FAM) or green (Ch2/VIC) channels, then this would signify that 
the probes were not binding to the target DNA sequences equally. 
 















Figure 2.21. Scatterplot of the Ratio of the Different Combination of Reference Genes 
The graph shows the ratio of different combination of genes using wild -type female DNA from 
FCWES01. The data was obtained from the Quantasoft software and was plotted on GraphPad 
Prism. One-Way ANOVA was calculated with Tukey’s Multiple Comparison Test; significant 
difference was not observed between any of the samples analysed. 
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From Figure 2.21, it is clear that by using a reference gene in ddPCR™, the resulted values are highly 
close to the expected results, where the ratio of RPP30 (labelled with FAM) to RPP30 (labelled with VIC) 
was exactly 1 for all of the replicates.  
2.3.6. Detection of Chromosomal Aneuploidies using ddPCR™ 
 
 
Using ddPCR™, three aneuploidy lymphoblastoid cell lines (Table 2.1) were analysed to observe the 
ratio change between genes AMELX and ALB (Figure 2.22) when whole cell populations contain 
aneuploidy chromosomes. With each additional chromosome X, approximately a 0.5 increase was 
detected. 
 

































































Figure 2.22 AMELX Detection in Aneuploid Cell Lines in ddPCR™ 
AMELX detection in chromosome X aneuploidy cell lines by ddPCR™ is shown. An increasing ratio of 
AMELX to ALB for different samples was observed. Approximately a 0.5 increase with each additional 
X. Standard error of mean is shown. Cell lines MCWES01 (XY), FCWES02 (XX), DD0567 (XXX), DD1473 
(XXXX) and DD0710 (XXY) were used. The raw data, normalised data and expected results are shown, 
the “Normalised Data” was adjusted to the diploid XX karyotype. 
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In order to observe how sub-populations of aneuploidies in cell culture look on the ddPCR™ machine, 
a 10% increment titration of XXX (Cell line DD0567) in a background of XX (Cell line FCWES02) 
experiment was designed. Figure 2.22 shows a steady increase in ratio of AMELX to ALB.  
In addition, a similar titration was performed with the addition of 2.5% of XXX (DD0567) into XX female 
DNA (FCWES02) to observe the ratio change of AMELX to ALB. Figure 2.24 shows the possibility of 
detecting a 2.5% of aneuploid cells in a background of wild-type DNA, whereas Figure 2.25 shows the 
ability of the assay to detect p to 1% aneuploidy in a background of diploid cells. 
 



























Figure 2.23. AMELX Detection in Chromosome X Aneuploidy in 10% Increments Sub-populations 
AMELX detection in the titration of trisomy X (DD0567) in wild-type female DNA (FCWES02) in 10% 
increments by ddPCR™. Increasing ratio of AMELX to ALB for different titrations is shown. 
Approximately a 0.05 increase (equivalent to an additional 10% AMELX target in the sample) with each 
additional 10% trisomy X titration was observed. Standard error of mean and the R2 value are shown. 
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Figure 2.24. Scatterplot of 2.5% Trisomy X Titration in Wild-Type Female DNA 
AMELX detection in the 2.5% titration of trisomy X (DD0567) in wild-type female DNA (FCWES02) by 
ddPCR™ is shown. Two-tailed t-test was calculated; significant difference is shown with asterisks. An F-


























Figure 2.25 Scatterplot of 1% Trisomy X Titration in Wild-Type Female DNA 
AMELX detection in the 1% titration of trisomy X (DD0567) in wild-type female DNA (FCWES02) by 
ddPCR™ is shown. Two-tailed t-test was calculated; significant difference is shown with asterisks. An F-
test was used to calculate the significantly different variances between the two samples. 
  
0 2.5 
% of XXX 
0 1 
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Droplet Digital Polymerase Reaction (ddPCR™) is a powerful tool, which can be utilised for the detection 
of rare events and copy number variation (CNV) (Pohl and Shih, 2004; Miotke et al., 2014). ddPCR™ has 
a reported sensitivity of detecting 1 SNP in a background of 10000 wild-type sequences (Huggett, 
Cowen and Foy, 2014)  and has already been developed for the detection of a number of aneuploidies 
(Fan et al., 2009).  Studies have shown that human pluripotent stem cells are susceptible to a number 
of aneuploidies (Baker et al., 2007) and the aneuploidies have been associated with prolonged growth 
in cell culture (Amps et al., 2011). Our aim in this study was to optimise and develop ddPCR™ as a quick, 
sensitive and consistent method for the detection of aneuploidies in human pluripotent stem cells. Our 
optimisation process included using model cell lines to mimic the accumulation of aneuploidies in the 
hPSC culture. In order to improve the sensitivity of the ddPCR™, the DNA was treated in different ways 
and the sensitivity of each method was carefully monitored.  
2.4.1. DNA fragmentation prior to ddPCR™ 
 
From the digestion results, we observed clearer and more distinct droplet segregation on the 2-D plot 
of our samples (Figure 2.9 and Figure 2.11). We suggest that the digested DNA produces fragments, 
allowing the formation of more droplets for ddPCR™ and consequently permits primers to bind to the 
specific DNA sequences more readily. This would then encourage the amplification of the target gene 
and the fluorescence frequency of the probe to increase. These observations are in line with current 
BioRad guidelines and the research of McMahon, et al., 2017 (McMahon et al., 2017) . 
The enzymatic digestion method is a quick and easy way of eliminating highly viscous DNA to enable its 
use in a PCR mix and has been used frequently by others (Hindson et al., 2011; Strain et al., 2013; Dong 
et al., 2014). Whilst enzymatic digestion is a common way of treating the DNA and is recommended by 
BioRad it does have its disadvantages. These include the possibility of the buffer in the digestion mix to 
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interact with the PCR mix (Yukl et al., 2014) , as well as reduced ddPCR™ target copies, due to the 
enzyme digesting the DNA sequence that required amplification (Shehata et al., 2017). 
Other methods, such as shredding or sonicating the DNA has also been proposed for the improvement 
of ddPCR™ results (Vitomirov et al., 2017). For the shredding of DNA, a QIAShredder (Qiagen) is 
recommended; the method is said to reduce the chance of any enzymatic buffer interactions with the 
PCR mix and have <1% chance of breakage within the amplicon sequence (Yukl et al., 2014). However, 
with both of these methods there is a risk of damaging the DNA integrity and therefore, losing your 
target gene sequence. Unlike the enzyme treatments, the sonication or shredding of DNA is random, 
so the risk of targeting your sample is higher. Nevertheless, the sonication of shredding of DNA 
eliminates the need to look for enzymes that do not cut in your amplicon sequence. This may prove 
difficult when designing experiments with multiple sequences being amplified (multiplexing). 
Additionally, a disadvantage of using enzymatic digestion is that the digested fragment sizes are not 
uniform. This problem may be reduced, however, with the use of a g-TUBE™ (Covaris, UK), which 
produced fragments of uniform size and is now incorporated for the pre-treatment of DNA prior to 
nanopore sequencing (Oxford NanoPore Technologies, UK) (Laver et al., 2015; Eckert et al., 2018). But 
as with every method of DNA fragmentation, the use of the g-TUBE™ may be limited in the absolute 
quantification of nucleic acids. Unlike in sequencing, where reads can be aligned, the amplicons have 
to be fully-amplified for the probe to fluoresce and therefore be read. 
Despite all of the different enzymatic treatments that we had tested on our DNA samples, none of them 
had any effect of the ratio of the two target genes, highlighting that none of the conditions affected the 
absolute quantification of gene copy numbers. Thus, a stock sample of sonicated DNA was created, as 
to avoid any inconsistencies in the sample fragmentation and used with each ddPCR™ run as a control.  
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2.4.2. Fluorophore Intensity Bias 
 
How well a fluorophore emits light is dependent on a number of factors, including the molar extinction 
coefficient- the ability of dyes to absorb light, the quantum yield – the ability to convert absorbed light 
into emission, photostability – the ability to undergo repeated excitations and dye environment – pH, 
temperature and solvent. From our results, we observed that the FAM signal intensity, that was usually 
labelling the AMELX gene, was always higher in comparison to the VIC signal intensity, usually labelling 
AMELY (Figure 2.10, Figure 2.12). This could be explained by the fact that possibly one fluorophore may 
have a stronger signal compared to the other due to a higher fluorescent intensity produced. Many 
commercial companies usually recommend labelling low copy number gene targets with FAM, due to 
its strong fluorescence signal, whereas lower signal fluorophores could be used for more abundant 
gene targets (Houck, 2015; Integrated DNA Technologies, 2015). FAM has been shown to be a stronger 
probe than VIC, due to its stronger relative signal height (Brabetz and Weber, 2014). 
Due to the possible bias from the FAM signal, it was decided that AMELX and AMELY probes were to be 
switched around so AMELX would now be labeled with VIC and AMELY with FAM.  After switching the 
probes around an equal “over-read” was observed on the AMELY gene as it was before on AMELX 
(Figure 2.13). This originally pointed back to the idea that the FAM signal may still be over-read by the 
BioRad ddPCR™ machine (independent of the bound-target). However, when running the RPP30 
control in both fluorophore channels (Figure 2.21), all of the droplets contained target copies positive 
for both channels. This demonstrated that the fluorophores are equally strong at binding to the target 
sequences. 
Alternatively, another factor contributing to this “over-expression” or “over-reading” of AMELX may be 
due to the DNA analysed being from cell pellet extractions. It has been known that chromosome Y is a 
small chromosome that often gets lost in culture and therefore it may explain the excess amount of 
FAM signal (Pierre and Hoagland, 1972). For this reason, wild-type male blood DNA samples were run 
on the ddPCR™ to see whether the amount of AMELX and AMELY would balance. Interestingly, the 
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fractional abundance of AMELX did decrease in the blood samples (Figure 2.14), in comparison to the 
cell culture samples (Figure 2.13), however all except one of the values were higher than 1. The results 
point to the theory that Y chromosome loss in cell culture probably does occur and is probably less 
evident in blood, but this theory does not explain why the VIC signal is rarely seen to be over 1. In order 
to adjust for this, all of the samples were run with a normal diploid cell line and later normalised to it. 
2.4.3. DNA Sonication 
 
Although sonication is not a recommended DNA treated method by BioRad’s manufacturer’s guidelines, 
it is nevertheless a treatment method that some groups use before ddPCR™ (George et al., 2013; 
Vitomirov et al., 2017). Additionally, when Formalin-Fixed, Paraffin-Embedded (FFPE) tissue, degraded 
DNA samples or cell-free DNA (cfDNA) is used, BioRad does not recommend enzymatic treatment since 
the DNA is already fragmented. From our results we have observed increased droplet numbers with 
sonication, albeit increased “rain” in our ddPCR™ 2-D plots. The increased readings in the ddPCR™ were 
in line with the work of Shehata et al., 2017. Increased rain has also been reported previously and 
software has been designed in an attempt to make calls whether a droplet belongs to one population 
or the other (Jones et al., 2014).  
Additionally, by running a control cell line with each run we are able to make sure the results in each 
ddPCR™ run is consistent, due to the possibility of normalising our data. This consistency allows us to 
directly compare results between different ddPCR™ runs. 
In conclusion, we have successfully established a sensitive ddPCR™ assay for the detection of low copy 
number chromosomal aneuploidies in a diploid background of DNA. To our knowledge, the method is 
the most sensitive assay currently available at the detection limit of up to 1% aneuploidy detection.  
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3.1.1. Chromatin Organisation in Interphase Nuclei 
  
In humans, wild-type nuclei contain forty-six chromosomes arranged into discrete non-randomly 
positioned chromosome territories. However, in some cases, an abnormal number of chromosomes 
are present in nuclei and are known as aneuploidies. Although aneuploidies represent 35% of 
spontaneous abortions (Hassold and Hunt, 2001), due to their copy  number variation in genes 
(O’Connor, 2008), some aneuploidies persist and are viable for life. The gene density distribution of 
chromosomes within nuclei suggests a biological significance; changes to this evolutionarily conserved 
arrangement proposes a disruption to the normal function of the nucleus  (Boyle et al., 2001; Petrova 
et al., 2007; Meaburn et al., 2009, 2016; Leshner et al., 2016). Conflicting evidence of chromosome 
positioning between aneuploid and diploid cells has been reported. Cremer et al., 2003 had found a 
general radial positioning of HSA1 and 19 maintained, but with marked differences in the chromosome 
territory positioning between tumour and wild-type cells in cell likes with both mosaic and stably 
abnormal karyotypes. Similarly, human pluripotent stem cells displayed significant differences in 
chromosome positioning between aneuploid and diploid cells (Wiblin et al., 2005; Shete et al., 2014). 
In chromosome X aneuploidies, Petrova et al., 2007 demonstrated a relocation of chromosome 
territories in comparison to wild-type nuclei; a shift in the active X (Xa) and chromosome 1 of XXXXY 
cells towards the nuclear periphery in comparison to their wild-type male XY (Petrova et al., 2007). On 
the other hand, Sengupta et al., 2007 concluded that artificially introduced chromosomes did not 
induce a global chromosome relocation, however each study had looked at different approaches to 
illustrate the genome positioning in the cells, which may contribute to the different in opinion 
(Sengupta et al., 2007). More recently, studies with 3-D FISH and Hi-C have shown that homologous 
chromosomes are far apart from each other and do not interact frequently (Heride et al., 2010; Selvaraj 
et al., 2013; Fraser, Williamson, et al., 2015).Although genome-wide approaches provide large datasets 
to understand the chromatin interactions in multiple sites and in whole cells populations, fluorescence 
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imaging methods provide single-cell level information to understand chromatin positioning using 
computational methods for position analysis (Ollion et al., 2015). In addition, chromosome 
rearrangement detected by FISH can be tissue-specific in diseases and aid in diagnostics and prognosis 
(Meaburn et al., 2016).  
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The aim of this part of the project was to use fluorescence in-situ hybridisation gene loci positioning to 
evaluate the impact of aneuploidies in the aneuploid nuclei. We utilised chromosome X aneuploidies 
to model the possible differences in gene loci positioning. Two genes were selected to compare the 
gene loci positioning in wild-type versus aneuploid nuclei. The housekeeping gene, “stable” in human 
pluripotent stem cells, ALB and a gene found on chromosome X, AMELX, were employed as probes. 
Additionally, the study was designed to observe the general morphology of the cell nuclei and whether 
there were any differences between wild-type and aneuploid cell nuclei. The objective was to 
determine whether the additional chromosomes in the aneuploid cell lines caused a change in the size 
or shape of the nuclei. We used the FISH images generated in Fiji (ImageJ) to analyse nuclear area and 
shape.  
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3.3. Methods and Materials 
 
3.3.1. 2-D FISH  
3.3.1.1. DNA Isolation  
 
Bacterial Artificial Chromosomes (BACs) with specific gene sequences can be tagged with fluorescent 
labels and used as probes for fluorescence in-situ hybridisation (FISH). Two BACs (ThermoFisher 
Scientific), Clone ID RP11.580P21 and RP11.121K9 for ALB and AMELX, respectively were used. The 
BACs were in DH11 Escherichia coli (E. coli) and were grown on Luria Broth (LB) agar (1% NaCl, 1% 
Tryptone, 0.5% Yeast Extract, 1.5% Agar) with 12.5μg/μl chloramphenicol (Sigma). Following this, a 
small number of cells were scraped off the agar plate and inoculated in LB supplemented with 
chloramphenicol and placed on an agitator/shaker overnight at 37⁰C.  To make low temperature stocks 
of BACs the bacterial culture was mixed with 50% of glycerol in cryovials, frozen and stored at -80⁰C.  
To isolate the BACs, an alkaline lysis method was used; the protocol was provided by Dr Temi Owoka 
from Dr Sabrina Tosi’s lab (Brunel University London). For 50ml of bacterial culture, the cells were spun 
down at 2500 x g for 10min and the supernatant removed. The pellet was then resuspended in 3ml of 
an ice-cold resuspension buffer (50mM Glucose, 25mM TrisCl (pH 8.0), 10mM EDTA (pH 8.0), 100µg/ml 
RNase A) and incubated on ice for 5min, followed by the addition of 6ml of lysis buffer (0.2M NaOH, 1% 
SDS). The mixture was inverted and incubated for 5min. Finally, 4.5ml of neutralisation buffer (3M 
Potassium Acetate (pH 4.8)) was added, the tube inverted and incubated on ice for 5min, followed by 
a centrifugation at 21 500 x g for 10min at 4⁰C.  The supernatant was transferred to a clean tube and 
re-centrifuged until the supernatant was clear. The supernatant was removed once again, and an equal 
amount of iso-propanol was added. The tube was inverted and centrifuged at 21 500 x g for 30min at 
RT. The supernatant was discarded, and the pellet was washed with ice-cold 70% ethanol, followed by 
a centrifugation at 21 500 x g for 5min at RT. The supernatant was removed, and the pellet allowed to 
air-dry for 15min. The pellet was then resuspended in an appropriate volume of nuclease-free water. 
The DNA was quantified by running an agarose gel and a Nanodrop 100 was used to look at any possible 
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RNA or protein contamination. To confirm that the BACs were truly the sequences we required, qPCR 
was performed on the Stratagene MX3000 qPCR machine, according to the same conditions, primers 
and probes as mentioned in Chapter II (Section 2.3.6). 
3.3.1.2. Degenerate Oligonucleotide-Primed Polymerase Chain Reaction 
 
Degenerate Oligonucleotide-Primed Polymerase Chain Reaction (DOP-PCR) was performed for whole 
chromosome FISH. The template chromosome paints were a kind gift from Michael Bittner and 
amplified for each use (Table 3.1) in a thermocycler under specific conditions (Table 3.2).  
For the labelling of the template chromosome paints either biotin of digoxygenin was used in the 
amounts described in Table 3.3. The thermocycling conditions are shown in Table 3.4. After this step 
the chromosome paints were precipitated (Section 3.3.1.4. Probe Hybridisation and Preparation). 
Table 3.1. DOP-PCR Template Amplification Reagents 
Reagent Amount (µl) 
5 x DOP-PCR Buffer (Sigma-Aldrich) 10 
dACGTP (2mM) (Promega) 5 
dTTP (2mM) (Promega) 5 
DOP Primers (20µM) 5 
Taq Polymerase (1U/µl) (KAPA Biosystems, USA) 1 
Water 23 
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Table 3.2. DOP-PCR Template Amplification Conditions  
 Temperature (⁰C) Time (Minutes) Process 
Step 1 95 3 DNA Denaturation 
Step 2 98 0.3 DNA Denaturation 
Step 3 62 1 Annealing 
Step 4 72 0.2 DNA amplification 
Go to Step 2 X 31 
Step 4 72 5 Final Step 




Table 3.3. DOP-PCR Chromosome Paint Labelling Reagents 
Reagent Amount (µl) 
5 x DOP-PCR Buffer (Sigma-Aldrich) 10 
dACGTP (2mM) (Promega) 5 
dTTP (2mM) (Promega) 2 
DOP Primers (20µM) 5 
Biotin-16-dUTP/Dig-11-dUTP (Roche) 10 
Taq Polymerase (1U/µl) (KAPA Biosystems, USA) 1 
Water 23 
Template Chromosome Paint DNA 5 
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Table 3.4. DOP-PCR Chromosome Paint Labelling Conditions 
 Temperature (⁰C) Time (Minutes) Process 
Step 1 95 3 DNA Denaturation 
Step 2 98 0.3 DNA Denaturation 
Step 3 62 1 Annealing 
Step 4 72 0.2 DNA amplification 
Go to Step 2 X 34 
Step 4 72 5 Final Step 
Step 5 4 Infinite Hold 
 
To make sure the genes labelled with digoxygenin (DIG) or biotin were approximately 200-500bps long, 
a 2% agarose gel with X25000 SybrSafe (ThermoFisher, UK) was prepared and run to 100V for 
separation. 2μl of the DIG-labelled mixture (~100ng) and 5l of the biotin-labelled mixture (~100ng) 
were usually prepared with x 12 loading buffer from the PeqGOLD DNA Sizer XIII (VWR Peqlab, UK). 
 
3.3.1.3. Nick Translation Labelling of Bacterial Artificial Chromosomes 
 
After the DNA extraction nick translation was performed to label the BACs with either biotin, Biotin-16-
dUTP (ThermoFisher Scientific) or digoxygenin (DIG), digoxygenin-11-dUTP (Roche). AMELX was 
labelled with DIG, whereas ALB was labelled with biotin nucleotides. Both nick translations were 
performed using the Nick Translation Labelling Kit (ThermoFisher Scientific). This was followed by a 
centrifugation using a MicroSpin Column (GE Healthcare, UK) to separate any unlabelled sequences 
from the labelled nucleotides.  
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3.3.1.4. Probe Preparation 
 
Both the biotin-labelled probe (ALB) and DIG-labelled probe (AMELX) were precipitated using 200ng of 
probe, 1μg of Cot-1 DNA (Roche), 1μg of Herring Sperm (ThermoFisher Scientific) with 1/10th of Sodium 
Acetate and X2 100% ice-cold ethanol (Table 3.1). The mixture was then incubated at -80⁰C for at least 
30min.  
 
Table 3. 5. Concentration of reagents used for the probe hybridisation in 2-D FISH 
Component Concentration/Amount 
DNA Probe 0.2-0.4μg 
Cot-1 DNA 7μg 
Salmon/Herring Sperm DNA 3μg 
3M Sodium Acetate 
1/10th Volume of Total of Probe, Cot-1 DNA and 
Salmon/Herring Sperm DNA 
100% Ethanol X2 of Total Volume 
 
After the incubation, the probes were centrifuged at 16 000 x g for 30min at 4⁰C. After the 
centrifugation, the supernatant was removed, and the pellet produced was washed with 400μl of ice-
cold 70% ethanol. The mixture was centrifuged again at 16 000 x g for 30min at 4⁰C and the supernatant 
removed. The pellet was then dried at 37⁰C on a hot block until it became transparent. 12μl of 
hybridisation buffer/mix (50% formamide, 10% dextran sulphate, 2X SSC and 1% Tween 20) was added 
to the dried pellet and it was allowed to dissolve at 37⁰C for 10 - 120min or left overnight at RT. The 
mixture was denatured at 75⁰C for 10min and allowed to re-anneal at 37⁰C for 10-120min.  
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3.2.1.5. Cell Fixation 
 
Cells were grown to approximately 70% confluency and centrifuged at 250 x g for 5min and the 
supernatant removed. The pellet was resuspended in freshly prepared 0.075M potassium chloride (KCl) 
for each sample, the solution was added slowly drop-by-drop whilst agitating the cells. Approximately 
5-7ml of KCl was used. Cells were then incubated at room temperature for exactly 15min. After the 
incubation, the cells were centrifuged at 120 x g for 5min, the supernatant was removed.  
Afterwards, the cell pellet was re-suspended in freshly prepared ice-cold fixative solution (methanol: 
acetic acid 3:1 v/v) agitating the cells and slowly adding the fixative. Again approximately 5-7ml of the 
fixative was used. The newly re-suspended cells were incubated for 1h at -20⁰C. 
After the incubation, the tubes were centrifuged at 120 x g for 5min. Then drop-by-drop freshly 
prepared ice-cold fixative was added to the pellet for re-suspension. These cells were then dropped 
onto damp SuperFrost slides (ThermoFisher Scientific) and visualised using a phase contrast Olympus 
CK2 inverted microscope to determine whether the cell density and quality was appropriate for use i.e. 
the loss of cytoplasm. The samples were stored at -20 ⁰C in the fixative indefinitely. 
3.3.1.6. Slide Preparation 
 
After dropping the fixed cells onto the slides, the slides were aged for either two days at RT or baked at 
70 ⁰C for 1h. The slides were allowed to cool down after which they were dehydrated via 70%, 90% and 
100% ethanol washes, 5min each. Slides were dried on a warm plate and placed into a 70⁰C oven for 
5min. The slides were then then placed in Denaturing Solution (70% Formamide and 2XSSC (pH 7.0)) at 
70⁰C for 2 min and then placed in ice-cold 70% ethanol for 5min. Following this, they were placed in 
90% and then 100% ethanol, for 5min each. Slides were dried on the warm plate again before 10μl of 
the prepared probe (3.3.1.4. Probe Preparation) was placed on each slide, a 22 X 22 coverslip was 
applied on top and secured in place with rubber cement. The slides were left in a humidified chamber 
for two days.  
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3.3.1.7. Slide Hybridisation, Washing and Counterstaining 
 
After the hybridisation, the rubber cement was removed from the coverslips and the slides were first 
washed three times in Wash Buffer 1 (50% Formamide and 2XSSC (pH 7.0)) for 5min at 45⁰C, followed 
by another three 5min washes in Wash Buffer 2 (0.1XSSC (pH 7.0)) which was pre-warmed to 60⁰C and 
then transferred to a 45⁰C waterbath once the slides were immersed. The slides were then placed in a 
room temperature 4XSSC solution for 10min. 
100μl of 4% Bovine Serum Albumin (BSA) in 4XSSC was added to each slide for blocking and covered 
with a 22 X 50 coverslip for 10min at RT. Coverslips were removed and 100μl of streptavidin-conjugated 
cyanine 3 (Cy3) (1:30 dilution (ThermoFisher Scientific)) in 1% BSA and 4XSSC was added to each biotin-
labelled slide. For DIG-labelled slides, anti-DIG mouse antibody FITC (Jackson Laboratories, USA) was 
re-suspended in 350μl and then a 1:100 dilution was used with 1% BSA and 4XSSC. 100μl of this solution 
was then applied onto each DIG-labelled slide. 22 X 50 coverslips were applied to the slides and 
incubated at 37⁰C for 30min, away from the light. The slides were washed three times in Wash Buffer 
3 (0.1% Tween 20 in 4XSSC) at 42⁰C for 5min. The slides were then quickly washed with deionized 
distilled water before counterstaining with 1.5µg/ml Vectashield 4`, 6-Diamidino-2-Phenyindole (DAPI) 
(Vector Laboratories, UK). 22 X 40 coverslips were applied to the slides. 
3.3.1.8. Image Capture   
 
Using the Olympus BX41 or Leica DM 4000 immunofluorescence microscope at X100 magnification with 
immersion oil, nuclei were visualised. The value of the fixed time exposure on the microscope was 
manual. To visualise the signals from the slides either “SmartCapture 3.0” (Digital Scientific, UK) for the 
Olympus microscope or “LAS AF” (Leica, UK) was used. Approximately one-hundred images of the nuclei 
with signals were taken for each slide.  
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3.3.1.9. Image Analysis   
 
To quantify the position of whole chromosomes or genes within the interphase nuclei, an erosion script 
analysis programme was run in IPLAB (Croft et al., 1999; Clements et al., 2016). The images were 
uploaded into the software and the programme divided each nucleus into 5 Shells of equal area. The 
1st Shell is the peripheral shell of the nucleus, where the 5th – internal (Figure 3.1). The software 
considers the intensity of the DAPI signal or DNA concentration by the pixel intensity of each image, 
alongside the intensity of the chromosome or gene signals. 
For each shell, the intensity of the probe’s signal was normalised; the percentage of the probe signal 
was divided by the percentage of the DAPI signal in each individual shell. The average probe:DAPI values 









Misshapen nuclei have been associated with a range of different diseases, including premature ageing 
(Taimen et al., 2009), Pelger–Huët anomaly, a blood laminopathy causing a differentiation defects in 
the white blood cells (Hoffmann et al., 2002) and cancers, such as cervical and small-cell lung 
carcinoma (Zink, Fische and Nickerson, 2004). In order to analyse the morphology of the nuclei, the 
Figure 3.1. Nuclear Positioning via the Erosion Script software IPLAB 
 A cartoon image is displayed with the yellow concentric circles surrounding the blue nucleus. The 1st 
shell or concentric circle is the most peripheral, whereas the 5th – the most internal. The genes being 
positioned are shown in green. 
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software Fiji (ImageJ) was used. A Macro was used to batch analyse the nuclei for cell area, circularity, 
aspect ratio and roundness. The circularity calculation formula is   4π (
𝑎𝑟𝑒𝑎
𝑝𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟2
); a perfect circle has 
the value of 1. The aspect ratio calculation formula is    
𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠
𝑚𝑖𝑛𝑜𝑟 𝑎𝑥𝑖𝑠
 ; a perfect circle as the value of 1. The 
roundness calculation formula 
 is   
4×𝑎𝑟𝑒𝑎
𝜋 ×(𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠)2
; roundness is the inverse of aspect ratio. Up to 200 cell nuclei were analysed for 
these calculations. 
3.3.1.10. Analysing Chromosome Number by Fluorescence In-Situ Hybridisation  
 
To block cells in metaphase, 05µg/mL of KaryoMAX Colcemid Solution (ThermoFisher Scientific) was 
added to the cell culture and incubated overnight at 37ᵒC. Following this the cells were fixed as per 
Section 3.2.1.5. 
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Fluorescence in-situ hybridisation (FISH) was performed with whole chromosome paints on all of the 
lymphoblastoid cell lines shown in Figure 3.2. The results were consistent with the karyotyping (shown 
in Appendix I) for chromosome X. Approximately 30 metaphase spreads were examined; the results 
confirmed the wild-type cell lines, MCWES01 and FCWES02, contained one and two X chromosomes, 
respectively. Additionally, the results established DD0710, DD0567, and DD1473 to contain two, three 
and four X chromosomes, respectively.  
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Figure 3.2. Chromosome X Presence in Interphase and Metaphase  
The different panels show examples of fluorescence in-situ hybridisation images in both wild-type and aneuploid lymphoblastoid cell lines. The top  row shows the cells 
in interphase, where the lower row shows cells in metaphase after colcemid treatmend. The  cell lines used are MCWES01 (XY), FCWES02 (XX), DD0710 (XXY), DD0567 
(XXX) and DD1473 (XXXX). The scale bars are shown.  Whole chromosome paints for chromosome X were used.  
 
XXY 
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3.4.1. Gene Positioning in Lymphoblastoid Cells 
 
Fluorescence in-situ hybridisation was performed using ALB and AMELX gene probes on the 
lymphoblastoid cell lines to compare their positioning in the nuclei dependent on their aneuploidy. 
Figure 3.3 shows a panel of both AMELX and ALB gene signals in wild-type and aneuploidy cell lines.  
For ALB positioning (chromosome 4), the cells displayed consistent results across all of the cell lines, 
except for two incidences, both in Shell 2. The significant difference was between FCWES02 (XX) and 
DD1473 (XXXX), and DD0567 (XXX) and DD1473 (XXXX) for Shell 2 (Figure 3.4). The samples were all 
compared to each other using one-way analysis of variance (ANOVA) and Tukey’s Multiple Comparison 
Test. For all of the lymphoblastoid samples, a peripheral positioning of ALB was observed.  
On the other hand, for AMELX positioning, a significant difference was shown in Shell 1 between cell 
lines MCWES01 (XY) and DD0710 (XXY), MCWES01 (XY) and DD0567 (XXX), and MCWES01 (XY) and 
DD1473 (XXXX) (Figure 3.5). For these statistical difference calculations, a Tukey’s Multiple Comparison 
Test was used. For samples MCWES01 (XY), FCWES02 (XX) and DD0567 (XXX) a peripheral positioning 
of AMELX was observed, however DD0710 (XXY) and DD1473 (XXXX) had shown a reduced localisation 
to the nuclear edge and displayed a more intermediate nuclear positioning of AMELX. 
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Figure 3.3. AMELX and ALB Fluorescence In-Situ Hybridisation Images of Wild-Type and Aneuploid Lymphoblastoid Cells 
The different panels show examples of fluorescence in-situ hybridisation nuclei in both wild-type and aneuploid lymphoblastoid cell lines. The cell lines used 
are MCWES01 (XY), FCWES02 (XX), DD0710 (XXY), DD0567 (XXX) and DD1473 (XXXX). The scale bar is shown.  
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Figure 3.4. ALB Positioning in Wild-Type and Aneuploid Cell Nuclei  
Different aneuploid cell lines’ ALB positioning is shown in approximately 100 nuclei using the 
Erosion Script on the IPLAB software. Panel A shows MCWES01 (XY), B – FCWES02 (XX), C – 
DD0710 (XXY), D – DD0567 (XXX) and E – DD1473 (XXXX). The symbols (* and     ) represent 
significant difference from Tukey’s Multiple Comparison Test; standard error of mean is shown 
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Figure 3.5. AMELX Positioning in Wild-Type and Aneuploid Cell Nuclei 
Different aneuploid cell lines’ ALB positioning is shown in approximately 100 nuclei using the 
Erosion Script on the IPLAB software. Panel A shows MCWES01 (XY), B – FCWES02 (XX), C – 
DD0710 (XXY), D – DD0567 (XXX) and E – DD1473 (XXXX). The symbols (*, * and     ) represent 
significant difference from Tukey’s Multiple Comparison Test; standard error of mean is shown 
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Additionally, to compare the effect of aneuploidies, if any, on the nuclei, the nuclear morphology, 
specifically the circularity, was analysed with Fiji (ImageJ; Figure 3.6). A significant difference in nuclear 
size was observed between the wild-type male and female cell lines, as well as between the wild-type 
and abnormal cell lines nuclear size. However, no significant difference was observed between the 
aneuploid cell lines. It seems like the aneuploid cell lines are all smaller in size, despite the extra 
chromosomes in their nuclei. In order to observe the characteristic shape of the nuclei, the cell 
circularity, aspect ratio and roundness were analysed. All three of the categories’ results for the nuclear 
shape were consistent, where significant differences were observed between the wild-type male and 
wild-type female cell lines, and between the wild-type male and DD0567 (XXX).   
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Figure 3.6 Cell Morphology Analysis 
Images from fluorescence in-situ hybridisation were analysed with a macro in Fiji (Image J); up 
to 200 nuclei were analysed. Nuclear area (A), nuclear circularity (B), aspect ratio (C) and 
roundness (D) were all parameters that were measured; SEM is shown.  The asterisk (*) 
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3.5.1. Model Cell Lines 
 
Lymphoblastoid cell lines have demonstrated gene-density dependent (Boyle et al., 2001; Tanabe et 
al., 2002) intrinsic organisation patterns between different wild-type EBV-immortalised cells lines with 
differential chromatin arrangement dependent on their proliferative state (Ollion et al., 2015). Unlike 
fibroblasts, lymphoblastoid cells have shown no modifications to chromosome territory arrangements 
in cell lines containing emerin or A-type lamin mutations (Meaburn et al., 2005). In addition, 
lymphoblastoid cells are a good model for studying chromosome and gene positioning, as they are easy 
to obtain and grow.  For our study, lymphoblastoid cells were derived from different donors, however 
the use of the same cell type makes them a good model for comparsion between different karyotypes. 
Previously, different cell types have been used for comparsion to make conclusions about the 
chromatin positioning alterations in aneuploidies (Cremer et al., 2003). The same paper had 
demonstrated differential positioning in different cells types (Cremer et al., 2003), therefore this 
comparison may not be the most suitable. Other studes have demonstrated, radial chromosome 
positioning to be conserved throughout species and cell types (Marshall et al., 1996; Bridger and 
Bickmore, 1998; Kuroda et al., 2004; Foster, Griffin and Bridger, 2012), however elusive differences do 
exist with differentiation (Wiblin et al., 2005; Meshorer and Misteli, 2006; Szczerbal, Foster and Bridger, 
2009; Fraser, Ferrai, et al., 2015). Therefore, for our study it is essential to use cell types from the same 
origin when comparing karyotypic effect on chromatin positioning within nuclei.  
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3.5.2. ALB and AMELX Positioning in Lymphoblastoids 
 
This chapter has explored the gene positioning of ALB and AMELX, located on chromosomes 4 and X, 
respectively.  The study was assessing the impact, if any, of the aneuploidies for chromosome X on the 
gene positioning in lymphoblastoid cells. Despite the low somatic mutation rate of EBV-transformed 
lymphocytes (Mohyuddin et al., 2004), we, firstly, had to assess whether the cells were truly aneuploid 
for chromosome X by performing 2-D FISH on the whole chromosome X. Our data were comparable to 
that of the Doctor’s Laboratory, which had performed the G-banding analysis of our cell lines (Appendix 
I). The confirmed data from both the metaphase cells and nuclei allowed us to carry on with our study 
of the effects of aneuploidies on the cell nuclei and the gene loci positioning. 
The 2D analysis assessed the positioning of gene loci and revealed that ALB had a peripheral position in 
the nuclei in all of the cell lines, regardless of the number of chromosome X’s. There was a slight 
difference in the Gene/DAPI intensity in Shell 2 between FCWES02 (XX) and DD0567(XXX), and FCWES02 
(XX) and DD1473 (XXXX), but generally all of the cell lines showed a peripheral positioning of ALB, which 
has been consistent with previous studies for chromosome 4 (Boyle et al., 2001). One possible 
explanation for these differences in ALB positioning could be the difference in the gene transcription. 
ALB expression can be gender-specific (Li et al., 2014) and sex hormones have been suggested as a 
possible cause for this preferential expression (Sugamori, Brenneman and Grant, 2011).  
On the other hand, AMELX positioning showed more obvious differences between the cell lines. Wild-
type cell lines MCWES01 (XY) and FCWES02 (XX), and aneuploid cell line DD0567 (XXX) positioned 
AMELX towards the nuclear periphery, whereas DD0710 (XXY) and DD1473 (XXXX) positioned AMELX 
more intermediately. No significant difference was observed between the wild-type cell lines, as 
expected, however all of the aneuploid cell lines showed a significant difference in the Gene/DAPI 
intensity at the periphery (Shell 1) with reference to the wild-type male, but not the female. This may 
be due to the larger amount of extra chromosome X’s between the male and aneuploid cell lines in 
comparison to the female. This difference in gene positioning with X chromosome aneuploidies has 
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been observed in previous studies (Petrova et al., 2007; Shete et al., 2014), where their data have 
shown that X chromosome aneuploidy does not necessarily only affect the positioning of chromosome 
X, but also globally across different territories. In contrast to the data of Petrova et al., 2007, where 
additional chromosome X’s in the nuclei caused an increased attraction to the nuclear periphery, our 
data had shown a loss of association with the nuclear edge in DD0710 (XXY) and DD1473 (XXXX), but 
not in DD0567 (XXX). 
For both of the genes, the data have  been consistent with previous studies performed on the same 
chromosome territories on which ALB and AMELX genes are located with the conserved spatial 
organisation, despite the varied karyotypes (Bolzer et al., 2005). Although a conserved radial positioning 
was identified in our study in all of the cells, independent of aneuploidies, subtle differences have been 
identified in the aneuploid cell lines in comparison to the wild-type.  Consistent with our results,  the 
artificial addition of chromosomes 7, 18 and 19 in the nuclei did not change the overall positioning of 
those chromosomes (Sengupta et al., 2007), however shifts in the chromatin organisation have been 
described with the addition of aneuploidies (Cremer et al., 2003; Wiblin et al., 2005; Sengupta et al., 
2007; Shete et al., 2014) . This coupled with the positioning of chromosome 4 and X being very similar 
to previous work from our lab (Mehta, et al., unpublished; Bikkul, et al., Manuscript in Preparation) and 
other labs (Kozubek et al., 2002; Cremer et al., 2003), suggests that although the general organisation 
remains the same, additional chromosomes do cause changes to the genome organisation. Recent 
studies have highlighted that homologous chromosome are located far apart from each other (Heride 
et al., 2010; Selvaraj et al., 2013; Fraser, Williamson, et al., 2015); it can be speculated that the nuclear 
space may be more adaptable to additional chromosomes and therefore, maintain the radial 
distribution of chromosome territories in the different karyotypes. 
Aneuploid nuclei have often displayed a very significant change in their gene expression profiling 
(Upender et al., 2004; Grade et al., 2006), especially an increase in transcripts for the specific 
chromosome that was gained (Upender et al., 2004) and also in the protein expression levels 
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(Habermann et al., 2007; Torres, Williams and Amon, 2008). How the aneuploidies in the cell lines from 
our study affect the overall gene expression in the cell is unknown. Further investigation is required; 
however, a good example would be to combine the work of Sengupta et al. and Habermann, et al., to 
model chromosome aneuploidies  transfer and then measure the protein expression levels (Habermann 
et al., 2007; Sengupta et al., 2007). The transcriptional changes observed in aneuploidies  (Upender et 
al., 2004; Grade et al., 2006) and work performed in the prognostic potential of chromosome 
positioning in cancer (Leshner et al., 2016; Meaburn et al., 2016) highlights the significance that 
chromatin modifications could potentially have on the normal functioning of the nucleus. Further 
investigation is required to study the implication of aneuploidies on chromatin organisation and 
thereby, transcription. 
3.5.3. Cell Morphology  
 
Cell morphology analyses were performed to study the possible differences between the wild-type and 
aneuploid lymphoblastoid cell lines. From our analyses, we have observed a significantly reduced cell 
area in the aneuploid cell nuclei in comparison to the wild-type lymphoblastoid cell lines. A potential 
factor that could impact the nuclear size is the source of the material. The aneuploid cell lines were 
from donor with genetic disorders; patients living with disorders caused from aneuploidies often 
experience health problems, including increased immunological disorders with increased X 
chromosome dose (Keller et al., 2013; Liu et al., 2016; Schatorjé et al., 2016); these included 
Kleinfelter’s and Turner’s Syndromes (Kurosawa, Kimura and Sagawa, 1991; Jørgensen et al., 2010; 
Aksglaede et al., 2013). Additionally, reports have shown a possible link between aneuploidies and 
immunodeficiency (Schwanitz and Zerres, 1987; Kurtyka et al., 1988; Ram and Chinen, 2011; Jiang et 
al., 2013; Schatorjé et al., 2016), however a precise mechanism is yet to be found (Keller et al., 2013; 
Schatorjé et al., 2016).  
In addition, the inactive and active chromosome X territories have been reported to be different in 
shape with the inactive X (Xi) observed to be more compact (Falk et al., 2002). This is due to the XIST 
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transcript that inactivates the X chromosome and causes heterochromatin formation, the resulting 
chromosome is then known as a Barr body (Brown et al., 1991). We propose that with the additional 
chromosomes that require X chromosome inactivation (XCI), more heterochromatin is formed via 
epigenetic modification creating a more compact genome and therefore, suggesting a possible 
explanation to the smaller aneuploid nuclei we observed. The increased production of XIST has been 
observed in X chromosome aneuploidies (Ji et al., 2015) and heterochromatin spreading has been  
reported previously (Talbert and Henikoff, 2006; Honda et al., 2010; Wang et al., 2014). For this reason, 
we propose the possibility of heterochromatin spreading from the aneuploid X chromosomes to the 
rest of the genome creating more compact nuclei overall. 
With regards to the data from the cell morphology analysis, we found a significant difference between 
the wild-type male and female cell lines and between the wild-type male and trisomy X cell lines. Cell 
morphology has often been used as an indicator for prognosis (Mitmaker, Begin and Gordon, 1991) and 
for blastomere selection (Agerholm et al., 2008). Despite this, no conclusive evidence has been given 
whether the cell’s circularity is a direct indicator of aneuploidy. In line with our findings, previous studies 
had observed no correlation of nuclear size or shape to aneuploidies (Cremer et al., 2003; Agerholm et 
al., 2008). Further studies into this topic are required for conclusive evidence. 
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4.1. Introduction 
4.1.1. Nuclear Lamins 
 
 
The aberrant expression and localisation of nuclear lamins is commonly featured in different cancers 
(Broers et al., 1993; Moss et al., 1999; Venables et al., 2001; Willis et al., 2008; Capo-chichi et al., 2011; 
Wazir et al., 2013) and studies have suggested abnormal expression to be associated with poorer 
patient outcomes caused from increased metastasis and cell proliferation (Venables et al., 2001; 
Davidson et al., 2014). In addition, lamin disruption can also cause chromatin mislocalisation and 
changes in morphology of interphase nuclei (Malhas et al., 2007; Meaburn et al., 2007; Mewborn et al., 
2010; Mehta et al., 2011; Solovei et al., 2013; Ranade et al., 2017), highlighting the role of lamin 
proteins in chromatin organisation and nuclear morphology.  
Lamins have been associated with the conservation of genomic stability (Vergnes et al., 2004; Kuga et 
al., 2014; Ranade et al., 2017). Although the complete knockout of B-type lamins causes lethality, the 
knockdown did permit aneuploidies in mice and cancerous cells (Vergnes et al., 2004; Ranade et al., 
2017), but not in keratinocytes (Yang et al., 2011). However, Ranade, et al., 2017 had demonstrated 
that in colorectal adenocarcinoma cells lamin A/C and B2 knockdown can cause transcriptional 
deregulation of specific chromosomes and lamin B2 knockdown to induce the formation of 
aneuploidies with changes in the chromosome territory positioning (Ranade et al., 2017). These studies 
suggest a link between B-type lamin depletion and genomic instability.  
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The aim of this study was to compare the lamin gene and protein expression levels between 
karyotypically normal and aneuploid cell lines. We were interested in assessing the distribution of the 
different staining paterns observed in nuclei. Our study was designed to quantify the total protein 
expression levels of each lamin protein via Western blotting and gene expression levels via RT-qPCR.  
 
  
Chapter IV: Correlation of Nuclear Lamins with Chromosomal Aneuploidies 
Marianne P Henry  Page | 111  
 
4.3. Methods and Materials 
4.3.1. Immunofluorescence 
 
Lymphoblastoid cells were grown in RPMI-1640 medium (Sigma-Aldrich, UK) supplemented with 10% 
Foetal Calf Serum (FCS) (Sigma-Aldrich, UK) and 5% L-Glutamine (Sigma-Aldrich, UK) in a 5% CO2 
atmosphere at 37⁰C. These cells were then centrifuged at 1500 x g and re-suspended in ice-cold 
methanol: acetone (1:1), and then dropped onto poly-L-lysine slides (Sigma-Aldrich, UK). The slides 
were washed three times for five minutes each time with agitation in 1xPBS and then the primary 
antibody was applied with 1% BSA in PBS (v/v). These slides were incubated in a humidified chamber 
for thirty minutes at 37⁰C or at room temperature for one hour. After this incubation, the slides were 
washed another three times in PBS with agitation for five minutes each time. The secondary antibody 
was applied diluted in 1% BSA in PBS and left for thirty minutes at 37⁰C or at room temperature for one 
hour in a humidified chamber. The slides were washed another three times on the shaker in PBS and 
finally washed in distilled water. A drop of VECTASHIELD Antifade Mounting Medium with DAPI 
(Vectorlabs, USA) was applied the slide and a 22 x 40 mm coverslip was placed on top and sealed. 
For the mouse lamin A antibody (Abcam, UK) a dilution of 1:100 was used, for rabbit lamin C 
(ThermoFisher, UK) – 1:200, for rabbit Lamin B1 – 1:500 and mouse Lamin B2 – 1:400. For the secondary 
antibodies a donkey anti-rabbit labelled with Cy3 (Merck MiliPore, UK) was used at a 1:500 dilution and 
goat anti-mouse labelled with FITC (Abcam, UK) – 1:1000. 
Ovarian cancer cells from the SKOV-3 cell line were stained for the A-type lamins as a positive control 
to confirm that the lamin A antibody was viable. The cells were grown by Aakila Sammy (Brunel 
University London) in the same media and conditions as the lymphoblastoid cells, however as the cells 
were adherent, the cells were first grown on coverslips and then subjected to indirect 
immunofluorescence. 
Chapter IV: Correlation of Nuclear Lamins with Chromosomal Aneuploidies 
Marianne P Henry  Page | 112  
 
Slides were analysed using the x100 lens with emersion oil on the Olympus BX41 and Leica DM4000 
fluorescent microscopes. The slides were scored for different distributions for each cell line and each 
protein stained. When a specific pattern of staining was observed, cells were scored until at least 200 
of them displayed that specific pattern. All of the types of patterns observed were then converted to 
percentages for analysis. This was performed for a minimum of three times for each cell line. 
  
Chapter IV: Correlation of Nuclear Lamins with Chromosomal Aneuploidies 
Marianne P Henry  Page | 113  
 
4.3.2. Western Blotting 
 
In order to quantify the amount of lamin proteins in the different cell lines, two million viable cells were 
counted using a manual haemocytometer (LabTech, UK). The cells were centrifuged at 500 x g, and the 
pellet washed two times with ice-cold PBS. The cell pellets were then re-suspended in 100µl of 3x 
Sample Buffer (SB) (100mM Tris-HCL (pH6.8), 4% SDS, 0.2% bromophenol blue, 20% glycerol, 0.2 % 
β-mercaptoethanol) via vortexing after being boiled at 100⁰C for at least fifteen minutes. 10µl of this 
solution, equivalent to 2 X 105 cells, was loaded into each well of 10% MiniPROTEAN® TGXTM precast 
polyacrylamide gels (Bio-Rad, UK) with TGS Running Buffer (BioRad, UK). Gels were run, at a constant 
voltage of 80-150V until the Precision Plus Protein Dual Colour Standard marker (BioRad, UK) exited the 
gel. The proteins in the gel were then transferred onto nitrocellulose membranes (Amersham 
Biosciences, UK) in transfer buffer (50 mM Tris, 380 mM glycine, 20% methanol (v/v)) on ice for one 
hour at 400mA. To check if the transfer was successful Ponceau S (Sigma-Aldrich, UK) staining was used. 
After the transfer, the membrane was washed three times for five minutes each on a shaker in Blot 
Rinse Buffer (BRB; 0.01M Tris, 0.15M NaCl, 0.001M of EDTA, 0.1% Tween 20, pH7.4). The nitrocellulose 
membrane was then blocked with 4% (w/v) dried skimmed milk (Marvel) in the BRB for at least one 
hour. After the blocking, the membrane was washed another three times with the BRB. The primary 
antibodies were diluted in 1% (w/v) dried skimmed milk in BRB and then placed onto the membrane 
overnight at 4°C on a shaker. The following morning the membrane was washed again in BRB another 
three times and the secondary antibody with 1% (w/v) dried skimmed milk in BRB was added for one 
hour at room temperature on a shaker. 
The primary antibodies from the immunofluorescence study were used; anti-lamin A was used at a 
dilution of 1:500, anti-lamin C – 1:100, anti-lamin B1 – 1:1000, anti-lamin B2 – 1:1000. Additionally, 
mouse and rabbit α-Tubulin antibodies (Abcam, UK) were used as controls in each membrane at a 
1:7000 dilution. Secondary antibodies goat anti-mouse IRDye 680RD (LI-COR, UK) and donkey anti-
rabbit IRDye 800CW (LI-COR, UK) were used at a 1:5000 dilution. The membranes were then visualised 
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using the Odyssey Imaging System (LI-COR, UK); bands in the 680RD range were visualised as red and 
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4.3.3. RNA Extraction and cDNA Synthesis 
 
The cells were grown in the conditions described in Chapter II (Section 2.3.1.). Invitrogen™ RNAlater™ 
Stabilization Solution was used to re-suspend the cells that were pelleted following cell culture, the 
solution was then incubated at 4⁰C overnight and then transferred to -80⁰C for long –term storage.  
The re-suspended cells were first thawed on ice and the RNA extraction was performed using the 
Maxwell® RSC simplyRNA Cells Kit (Promega) and Maxwell® RSC Instrument (Promega). The solution of 
cells was centrifuged at 300 x g for 5min, followed by a wash in ice-cold 1XPBS and then centrifuged at 
300 x g for another 5min. The supernatant was removed and 200μl of 1-Thioglycerol/Homogenization 
Solution was added, and the cells were vortexed until the pellet dispersed. Next, 200μl of Lysis Buffer 
was added, followed by vortexing and the 400μl of lysate was transferred to the first well on the 
Maxwell RSC Cartridge. DNase I solution of 5μl was added to the fourth well, a Plunger was placed into 
the eighth well and 50μl of nuclease-free water was added to the elution tubes. The cartridges were 
then loaded onto the instrument and RNA was automatically extracted. For quantification and 
qualification of RNA, the QIAxpert (Qiagen) was used. To make sure the RNA was of high quality- RNA 
Integrity Number, RIN, value of at least 8- the RNA samples were run on the Agilent TapeStation 
Bioanalyser, as described in Chapter II (Section 2.3.5). 
For cDNA synthesis, the High-Capacity cDNA Reverse Transcription Kit (ThermoFisher Scientific) was 
used with 200ng of RNA. First, a reverse transcription (RT) master mix (Table 5.1) was made with RNase 
Inhibitor on ice. Next, 10µl of the 2 X RT master mix was pipetted into each well of a 96-well reaction 
plate or individual tube with 200ng of RNA sample in a maximum volume of 10µl; if necessary the 
volume was supplemented with nuclease-free water.  The solution was mixed and centrifuged to 
eliminate any air bubbles and then loaded onto a thermocycler using the conditions described in Table 
5.2.  
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Table 5.1. cDNA Synthesis Kit Components and Volumes 
The High-Capacity cDNA Reverse Transcription Kit components and volumes are shown below. 
Component Volume (μl) 
10 X RT Buffer 2.0 
25 X dNTP Mix (100mM) 0.8 
10 X RT Random Primers 2.0 
MultiScribe™ Reverse Transcriptase 1.0 
RNase Inhibitor 1.0 
Nuclease-free Water 3.2 
 
 
Table 5.2. cDNA Synthesis Thermocycling Conditions 
The High-Capacity cDNA Reverse Transcription Kit thermocycling conditions are shown below. 
 Step 1 Step 2 Step 3 Step 4 
Temperature (⁰C) 25 37 85 4 
Time (min) 10 120 5 Hold 
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4.3.4. Quantitative Reverse Transcription PCR (RT-qPCR) 
 
Quantitative reverse Transcription PCR (RT-qPCR) was performed for lamins A, C, B1 and B2 to measure 
the levels of gene expression in diploid cell lines FCWES02 and MCWES01, and in aneuploid cell lines 
DD0567, DD0710 and DD1473. The gene expression was measured relative to the ratio of GAPDH 
expression via duplex assays for each reaction; all of the work was performed in triplicate. 
For lamins A and C gene expression analysis, the protocol was established by (Rodriguez et al., 2009). 
The sequences are shown in Table 5.3. The primers were custom-ordered from IDT, whereas the probes 
were custom-ordered as Taqman® MGBNFQ from ThermoFisher. For the RT-qPCR reaction mix, a total 
of 20μl was used per well; 300nM forward primer, 900 nM reverse primer, and 200nM of the MGB 
probe were used. The thermocycling conditions are shown in Table 5.4. The Stratagene RT-qPCR 
machine was used (Agilent Technologies). TaqMan® Gene Expression Master Mix was used at x2 
concentration. 
Table 5.3. Lamins A and C Primer and Probe Sequences 
The primer and probe sequences from Rodriguez, et al., 2009 are shown below. Both probes were 
labelled with FAM. 
 Lamin A Lamin C 
Forward Primer 5′-TCTTCTGCCTCCAGTGTCACG-3′ 5′-CAACTCCACTGGGGAAGAAGTG-3′ 
Reverse Primer 5′-AGTTCTGGGGGCTCTGGGT-3′ 5′-CGGCGGCTACCACTCAC-3′ 
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Table 5.4. Lamins A and C RT-qPCR Thermocycling Conditions 
The RT-qPCR thermocycling conditions for the gene expression analysis of lamins A and C. The 
conditions were established by Rodriguez, et al., 2009. 
 Step 1 Step 2 Step 3 Step 4 
Temperature (⁰C) 
50 95 95 60 
Time (min) 
2 10 0.25 0.75 
No. of Cycles 
1 1 50 
 
For the gene expression analysis of Lamin B1 (LMNB1) and B2 (LMNB2), as well as the reference gene, 
GAPDH, custom–made mixes of primers and probes were ordered from ThermoFisher Scientific. For 
GAPDH on VIC, the Assay ID was Hs02758991_g1, for LMNB1 on FAM – Hs01059210_m1 and LMNB2 
on FAM - Hs00383326_m1. Each of the primer and probe mixes from ThermoFisher Scientific contained 
900nM of primers and 250nM of probe; 1μl was used per reaction. TaqMan® Gene Expression Master 
Mix was used x2. Thermocycling conditions for the ready-made assays are shown in Table 5.5. 
 
Table 5.5. Lamins B1 and B2 RT-qPCR Thermocycling Conditions 
The RT-qPCR thermocycling conditions for the gene expression analysis of lamins B1 and B2.  
 Step 1 Step 2 Step 3 Step 4 
Temperature (⁰C) 50 95 95 60 
Time (min) 2 10 0.25 1 
No. of Cycles 1 1 40 
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4.4.1. A-Type Lamins 
4.4.1.1. Indirect Immunofluorescence 
 
Indirect immunofluorescence was performed for the whole panel of lymphoblastoid cell lines. As a 
positive control the lamin A and lamin C antibodies were used in an ovarian cell line SKOV-3 (Figure 4.1) 
to confirm that the antibodies were viable. For A-type lamins, absence of lamin A staining in the cell 
nuclei of all of the cell lines tested was observed (Figure 4.2). Both lamins A and C positively stained the 
SKOV-3 cells and confirmed that the lamin A and lamin C antibodies were working in our hands. The 
SKOV-3 nuclei showed peripheral staining for both A-type lamins with large internal foci within the 
nucleoli. As no staining of lamin A was observed in any of the lymphoblastoid cell lines, we did not 
quantify this further. On the other hand, for lamin C staining in the lymphoblastoid cells lines, internal 
foci within the nuclei were observed, as well as negative staining (Figure 4.2). The lamin C foci tended 
to be randomly dispersed across the nuclei, but occasionally clustered towards the nuclear periphery. 
Such examples of the internal foci are shown in Figure 4.3. 
In order to quantify the different lamin C patterns observed from the immunofluorescence, a pattern 
analysis of staining within the nuclei was performed for lamin C. The results had shown that the majority 
of the cell lines had stained for a pattern of internal foci within the nuclei with the wild-type female cell 
line, FCWES01 expressing the highest amount, 96%. In contrast, the aneuploid cell line DD0710 
expressed the lowest amount at 78% (Figure 4.4). The only other category of staining detected for lamin 
C staining analysis was negative staining.  
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Figure 4.1. Lamin A and C Staining in SKOV-3 Cells 
Staining for the nucleus in the DAPI channel, Lamin A in the FITC channel and Lamin C in the Cy3 channel 
are shown in grayscale and then merged together with DAPI in blue, Lamin A in green and Lamin C in 
red. The scale bar is shown. 
 
Figure 4.2. Lamin A Staining in Lymphoblastoid Cells 
Staining for the nucleus in the DAPI channel and Lamin A in the FITC channel are shown in grayscale 




DAPI Lamin A Merged 
DAPI Lamin A Merged Lamin C 
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Figure 4.3. Lamin C Staining in Lymphoblastoid Cells 
Staining for the nucleus in the DAPI channel and Lamin C in the Cy3 channel are shown in grayscale and 
then merged together with DAPI in blue and Lamin C in red. The scale bar is shown. Lamin C staining 
showed internal foci dispersed throughout the nuclei. Each of these staining patterns shown above 
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Figure 4.4. Lamin C Staining Pattern Analysis 
The cell nuclei were stained for Lamin C and their staining patterns analysed. Two staining patterns for 
Lamin C were identified, negative staining and internal foci. The percentage of nuclei for each staining 
pattern type is shown. Cell lines FCWES02, MCWES01, DD0567, DD0710 and DD1473 with karyotypes 









         XX            XY XXX    XXY     XXXX 
Chapter IV: Correlation of Nuclear Lamins with Chromosomal Aneuploidies 
Marianne P Henry  Page | 123  
 
4.4.1.2. Western Blotting  
 
Western Blotting was performed for all of the lymphoblastoid cell lines, FCWES01, FCWES02, 
MCWES01, MCWES02, DD0567, DD0710, DD1473 and for the control primary human dermal fibroblast 
cell line NB1, for A-type lamins, A and C separately, as well as β-tubulin as the reference gene. Their 













No lamin A was observed in any of the lymphoblastoid cell lines by Western blotting; the NB1 cell were 
positive for lamin A at 74kDa and all of the cell lines expressed the reference gene, β-tubulin at 50kDa 
(Figure 4.5). A minimum of three independent Western blots were performed. 
  
β-Tubulin  







Figure 4.5. Lamin A and Beta-Tubulin Western Blot 
Lymphoblastoid cell lines FCWES01, FCWES02, MCWES01, MCWES02, DD0567, DD0710, DD1473 and 
fibroblast NB1s were analysed. All of them were negative for Lamin A, except the positive control NB1 
for Lamin A that was observed at 74kDa. The positive control (β-Tubulin) was observed at 
approximately 50kDa in the 800CW channel. 
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Similarly, western blotting was performed for all of the lymphoblastoid cell lines for lamin C and β-
tubulin. Their expression levels were monitored and compared alongside NB1 cells that were used as 
the positive control. Similar to the lamin A results (Figure 4.5), the lymphoblastoid cell lines did not 
express lamin C, unlike the NB1 cells used as the positive control (Figure 4.6). The lamin C protein 
showed at approximately 65kDa. All of the cell lines expressed the reference gene, β-tubulin in the 



























Figure 4.6. Lamin A and Beta-Tubulin Western Blot 
Lymphoblastoid cell lines FCWES01, FCWES02, MCWES01, MCWES02, DD0567, DD0710, DD1473 and 
fibroblast NB1s were analysed. All of them were negative for Lamin A, except the positive control NB1 
for Lamin A that was observed at 65kDa. The positive control (β-Tubulin) was observed at approximately 
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4.4.1.3. Reverse Transcription PCR 
 
 
For lamin A, an extremely significant difference in the gene expression was observed (Figure 4.7A; 
p<0.0001). The wild-type female cell line, FCWES02, showed extremely significant difference to the 
male wild-type cell line, MCWES01 and very significant difference to the aneuploid cell lines, DD0567 
and DD0710. MCWES01 had also shown extremely significant difference to all of the aneuploid cell 
lines. Additionally, aneuploid cell line, DD1473, had shown very significant difference to the remaining 
aneuploid cell lines, DD0567 and DD0710. 
For lamin C, an extremely significant difference in the gene expression was observed (Figure 4.7B; 
p<0.0001). The wild-type female cell line, FCWES02, showed extremely significant difference to the 
male wild-type cell line, MCWES01 and very significant difference to the aneuploid cell line, DD1473. In 
addition, the male wild-type cell line, MCWES01 had demonstrated extremely significant difference to 
all of the aneuploid cell lines. Between the aneuploid cell lines, DD1473 displayed extremely and very 
significant difference to both DD0567 and DD0710. 
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Figure 4.7. A-Type Lamin Gene Expression in Lymphoblastoid Cell Lines 
A-type lamin gene expression was measured via RT-qPCR in a duplex reaction with GAPDH as the 
reference gene. The relative gene expression to GAPDH were plotted for each cell line and a one-
way analysis of variance (ANOVA) and Tukey’s Multiple Comparison Test was performed between 
each sample; the significant differences between samples are shown in asterisks. The gene 
expression of lamin A (A) and lamin C (B) are shown. Wild-type lymphoblastoid female and male 
cells lines, FCWES02 and MCWES01 are shown, respectively, alongside aneuploid lymphoblastoid 
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4.4.2. B-Type Lamins 
4.4.2.1. Indirect Immunofluorescence 
 
 
For B-type lamins, lamin B1 and B2 were stained via immunofluorescence and the distribution analysis 
was performed for all of the cell lines. The results demonstrated that most of the nuclei, regardless of 
the cell line, expressed lamin B1 protein staining as a rim around individual nuclei. An example of this 
is shown in Figure 4.8.In addition, the wild-type female cell line, FCWES02 and the aneuploid cell line, 
DD1473 expressed the highest amounts of rim staining around the nuclei, both close to 99%. In 
contrast, the wild-type male, MCWES01 expressed the lowest amount of lamin B1 rim staining at 80% 
(Figure 4.9). Another type of staining pattern observed in the lymphoblastoid cells for the intranuclear 
staining, the lamin B1 staining was also observed within the nuclei (Figure 4.8). The highest amount was 
observed in the wild-type male cell line, MCWES01 with nearly 20%, whereas the lowest was observed 
in the aneuploid cell line DD1473 with less than 1% intranuclear staining. A one-way analysis of variance 
was carried out for all of the cell lines and the lamin B1 staining distribution that was observed; 
p<0.0001 demonstrating extreme statistically significance between the samples for both rim and 
intranuclear staining in the cell lines.  
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Figure 4.8. Lamin B1 Rim and Intranuclear Staining in Lymphoblastoid Cells 
Staining for the nucleus in the DAPI channel and Lamin B1 in the Cy3 channel are shown in grayscale 
and then merged together with DAPI in blue and Lamin B1 in red. The scale bar is shown. Lamin B1 
staining showed as a rim in A and as intranuclear staining in the nuclei with either dots dispersed 
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Figure 4.9. Lamin B1 Staining Pattern Analysis 
Indirect immunofluorescence was performed for Lamin B1 in the whole panel of lymphoblastoid cell 
lines and their distribution was analysed. Two staining patterns for Lamin B1 were identified as a rim 
around the periphery of the nucleus and intranuclear staining referring to dispersed dots and 
homogenous staining of the nuclei. The percentage of nuclei for each staining pattern type is shown 
with standard error of mean error bars. Cell lines FCWES02, MCWES01, DD0567, DD0710 and DD1473 
with karyotypes XX, XY, XXX, XXY and XXXX, respectively, were analysed. A one-way analysis of variance 
was calculated for the rim and intranuclear staining patterns across the different cell lines; p<0.0001 
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For lamin B2 staining, the results had demonstrated that most of the samples, except DD0567, 
expressed lamin B2 protein staining as a rim around the nuclei, as previously observed for the lamin B1 
staining. Examples of such staining patterns are shown in Figure 4.10. A percentage of the cells 
demonstrated intranuclear staining, similar to the intranuclear staining observed in lamin B1 (Figure 
4.11). 
To quantify the lamin B2 staining results, a pattern analysis within the nuclei was performed. The results 
displayed that all of the cell lines had mostly stained for a rim around the periphery of the nucleus with 
the aneuploid cell line, DD1473 expressing the highest amount, 89%, whereas the aneuploid cell line, 
DD0567, the lowest amount of 8% (Figure 4.12). In addition, the lamin B2 staining in the nuclei was also 
observed within the nuclei, as per Figure 4.11. The highest amount was observed in the aneuploid line, 
DD0567 with nearly 92%, whereas the lowest was observed in the aneuploid cell line DD1473 with 11% 
intranuclear staining. A one-way analysis of variance was carried out for all of the cell lines and the 
lamin B2 staining distribution that was observed; p<0.0001 demonstrating extreme statistically 
significance between the samples for both rim and intranuclear staining in the cell lines. 
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Figure 4.10. Lamin B2 Rim Staining in Lymphoblastoid Cells 
Staining for the nucleus in the DAPI channel and Lamin B2 in the FITC channel are shown in grayscale 
and then merged together with DAPI in blue and Lamin B2 in green. The scale bar is shown. Lamin B2 
staining showed rim staining around the periphery of the nuclei. Each of these staining patterns shown 








Figure 4.11. Lamin B2 Intranuclear Staining in Lymphoblastoid Cells 
Staining for the nucleus in the DAPI channel and Lamin B2 in the FITC channel are shown in grayscale 
and then merged together with DAPI in blue and Lamin B2 in green. The scale bar is shown. Lamin B2 
staining showed an intranuclear staining in the nuclei with either dots dispersed throughout the nuclei 
with a homogenous staining. Each of these staining patterns shown above were identified and classified 
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Figure 4.12 Lamin B2 Staining Pattern Analysis 
The cell nuclei were stained for Lamin B2 and their staining patterns analysed. Two staining patterns 
for Lamin B2 were identified as a rim around the periphery of the nucleus and intranuclear staining 
referring to dispersed dots and homogenous staining of the nuclei. The percentage of nuclei for each 
staining pattern type is shown with standard error of mean as error bars. Cell lines FCWES02, 
MCWES01, DD0567, DD0710 and DD1473 with karyotypes XX, XY, XXX, XXY and XXXX, respectively, were 
analysed. A one-way analysis of variance was calculated for the rim and intranuclear staining patterns 
across the different cells lines; p<0.0001 signifying extreme statistical significance for the rim staining 
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4.4.2.2. Western Blotting 
 
For B-type lamins, western blotting was performed out on the lymphoblastoid cells for lamins B1 and 
B2, alongside β-Tubulin, as the reference gene. An example western blot of lamin B1 and β-tubulin is 
shown in and the ratio of the mean gray intensities of lamin B1 to β-tubulin was plotted (Figure 4.13 B). 
No significant difference was observed from a One-way analysis of variance (ANOVA; P= 0.7087) and 
Tukey’s Multiple Comparison Test in the different lymphoblastoid cell lines for Lamin B1 protein 
expression from the Western Blots. Images were analysed via Fiji/ImageJ in a minimum of three by 
monitoring the mean gray intensities of the bands in reference to the positive control, β-tubulin. 
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Figure 4.13. Lamin B1 and Beta-Tubulin Western Blot 
Lymphoblastoid cell lines FCWES01, FCWES02, MCWES01, MCWES02, DD0567, DD0710, DD1473 were 
positive for Lamin B1 at approximately 68kDa and for the positive control, β-tubulin at approximately 
50kDa (A). 
The ratio of the mean gray intensities of lamin B1 to β-tubulin were plotted (B). The standard error of 
mean was used as the error bars. A minimum of three blots were analysed. No significant difference 
was observed between the different samples using a One-way analysis of variance (ANOVA; p=0.7087) 
and Tukey’s Multiple Comparison Test. 
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Similarly, lamin B2 western blots were performed with the lymphoblastoid cells and with β-tubulin as 
the reference gene and the ratio of the mean gray intensities of lamin B2 to β-tubulin were plotted 
(Figure 4.14). No significant difference was observed from a One-way ANOVA (p= 0.7944) and Tukey’s 
Multiple Comparison Test in the different lymphoblastoid cell lines for Lamin B2 protein expression. 
Images were analysed via Fiji/ImageJ in a minimum of three by monitoring the mean gray intensities of 
the bands in reference to the positive control, β-tubulin. 
 
  
Chapter IV: Correlation of Nuclear Lamins with Chromosomal Aneuploidies 




















































































Lamin B2  65 
50  






Figure 4.14. Lamin B2 and Beta-Tubulin Western Blot 
Lymphoblastoid cell lines FCWES01, FCWES02, MCWES01, MCWES02, DD0567, DD0710, DD1473 were 
positive for Lamin B2 at approximately 65kDa and for the positive control (β-Tubulin) was observed at 
approximately 50kDa (A). 
The ratio of the mean gray intensities of lamin B2 to β-tubulin were plotted (B). The standard error of 
mean was used as the error bars. A minimum of three blots were analysed. No significant difference was 
observed between the different samples using a One-way analysis of variance (ANOVA; p=0.7944) and 
Tukey’s Multiple Comparison Test. 
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4.4.2.3. Reverse Transcription PCR 
 
 
To measure the gene expression of the B-type lamins, RT-qPCR was performed on all of the 
lymphoblastoid cell lines; relative expression to GAPDH was measured. A One-way ANOVA and Tukey’s 
Multiple Comparison Test was performed between all of the cell lines for each gene.  
Interestingly, lamin B1 gene expression did not show any significant difference between any of the 
samples analysed (ANOVA p= 0.2234; Figure 4.15 C). In contrast, for lamin B2 gene expression the wild-
type female cell line, FCWES02 had shown significant difference to the aneuploid cell line, DD0170 and 
very significant difference to aneuploid cell line DD1473 (ANOVA p=0.0045; Figure 4.15 D). 
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Figure 4.15. B-Type Lamin Gene Expression in Lymphoblastoid Cell Lines 
B-type lamin gene expression was measured via RT-qPCR in a duplex reaction with GAPDH as the 
reference gene. The relative gene expression to GAPDH were plotted for each cell line and a one-
way analysis of variance (ANOVA) and Tukey’s Multiple Comparison Test was performed between 
each sample; the significant differences between samples are shown in asterisks ; * for 
statistically significant different (p<0.05) and ** for very statistically significant different 
(p<0.01). The gene expression of lamin B1 (A) and lamin B2 (B) are shown. Wild -type 
lymphoblastoid female and male cells lines, FCWES02 and MCWES01 are shown, respectively, 
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 4.5. Discussion 
 
 
The inner nuclear membrane has a role in the maintenance of nuclear morphology (Bridger et al., 2007) 
and also has functions in the regulation of gene expression in different tissues and in chromatin 
organisation (Dechat et al., 2008). Our results have been consistent with previously studies that 
observed the lack of A-type lamins in lymphoblastoid cell lines. However, unlike our result, this study 
did observe small amounts of lamins A and C (Reichart et al., 2004). Although, we did not observe any 
A-type lamins using western blotting for protein detection, we did see some small amounts of staining 
using immunofluorescence. One possible explanation of this could be the antibodies used in this study. 
Most studies have not used antibodies for both lamins A and C separately, but instead stain for lamin 
A/C. As lamin A and C differ only by the last 98 amino acids, antibodies to distinguish the two target the 
ends of these proteins. For this reason, it is possible that during the protein preparation for western 
blotting the ends of these proteins denature so that the antibody cannot bind and therefore detect 
them on the western blots. Further work would be required using different antibodies to establish 
whether the antibody used in this study did not detect small amounts of protein in the cell nuclei. 
Alternatively, another technique, such as enzyme-linked immunosorbent assay (ELISA) could confirm 
the presence or absence of lamin protein and more sensitively quantify them in these cell lines. 
Furthermore, our IF data demonstrated significantly increased levels of negative lamin C staining in the 
aneuploid cell lines. As very few research groups stain for both A-type lamins, it is difficult to compare 
our data with other findings. Previously, one group had identified that the absence of lamin A can cause 
lamin C intranuclear speckles to aggregative throughout the nucleus and suggested that lamin A is 
required for the nuclear envelope localisation of lamin C (Pugh et al., 1997; Vaughan et al., 2001). 
Similarly, not much is known about the state of lamin proteins in aneuploid cell types, the reduced 
percentage of lamin C internal foci may be a possible indicator of the difference in chromosome copy 
number, however further work is required to reach a conclusion.  
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Interestingly, although no significant difference was observed in B-type lamin protein expression 
between the wild-type and aneuploid cells, B2 protein expression was lower in the aneuploid cell lines. 
In addition, using RT-qPCR we confirmed a significant difference between the wild-type female cell line 
and the aneuploid cell lines DD0710 and DD1473 with karyotypes XXX and XXXX, respectively, 
suggesting a link between the two.  In addition, DD0567 with XXY karyotype expressed the least rim-
like patterns of lamin B2. Previously, a study had observed reduced lamin B2 to cause the accumulation 
of aneuploidies in the cell nuclei (Ranade et al., 2017). Further research into this with more cell lines 
with known aneuploidies and using B2 depletion techniques, such as siRNA, is required to establish this 
link between aneuploidies and lamin B2 reduction. 
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Chapter V: The Effects of Different Media-Matrice Combinations on the Genomic Instability of Human 
Pluripotent Stem Cells 




As mentioned in Chapter I, currently no method or media for the growth of human pluripotent stem 
cells has been standardised. Human embryonic stem cells and induced pluripotent stem cells are 
commonly grown on a layer of human dermal fibroblasts as feeder cells or on a soluble basement 
membrane, such as Matrigel™. Although the latter is a good xeno-free alternative to feeders (Ludwig 
et al., 2006), it has not been readily used by researchers, partly due to the high cost of feeder-free 
basement membranes (Khadun, 2013). 
Similarly, the passage number of stem cells needs to be monitored more closely, along with the method 
of culture, including whether the cells are manually or enzymatically passaged. This would help during 
the characterisation of these cells, as certain methods may allow faster cell culture, but may also have 
disadvantages, such as the faster accumulation of chromosome aneuploidies in culture (Brimble et al., 
2004; Buzzard et al., 2004; Draper et al., 2004; Schwartz et al., 2011; Garitaonandia et al., 2015). 
With emerging practises for the upscaling of hPSCs, novel methods are required to monitor and 
standardise the use and production of cellular materials intended for therapeutic use. Despite the 
increasing availability of novel techniques to increase the yield and/or quality of cells, the quality control 
for these cells remains unchanged; karyology, flow cytometry, differentiation potential and gene 
expression studies typically make up the characterisation of hPSCs. More sensitive and high-throughput 
methods need to be developed to understand how the novel techniques may affect the potential end-
products. For example, despite the advancement in the large-scale production of human pluripotent 
stem cells, the low resolution and insensitive karyotyping method, G-banding, still remains the gold 
standard for karyology. Similarly, the use of methods, such as qPCR for observing gene expression of 
“pluripotent” genes remains a widely-used method for stem cell characterisation, despite the need for 
standard curves for accurate quantification. Newer techniques are required to sensitively characterise 
hPSCs, as well as be practical to be used widely across different laboratories. High-throughput methods 
are required to screen hPSC that can accurately determine the cells’ pluripotency and genomic stability. 
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Although newer methods, such as the NanoString Technologies™ Human Karyotype Panel, a 
microarray-based technique for aneuploidy detection, BioRad’s Droplet Digital PCR™ for absolute 
quantification of nucleic acids and BioMark™ Fluidigm®, a high-throughput PCR system, are being 
developed, these methods need to be better integrated into the stem cell community.  Firstly, these 
newer methods are semi-automated, reducing the risk of both contamination and human error, as well 
as utilise microfluidic technology for the use of small sample volumes to multiplex their assays. 
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The aims of this study were to evaluate the genomic health of the human pluripotent stem cells 
provided by our collaborators using minimum sample quantities. The UKSCB performed an evaluation 
on the effect of different media and matrices combinations on viability, genomic stability, 
differentiation potential and pluripotency marker expression. Whilst the UKSCB’s usual method of 
determining genomic stability is via G-banding, we aimed to assess whether ddPCR™ using AMELX as a 
model for aneuploidy detection could provide a more sensitive method to evaluate the genomic 
stability and FISH to characterise the genome organisation of AMELX and ALB within these cells. In 
addition, we investigated whether specific media and matrices combinations have a particular negative 
or positive effect on the genomic instability of the hPSCs and their genome organisation in interphase 
nuclei. 
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5.3. Methods and Materials 
 
All cell culture work was performed by Jennifer Man and Craig Nowell (UKSCB). Cell pellets were 
provided for ddPCR™, whereas FISH sample were collected and fixed as per Chapter III by me.  
5.2.1. Cell Culture 
 
After thawing from a cryopreserved vial, the H9 human embryonic stem cells, also known as WA09 
(WiCell, USA), originally derived at the University of Wisconsin by Dr James Thomson (Thomson et al., 
1998), were first stabilised for approximately  five passages on inactivated human dermal fibroblasts 
(HDFs; used internally at the UKSCB), after which they were transferred to different media and matrix 
combinations. On thawing, the H9 cells were labelled as P0; every subsequent passage was labelled as 
PnPS (passage, number of passages and post-seed). 
The H9 cells were grown in 6-well plates and 12 different media-matrix combinations were tested 
(Table 5.6). During each passage, samples were collected for analyses, including flow cytometry, G-
banding, embryoid body (EB) formation and qPCR. Figure 5.1 shows how the cells were scaled up for 
the UKSCB use. 
 
 
Table 5.6. Media and Matrices Used  
Medium Matrix 
Essential 8™ Medium (ThermoFisher Scientific) Matrigel (Corning) 
NutriStem XF/FF Culture Medium for Human iPS 
and ES Cells (Stemgent, USA) 
Laminin 511 (BioLamina, Sweden) 
TeSRTM2 (Stem Cell Technologies, UK) 
 
Laminin 521 (BioLamina, Sweden) 
 Vitronectin XF™ (Stem Cell Technologies, UK) 
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Figure 5.1. Media and Matrices Combination Flowchart 
The image above shows the experimental workflow of the project. The H9 cells were thawed from 
the mastercell bank (MCB) at passage 29 (P29) and sent for karyotyping. The cells  were then 
allowed to stabilise on inactivated human dermal fibroblasts until P34, where they were sent for 
karyotyping again and re-labelled as P0. The cells were then passaged onto different media and 
matrices combinations i.e. TeSR™, NutriStem XF/FF and  Essential 8™ media in combination with 
Matrigel®, Vitronectin XF™, Laminin-521 and Laminin-511 matrices. At passages 1, 3, 5 and 10 in 
each combination, the cells were sent for karyotyping.  
P0 





















Figure 5.2. Flowchart of the Different H9 Media and Matrices Growth Conditions 
The flowchart shows how the H9 cells were initially grown on human dermal fibroblasts (HDFs) for stabilisation, followed by t he individual media and matrices 
combinations used in the study. The red circles show the samples grown in TeSR2™ m edium, the blue – Essential 8™ medium and the green – NutriStem XF/FF 
medium, whereas the different coloured outlines signify the different matrices. The red outlined circles indicate the use of Matrigel®, the yellow – Vitronectin XF™, 
the turquoise – Laminin-511 and purple – Laminin 521. The samples used in the ddPCR™ are shown as passage number post-seed (PnPS) in pink circles; the black 
outlined samples are the ones that were also used for both ddPCR™ and for fluorescence in-situ hybridisation (FISH) experiments. 
    
 
5.2.2. Quality Control 
 
For quality control monitoring of the cells, the UKSCB test hPSCs for a number of different factors, 
including qPCR for stem cell markers, flow cytometry for pluripotency cell surface markers, karyology 
via G-banding, differentiation efficiency via embryoid body (EB) formation (tested for differentiation 
markers on qPCR) and viability (tested on the NuceleoCounter, NC-100TM (Chemometec, Denmark). 
These assays were performed by Drs Man and Nowell. 
The H9 cells were karyotyped by G-banding at the Sheffield Diagnostic Genetics Service (Sheffield 
Children’s NHS Foundation Trust, UK); the master cell bank of H9 cells were karyotyped after thawing 
(P29), immediately before passaging (P34 or pre-seed) onto the different media and matrice conditions 
and also P1PS, P3PS, P5PS and P10PS (Figure 5.1).  
5.2.3. Droplet Digital PCR 
 
DNA was extracted as per Section 2.2.2. using the GenElute DNA Extraction Kit. The DNA quantification 
and quality monitoring were performed as per Section 2.2.3. For the ddPCR™, the concentration of 
primers and probes were used as per Section 2.2.6, using AMELX and ALB. The DNA was neither 
enzymatically treated nor sonicated, due to the small amount provided by the UKSCB. The AutoDG was 
used for all of the experiments. Wild-type female samples, FCWES01 and FCWES02, and sonicated 
FCWES01 were used as the positive controls. All of the data in this study were normalised to the average 
of these controls as per Chapter II. 
As the design of the experiment originally did not include ddPCR™, there were not always enough 
samples at each passage for ddPCR™ to be performed. Figure 5.2 shows which samples were used for 
ddPCR™; all of the pink circles are the samples used in ddPCR™. 
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5.2.4. Fluorescence In-Situ Hybridisation and Image Analysis 
 
 All of the fluorescence in-situ hybridisation (FISH) work and the associated image analysis for the cell 
morphology was performed as per Section 3.3.1. using AMELX and ALB fluorescent probes for a 
minimum of 100 nuclei for FISH and 200 for morphology analyses. 
As the design of the experiment originally did not include FISH, there was not always enough sample at 
each passage for our FISH experiments. Figure 5.2 shows pink circles with black outlines which were 
the samples used for both FISH and ddPCR™. 
5.2.5. Statistical Analysis 
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Human embryonic stem cells from H9 were originally derived in 1998 and karyotyped at passage 2 to 
9; the results showed a normal 46, XX karyotype (Thomson et al., 1998). The H9 cells used in this study 
were sent for karyotyping by G-banding at passage 29 (P29) when they were first thawed onto feeder 
cells and then again at P34. Both passages showed normal 46, XX karyotypes (personal correspondence, 
J. Man, UKSCB). A further 48 samples were sent for G-banding at P1PS, P3PS, P5PS and P10PS in each 
media and matrix condition, although for unknown reasons results for only 38 of the samples were 
provided. All 38 samples demonstrated a diploid female karyotype of 46, XX in all 20-30 of the 
metaphase cells, except in 1 sample, where a gain of whole chromosome 12 (47, XX +12) was observed 
at P1PS in TeSR2™ Laminin-521 (personal correspondence, J. Man, UKSCB). However, this was observed 
only in one of thirty metaphase spreads examined and was not present in the later passages i.e. P3PS, 
P5PS and P10PS.  
5.4.1. ddPCR™ of H9 Cells 
 
 
The H9 cells were then assessed for an alteration in the ratio of AMELX to ALB by ddPCR™ as an indicator 
of X chromosome aneuploidy. In order to stratify the data analysis, the samples were grouped into 
three categories, according to the medium in which they were cultured; TeSR™, NutriStem XF/FF and 
Essential 8™ (Figure 5.3, Figure 5.4 and Figure 5.5 ).  
Figure 5.3 shows that the TeSR™ combinations for H9 cells had no significant difference between the 
samples provided by the UKSCB and the diploid female control used (As per Chapter II) for the number 
of AMELX copies.  No effect was observed over time or in the different matrices used in combination 
with TeSR2™. 
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Figure 5.3. Relative AMELX Copy Number Measurement via ddPCR™ in H9 Cells Grown in TeSR™ 
Medium 
ddPCR™ results for the ratio of AMELX to ALB is shown for each sample. H9 cells were grown in TeSR2™ 
medium with different matrices – Matrigel ®, Vitronectin XF™, Laminin-521 and Laminin-511 across 
different passages labelled as P followed by the number of the passage and PS (post-seed of P34) in the 
format PnPS.  
A two-tailed t-test and F-test were performed for each sample to the control, the average of the wild-
type female lymphoblastoid cell lines, FCWES01 and FCWES02. Both control and the samples were 
analysed in triplicates, the standard error of mean is shown for error bars. No significant difference was 
observed in any of the samples analysed.  
 
In Figure 5.4, 10 of 11 of the NutriStem XF/FF™ combinations for H9 cells showed a significant difference 
between the control and the individual sample; a two-tailed t-test and F-test were used. Figure 5.4 
shows the level of significance between each sample. The only combination that showed no statistically 
significant difference from the control was NutriStem XF/FF™Laminin-511 at P1PS, which at the later 
passages of P9PS and P10PS had displayed a reduction in the AMELX copy number to 82.7% and 78.77%, 
respectively (derived from the ratio of AMELX to ALB). Similar reductions in the copy number of AMELX 
were observed in the Matrigel® and Laminin-521 combinations to approximately 60% and 90%, 
respectively. Conversely, the Vitronectin XF™ combination had shown an increase of AMELX in 
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Figure 5.4. Relative AMELX Copy Number Measurement via ddPCR™ in H9 Cells Grown in NutriStem 
XF/FF™ Medium 
ddPCR™ results for the ratio of AMELX to ALB is shown for each sample. H9 cells were grown in 
NutriStem XF/FF™ medium with different matrices – Matrigel ®, Vitronectin XF™, Laminin-521 and 
Laminin-511 across different passages labelled as P followed by the number of the passage and PS 
(post-seed of P34) in the format PnPS.  
A two-tailed t-test and F-test were performed for each sample to the control, the average of the wild-
type female lymphoblastoid cell lines. Both control and the samples were analysed in triplicates, the 
standard error of mean is shown for error bars. Significant difference between the control and sample 
is shown as * when p<0.05, ** when p<0.01 and *** when p<0.001. 
 
 
In Figure 5.5, seven of nine Essential 8™ combinations for H9 cells showed a significant difference 
between the control and the individual sample; a two-tailed t-test and F-test were used. Figure 5.5 
shows the level of significance between each sample. The only combination that showed no statistical 
significance to the control was Essential 8™ Matrigel® at P7PS and Laminin-511 at P7PS. Interestingly, 
unlike the NutriStem XF/FF™ samples, the AMELX copy number have shown a gradual increase across 
passages in all of the matrices combinations. Although the increase in AMELX copy number, it did range 
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Figure 5.5. Relative AMELX Copy Number Measurement via ddPCR™ in H9 Cells Grown in Essential 
8™ Medium 
ddPCR™ results for the ratio of AMELX to ALB is shown for each sample. H9 cells were grown in Essential 
8™ medium with different matrices – Matrigel ®, Vitronectin XF™, Laminin-521 and Laminin-511 across 
different passages labelled as P followed by the number of the passage and PS (post-seed of P34) in the 
format PnPS.  
A two-tailed t-test and F-test were performed for each sample to the control, the average of the wild-
type female lymphoblastoid cell lines. Both control and the samples were analysed in triplicates, the 
standard error of mean is shown for error bars. Significant difference between the control and sample 
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5.4.2. Fluorescence In-Situ Hybridisation 
 
 
FISH was performed on the different media and matrix combinations on H9 cells provided by Drs 
Jennifer Man and Craig Nowell from the UKSCB. A one-way analysis of variance (ANOVA) and Tukey’s 
Multiple Comparison Test were used to compare the samples to each other. For the ALB positioning, 
only two samples showed a significant difference between each other. This was observed between Shell 
5 of NutriStem XF/FF™ Laminin-511 P10PS (Figure 5.7 Panel B) and Essential 8™ Laminin-521 P6PS 
(Figure 5.8 Panel D). The ALB positioning in all of the samples generally maintained a peripheral 
positioning in the cell nuclei, with the exception of NutriStem XF/FF™ Laminin-511 P10PS (Figure 5.7 
Panel B), where there seemed to be a more central positioning for ALB and Essential 8™ Vitronectin 
XF™P3PS (Figure 5.8 Panel B) displays a more intermediate positioning of ALB in the nuclei of the cells. 
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Figure 5.6. ALB Positioning in TeSR2™ Media in Combination with Different Matrices  
Cell line H9 was grown under different combinations of TeSR2™ medium and Matrigel® (A) and 
Laminin-521 (B) matrices at passages 3 and 9, respectively. ALB positioning is shown in 
approximately 100 nuclei using the Erosion Script on the IPLAB software. Neither of the samples 
had shown any significant difference to the other samples in the one-way analysis of variance 
(ANOVA) and from the Tukey’s Multiple Comparison Test; standard error of mean is shown as 
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Figure 5.7. ALB Positioning in NutriStem XF/FF™ Media in Combination with Different Matrices  
Cell line H9 was grown under different combinations of NutriStem XF/FF™ medium with Matrigel® at 
P6PS (A), Laminin-511 at P10PS (B) and Laminin-521 at P6PS (C). ALB positioning is shown in 
approximately 100 nuclei using the Erosion Script on the IPLAB software. The asterisk (*) in B represents 
a significant difference to Essential 8™ Laminin-521 at P6PS (Figure 5.8 Panel D) in Shell 5 using one-
way analysis of variance (ANOVA) and Tukey’s Multiple Comparison Test; standard error of mean is 
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Figure 5.8. ALB Positioning in Essential 8™ Media in Combination with Different Matrices  
Cell line H9 was grown under different combinations of Essential 8™ medium with Matrigel® at P7PS 
(A), Vitronectin XF™ (B) at P3PS, Laminin-511 (C) at P7PS and Laminin-521 at P6PS (D). ALB positioning 
is shown in approximately 100 nuclei using the Erosion Script on the IPLAB software. The asterisk (*) 
represents a significant difference to NutriStem XF/XX Laminin-511 at P10PS (Figure 5.7 Panel D) from 
the one-way analysis of variance (ANOVA) and Tukey’s Multiple Comparison Test; standard error of 
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For the AMELX positioning more differences in the gene positioning were observed in comparison to 
ALB, especially for Shell 5, the innermost shell of the nucleus. The sample that had shown the most 
significant difference to all of the other samples is Essential 8™ Laminin-521 P6PS (Figure 5.11 Panel D), 
where for Shells 1 and 2 were significantly different to Essential 8™ Laminin-511 P7PS (Figure 5.11 Panel 
C) and for Shell 5, it was again significantly different to  Essential 8™ Laminin-511 P7PS (Figure 5.11 
Panel C), and in addition to all of the NutriStem  samples i.e. NutriStem XF™ Matrigel® P6PS (Figure 5.10 
Panel A), NutriStem XF™ Laminin-511 P10PS (Figure 5.10 Panel B), NutriStem XF™ Laminin-521 P6PS 
(Figure 5.10 Panel C) and also to Essential 8™ Matrigel® P7PS (Figure 5.11 Panel A). 
Additionally, Essential 8™ Laminin-511 P7PS (Figure 5.11Panel C) had shown a central positioning, 
whereas TeSR2™ Matrigel P3PS (Figure 5.9 Panel A) and NutriStem XF/FF™ Matrigel® P6PS (Figure 5.10 
Panel A) had a more intermediate positioning for AMELX. Interestingly, both ALB and AMELX in TeSR2™ 
Matrigel P3PS (Figure 5.6 Panel A and Figure 5.9 Panel A, respectively) samples had shown this 
intermediate positioning. 
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Figure 5.9. AMELX Positioning in Essential 8™ Media in Combination with Different Matrices  
Cell line H9 was grown under different combinations of Essential 8™ medium with Matrigel® at 
P3PS (A) and Laminin-521 at P9PS (B). AMELX positioning is shown in approximately 100 nuclei 
using the Erosion Script on the IPLAB software. Neither of the samples had shown any significant 
different to the other samples in the one-way analysis of variance (ANOVA) and from the Tukey’s 
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Figure 5.10. AMELX Positioning in NutriStem XF/FF™ Media in Combination with Different Matrices 
Cell line H9 was grown under different combinations of NutriStem XF/FF™ medium with 
Matrigel® at P6PS (A), Laminin-511 at P10PS (B) and Laminiin-521 at P6PS (C). AMELX positioning 
is shown in approximately 100 nuclei using the Erosion Script on the IPLAB software. The symbols              
and    on NutriStem XF™ Matrigel® (A) at P6PS represents a significant difference to Essential 8™ 
Vitronectin XF™ at P3PS (Figure 5.11 Panel B) and Essential 8™ Laminin-521 at P6PS (Figure 5.11 
Panel D), respectively, in Shell 5, whereas the dot symbol (•)  in NutriStem XF™ Laminin -511 at 
P10PS (B) and the square symbol (   ) in NutriStem XF™ Laminin -521 at P6PS (C) represents a 
significant difference to Essential 8™ Laminin-521 at P6PS (Figure 5.11 Panel D) from the one-
way analysis of variance (ANOVA) and Tukey’s Multiple Comparison Test; standard error of mean 
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Figure 5.11. AMELX Positioning in Essential 8™ Media in Combination with Different Matrices  
Cell line H9 was grown under different combinations of Essential 8™ medium with Matrigel® at P7PS 
(A), Vitronectin XF™ at P3PS (B), Laminin-511 P7PS (C) and Laminin-521 at P6PS (D). AMELX positioning 
is shown in approximately 100 nuclei using the Erosion Script on the IPLAB software. The symbols Δ and 
X on Essential 8™ Matrigel ® at P7PS (A) and Essential 8™ at P7PS (C), respectively, represent statistical 
significance to Essential 8™ Laminin-521 at P6PS (D) on Shell 5. The   symbol on Essential 8™ Vitronectin 
XF™ at P3PS (B) represents a significant difference to NutriStem XF/FF™ Matrigel® at P6PS (Figure 5.10 
Panel A) in Shell 5 and the asterisk symbols (*) on Essential 8™ Laminin-511 at P7PS (C) represent a 
significant different to Essential 8™ Laminin-521 at P6PS (D) in Shells 1 and 2. The symbols     , • ,     and  
represent significant difference of Essential 8™ Laminin-521 at P6PS (D) to NutriStem XF/FF™ Matrigel 
® at P6PS (Figure 5.10 Panel A), NutriStem XF/FF™ Laminin-511 at P10PS (Figure 5.10 Panel B), 
NutriStem XF/FF™ Laminin-521 (Figure 5.10 Panel C), respectively, in Shell 5. For all of the statistically 
significant different calculations a one-way analysis of variance (ANOVA) and Tukey’s Multiple 
Comparison Test was performed; standard error of mean is shown as the error bars.  
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5.4.3. Nuclear Morphology Analysis 
 
In addition to the gene positioning, the morphology of the nuclei from the different conditions were 
also analysed via Fiji (ImageJ; Figure 5.12). Using One-way analysis of variances (ANOVA) and Tukey’s 
Multiple Comparison Test, significant difference was found in the nuclear area between all of the 
individual matrices samples in each category i.e. different matrix combination of cells grown in TeSR2™, 
NutriStem XF™ and Essential 8™. Details of the statistical significance between each of the samples is 
shown in Appendix II. 
Despite the same cell line H9 being used this study, the morphology of the nuclei varied greatly, 
dependent on the conditions. This suggests that the media and matrices composition have a huge 
impact on the cells. The results had shown that the two TeSR2™ conditions, TeSR2™ Matrigel P3PS and 
TeSR2™ Laminin-521 P9PS, one out of four of the Essential 8™ conditions - Essential 8™ Vitronectin 
P3PS and one out of three conditions for the NutriStem XF/FF conditions – NutriStem XF/FF Laminin-
511 P10PS had shown the least statistically significant difference from the rest of the samples. In all 
three of the aforementioned cases, the samples showed no significant difference (N.S.) to three or 
more different medium-matrix combinations.  
On the other hand, the samples that showed the most significant difference to the rest of the media 
and matrice study samples were the Essential 8™ conditions - Essential 8™ Matrigel P7PS and Essential 
8™ Laminin-511 P7PS and the NutriStem XF/FF Matrigel P6PS. From the Tukey’s Multiple Comparison 
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Figure 5.12. Nuclear Area of the Different Media and Matrices Combinations 
Images from fluorescence in-situ hybridisation were analysed in Fiji (Image J); up to 200 nuclei 
were analysed. Nuclear area is shown in μm2; standard error of mean is shown as error bars. 
Tukey’s Multiple Comparison Test was carried out between the samples and the p values are 
shown in Appendix II. 
 
 
Additionally, the nuclear circularity was calculated on Fiji (ImageJ) to determine the shape of the nuclei 
had changed in the different media and matrices conditions (Figure 5.13). 
Similar to the nuclear area statistical analysis (Figure 5.12), all of the samples in the same category 
(TeSR2™, NutriStem XF/FF™ and Essential 8™) had shown significant difference between each other 
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Figure 5.13. Nuclear Morphology Analysis 
Images from fluorescence in-situ hybridisation were analysed in Fiji (Image J) for nuclear 































































    
 
Table 5.7. Media and Matrices Study Combined Results 
The table shows all of the results from this study, including the ddPCR™ AMELX to ALB ratios, the FISH gene positioning data, nuclei area and nuclei circularity. 









TeSR2™ Matrigel P3PS 
1.01 (N.S.) Intermediate Intermediate 358.5 0.62 
TeSR2™ Laminin-521 P9PS 
0.95 (N.S.) Peripheral Intermediate 303.3 0.79 
NutriStem XF/FF Matrigel P6PS 
0.87 (***) 
Central and Peripheral  
(Sig. Diff. in Shell 5) 
Peripheral 464.7 0.58 
NutriStem XF/FF Laminin-511 P10PS 
0.79 (***) Peripheral 
Central 
(Sig. Diff. in Shell 5) 
320.9 0.63 
NutriStem XF/FF Laminin-521 P6PS 
0.83 (***) 
Central and Peripheral  
(Sig. Diff. in Shell 5) 
Peripheral 398.1 0.64 
Essential 8™ Matrigel P7PS 
0.96 (N.S.) 
Peripheral 
(Sig. Diff. in Shell 1) 
Intermediate 271.7 0.68 
Essential 8™ Vitronectin P3PS 
0.95 (*) 
Peripheral 
(Sig. Diff. in Shell 5) 
Intermediate 343.0 0.67 
Essential 8™ Laminin-511 P7PS 
0.99 (N.S.) 
Intermediate 
(Sig. Diff. in Shell 1, 2 and 5) 
Peripheral 494.7 0.78 
Essential 8™ Laminin-521 P6PS 
0.93 (*) 
Peripheral 
(Sig. Diff. in Shell 1, 2 and 5) 
Peripheral 
(Sig. Diff. in Shell 5) 
389.1 0.72 




To assess human pluripotent stem cells intended for therapeutic use, the cells must fall into specific 
criteria to warrant their safety, including demonstrating a normal diploid karyotype of 46 
chromosomes. Although human pluripotent stem cells have widely been reported to accumulate 
and/or lose whole chromosomes (Draper et al., 2004; Baker et al., 2007; Amps et al., 2011; Avery et al., 
2013), the exact mechanism of how this occurs is yet to be explained. Suggestions have been made that 
poor cell culture techniques may be to blame (Kim et al., 2012) and more recently the quality of the 
preserved material has been suggested to be dictated by the individual cell’s size, morphology and the 
preservation medium (Stacey et al., 2017). In this study, we focused on the effects of the combinations 
of different matrices and media on cell size, morphology, gene positioning and karyology in hESC line 
H9. 
5.5.1. ddPCR™ Results 
 
In our study, the ddPCR™ results have suggested that a small amount of the X chromosome instability 
occurs in the H9 cells as indicated by AMELX copy number changes, dependent on culture conditions 
i.e. the media and/or matrix used. Despite the genomic instability that we had observed with ddPCR™, 
the G-banding data from the UKSCB did not show any significant number of chromosomal gains or 
losses for the cells that were analysed by Sheffield Genetics Service. Although human pluripotent stem 
cells are known to be highly unstable with frequent recurrent aneuploidies for chromosomes 12, 17, 
20 and X (Brimble et al., 2004; Baker et al., 2007; Amps et al., 2011), the karyology results for H9 had 
not suggested such an occurrence. This demonstrates that ddPCR™ is a much more sensitive method 
for the detection of small copy number variations.  
From Figure 5.3, we can see that the TeSR2™ had shown the most stability with regards to the different 
matrices and also over time. Due to the lack of data for the later passages, we cannot be certain 
whether TeSR2™ combinations with Vitronectin XF™ and Laminin-511 would also have been as stable 
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as Matrigel® and Laminin-521. However, we can hypothesise from the rest of our results that the 
TeSR2™ medium generates the most genomically stable hPSCs. On the other hand, the use of NutriStem 
XF/FF™ medium demonstrated the most abnormalities on the H9 cells, regardless of the matrix used. 
Even at P1PS, three out of four of the different matrices already had significant differences in 
comparison to the control. And for the one sample that was not significantly different (NutriStem 
XF/FF™ Laminin-511) at P1PS, in the later passages i.e. P9Ps and P10PS, showed significant difference 
to the control.  
In addition, the NutriStem XF/FF™ medium combinations, always exhibited a reduced copy number of 
AMELX (corresponding to chromosome X in our study), was observed over time. This was particularly 
apparent in Figure 5.4, where the NutriStem XF/FF Matrigel® combination had reduced very sharply to 
approximately 68% AMELX copy numbers, which may be attributed to the loss of a normal diploid 
genome and emergence of a monoploid X population. Similarly, the NutriStem XF/FF™ combination 
with Laminin-511 and -521 had seen this reduced amount of AMELX. These results suggest that the 
NutriStem XF/FF™ medium may not be a suitable choice to maintain a normal diploid karyotype. 
Furthermore, a reduced amount of AMELX in reference to ALB was also observed in most of the 
Essential 8™ matrices combinations. However, there was not a sudden drop in AMELX, as seen in the 
NutriStem XF/FF™ combinations, in the later passages. Our results have found that TeSR2™ is the most 
stable medium to use for the growth of hPSCs in combinations with most of the matrices for the 
maintenance of genomic stability in the cells.  
It is important to point out, that genomic instability does not equate to the maintenance of pluripotency 
in hPSCs. The UKSCB fluorescent-activated cell sorting (FACS) data highlighted that the TeSR2™ medium 
was, in fact, the worst medium for the maintenance of pluripotency markers, NANOG and OCT4 
expression. However, with the exception of TeSR2™ Vitronectin XF™, which demonstrated 0% positive 
NANOG and OCT4 expression, all of the TeSR2™ samples showed an improvement in the NANOG and 
OCT4 expression over time in cell culture. Comparing the early passage TeSR2™ samples to the later 
Chapter V: The Effects of Different Media-Matrice Combinations on the Genomic Instability of Human 
Pluripotent Stem Cells 
 
Marianne P Henry  Page | 168  
 
passage samples, a consistent increase in the pluripotency marker expression from an average of 10% 
to 80% was observed. On the other hand, the NutriStem XF/FF™ combinations that demonstrated the 
most genomic instability on the ddPCR™ results, showed the highest pluripotency marker expression. 
Similarly, the NutriStem XF/FF™ and Essential 8™ Laminin-511 or -521 combinations had shown the 
best differentiation potential when looking at qPCR gene expression for lineage specific genes after EB 
formation (personal correspondence with J. Man). These data suggest that although the cells grown in 
TeSR2™ medium display genomic stability, the medium does not maintain their pluripotent 
characteristics. Tosca et al., had found that small copy number variations detected by aCGH in the hPSC 
culture did not affect the differentiation capabilities of the hPSCs (Tosca et al., 2015), however Fazeli et 
al., had found altered patterns of differentiation in abnormal cells karyotyped by G-banding (Fazeli et 
al., 2011). This suggests that although small copy number variations may not affect the differentiation 
of hPSCs, larger abnormalities may significantly disrupt both gene expression and differentiation of 
these cells. 
5.5.2. Gene Positioning Results 
 
From previous studies in our lab (Mehta, et al., 2010; Bikkul, et al., Manuscript in Preparation), other 
labs (Kozubek et al., 2002; Cremer et al., 2003) and Chapter III, we know that both the chromosomes 
that  have AMELX and ALB have a peripheral positioning in the nucleus. This seemed to have been 
maintained for some of the growth conditions, but interestingly not for all of them, despite the cells 
being from one source.  
From our FISH data, we have observed the most atypical positioning of AMELX and ALB in the NutriStem 
XF/FF™ and Essential 8™ medium combinations. For the ALB positioning, all of the different media and 
matrice combinations demonstrated a general peripheral or intermediate positioning for the gene, 
except NutriStem XF/FF™ Laminin-511 at P10PS, which showed a central positioning of the gene. 
Previous studies have shown that transcription and differentiation can affect the genome positioning 
of genes (Volpi et al., 2000; Mahy, Perry and Bickmore, 2002; Wiblin et al., 2005) and in both human 
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and mouse ESCs, ALB gene expression can vary according to the  growth factors that supplement the 
medium (Shirahashi et al., 2004; Davidson et al., 2014). This may be a possible explanation as to why 
the positioning of ALB varies in the different growth conditions, despite the stability of the gene copy 
number. 
On the other hand, AMELX positioning demonstrated much more varied results, in comparison to ALB. 
For NutriStem XF/FF™ Matrigel® at P6PS and NutriStem XF/FF™Laminin-511 at P10PS a central and 
peripheral positioning was observed, where both Shells 1 and 5 displayed increased amount of signal 
in comparison to the background. This suggests that in the case of a normal diploid genome, where two 
chromosomes or gene copies are present, that one chromosome is in the periphery, whereas the other 
is localised more centrally in the nuclei. From the ddPCR™ results we know that for both of these 
conditions, the samples displayed a loss in AMELX copy number of approximately 15-20%. One possible 
explanation of this is that with the loss of chromosome X in a small number of the cell population, the 
monosomy X nuclei have a more central positioning, whereas the diploid X chromosomes maintain the 
peripheral positioning. This could be why we observe the central and peripheral positioning in those 
particular samples.  
5.5.3. Nuclear Morphology Analysis 
 
With regards to the effects individual media and matrix combinations can have on the nuclear circularity 
and nuclear area, to our knowledge no study has looked this before. Previously, studies for the effects 
of different feeder cells on the colony shape of hPSC have shown differences whether MEFs or HDFs 
were used; HDF grown cells had shown elongated colonies (Amit et al., 2003; Khadun, 2013). It is 
unknown how the nuclear circularity of hPSCs, could affect their characteristics. Our data demonstrated 
that the NutriStem XF/FF™ medium, the medium with the most abnormalities and positioning 
disruption, had the least circular nuclei (Average of 0.62), whereas the TeSR2™ and Essential 8™ media 
- the most circular (Average of 0.71 for both categories). This suggests that perhaps with more genomic 
instability, the cells are less round in shape. It is difficult to speculate whether this is a direct effect of 
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the genomic instability in these cells or whether the cells are simply shaped in that way. However, the 
fact that the cells with the highest circularity (0.79) were grown in the TeSR2™ Laminin-521 condition, 
one of the worst conditions for the maintenance of pluripotent markers (personal correspondence with 
J. Man), suggests that is may be differentiation or cell type-specific. Despite some studies using nuclear 
shape as a prognostic discriminant (Mitmaker, Begin and Gordon, 1991), further studies into the 
different circularity of hPSCs is required to understand this.  
5.5.4. Future Work 
 
Despite the efforts of many researchers no perfect marker, gene or cell surface marker, has been 
identified to characterise the pluripotency of the cell and its ability to differentiate into all three 
lineages. Further investigation with chemically-defined culture conditions is required to investigate the 
effects of different media and matrices on human pluripotent stem cells.  
Of all three media used in combinations with different matrices over time, TeSR2™ had demonstrated 
the most karyotypic stability for the cells, whereas NutriStem XF/FF - the least. 
 From personal correspondence with Dr Jennifer Man, we know that the TeSR2™ Matrigel® 
combination did not work well in terms of its NANOG and OCT4 expression (by flow cytometry), 
whereas the NutriStem XF/FF and Essential 8™ Laminin-511 or -521 worked very well with over 80% of 
the cells being positive for both markers. Additionally, Drs Nowell and Man’s data has also shown good 
differentiation potential of the cells from NutriStem XF/FF and Essential 8™ Laminin-511 or -521 
combinations when looking at qPCR gene expression for lineage specific genes after EB formation. This 
suggests that despite the normal ratio of AMELX to ALB that we observed on the ddPCR™ of the TeSR2™ 
combinations, the cells are in reality not stem cells anymore and perhaps the gene positioning change 
from FISH data is an indicator of this change. The UKSCB had suggested that the NutriStem XF/FF™ and 
Essential 8™ Laminin-511 or -521 combinations could be investigated further to be used as a potential 
stable feeder-free expansion method. Laminin-511 and -521 matrices are becoming more popular due 
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to their reliability of maintained of hPSCs (Hongisto et al., 2012, 2017; Albalushi et al., 2017). From our 
data we found the NutriStem XF/FF™ combinations to be potentially the most genomically unstable, 
however whether these aberrations are too small to cause any phenotypic affect is unknown (Barber, 
2005; Khadun, 2013). In addition, hPSCs are known for their genomic instability in culture (Brimble et 
al., 2004; Maitra et al., 2005; Amps et al., 2011) and perhaps that is a characteristic that is normal for 
them, therefore a higher level of aneuploidies in hPSCs in comparison to somatic cells may be normal. 
Unfortunately, smaller aberrations found by cytogeneticists during G-banding are not always reported 
(Barber, 2005), as they are a frequent occurrence in the general human cell population and do not have 
an apparent phenotype (Khadun, 2013). Therefore, it is possible that these smaller aberrations normally 
would be regarded as insignificant and are reported more in stem cell culture documentation. More 
guidance for cytogeneticists is required for the appropriate standardisation of reporting of karyotypic 
abnormalities. And in addition, it is still vital, for researchers to understand the presence and effect of 
low-level aneuploidies in cell intended for therapeutic use. Further investigation into these different 
media and matrices combinations and their effects on the cells is required. 
In addition, the media that were used for this study are not chemically-defined, so whether a specific 
growth factor or molecule in the medium or a combination of those factors with the matrix is good or 
bad for the cell culture, it is not possible to establish a straightforward answer without further 
information.  Additionally, metabolomics analysis of the exchange media can be analysed to make sure 
none of the growth conditions used limit the cells due to either substrate loss or toxic accumulation. 
The metabolites in the media have an essential role in the regulation of stem cell fate (Ito and Suda, 
2014; Vernardis et al., 2017), epigenetic landscape, reprogramming (Kida et al., 2015), (Sperber et al., 
2015) and differentiation (Bhute et al., 2017). Such analysis can not only help understand specific 
molecules responsible for the maintenance of pluripotency, but can also promote the integration of 
new technology for the mass expansion of hPSCs (Silva et al., 2015).  
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6.1.1. The Genomic Health of Human Pluripotent Stem Cells 
 
In recent years, human pluripotent stem cells have been widely used in research laboratories and many 
advances have been made for their use in the clinic. However, the safety of the therapeutic use of hPSC 
is still debated, mainly due to the lack of understanding of their genomic health. As described before in 
Chapter I and V, human embryonic stem cell (hESCs) and induced pluripotent stem cells (iPSCs) are a 
good source of hPSC material, however they are prone to genomic instability, often with specific whole 
chromosome gains and losses. In addition, as the telomerase enzyme is active in these cells it is 
currently unknown how the cells’ self-renewal capabilities can be controlled during clinical use. These 
characteristics, coupled with the lack of standard methods of culture for hPSCs, the lack of consistent 
assays for their characterisation and the lack of sensitive methods to detect potential aneuploidies in 
the culture, has contributed to the slow development of hPSCs as therapeutics. 
Currently, very few studies have observed the chromatin organisation of both hESCs and iPSCs (Wiblin 
et al., 2005; Bártová et al., 2008). Although studies have demonstrated the general epigenetic profile 
of these cell types, they mainly describe histone modifications and methylation profiles in comparison 
to somatic cell types (Branco and Pombo, 2006; Meshorer et al., 2006). These studies have been the 
basis of researchers suggesting the plasticity of the hPSC genome and it has been that speculated that 
it is because of this particular quality that hPSCs can differentiate into a wide range of different cell 
types.  
To our knowledge, no study has observed interphase gene positioning, nuclear morphology and gene 
expression in hPSCs grown for extended periods under different growth conditions.  
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The aim of this chapter was to investigate the genomic health of the different sub-populations of the 
hESC cell line Shef2. The study was designed to grow the two cell sub-types over time in different 
conditions and monitor them using the different optimised technologies; ddPCR™, qPCR, FISH and IF, 
as well as RNA-Seq to monitor the global gene expression changes in the two cell lines. Our aim was to 
look at the different pathways up- and/or down-regulated between cell lines, different cell culture 
conditions, and the effect of time in culture.  
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6.3. Methods and Materials 
 
6.3.1. Cell Culture and Methodology 
 
The cell culture for the cell lines used in this study was performed by Drs Jennifer Man and Yvonne 
Pang. Human embryonic stem cell line, Shef2, was grown from two separate vials, one early passage at 
P19 and one later at P23. Although both vials were from the same original cell line, the early passage 
was from a master cell bank, referred to as masterShef2, and was banked as a clinical grade cell line, 
whereas the later was a research cell line, referred to as mShef2. For this study, both sub-cultures are 
referred to as separate cell lines, despite their shared origin.  
The masterShef2 and mShef2 cell lines were grown in NutriStem XF/FF™ Culture Medium for Human 
iPS and ES Cells (STEMGENT, USA) and stabilised on human dermal fibroblasts (HDFs) as the feeder 
basement layer for four passages post-thaw, similar to Chapter V. Following this, each cell line was then 
divided into two; one continued to be cultured on the feeder cells, whereas the other was grown in 
non-feeder conditions, on Matrigel®. The Matrigel® basement layer was diluted in DMEM/F-12 with 
15mM HEPES (STEMCELL Technologies, UK) as per manufacturer’s guidelines. The NIBSC-5 iPSC line 
was established by the UKSCB from the MRC-9 primary human dermal fibroblasts. The cells were grown 
on standard 6-well plate in mTesR1 (STEMCELL Technologies) medium on a base of Matrigel®. All cell 
lines were enzymatically passaged using TrypLE Express Enzyme™ (ThermoFisher Scientific; as per 
Chapter II) and grown in 6-well plates in a 5% CO2 atmosphere at 37⁰C. The medium was changed every 
2-3 days and the cells passaged once a week and divided 1:6. 
This study was designed similarly to Chapter V, however at each passage cells were collected for 
ddPCR™, FISH and IF. The cells were karyotyped at passage 5 post-seed (P5PS) by Sheffield Diagnostic 
Genetics Service (Sheffield Children’s NHS Foundation Trust) for 30 metaphase cells.  At P9PS to P11PS, 
qPCR and RNA-Seq was performed on the samples. 
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6.3.2. DNA/RNA Extraction 
 
DNA was extracted using the GenElute DNA Extraction Kit (Sigma) as per Chapter II. For DNA 
quantification a Qubit 2.0 Fluorometer (Thermo Fisher Scientific, UK) was used, a Nanodrop ND-1000 
(Thermo Fisher Scientific) was used to check the purity of the sample, and a TapeStation Bioanalyser or 
agarose gel was used determine the DNA integrity.  
For RNA extraction the Maxwell® RSC simplyRNA Cells Kit (Promega) and Maxwell® RSC Instrument 
(Promega) were used as per Chapter IV. For quantification and qualification of RNA, the QIAxpert 
(Qiagen) was used. To ensure the RNA was of high quality, an RNA Integrity Number (RIN) value of at 
least 8 was obtained following resolution on the TapeStation Bioanalyser (described in Chapter II). 
6.3.3. Droplet Digital PCR and Fluorescence In-situ Hybridisation 
 
The DNA from each passage was used for ddPCR™ analysis of genomic stability monitoring; using the 
AutoDG system to generate droplets.  AMELX was labelled with FAM and ALB with VIC, as per Chapter 
II. 
For gene positioning analysis, gene AMELX and ALB were labelled using nick translation and FISH was 
performed on each cell line at each passage. The Erosion script was run in IPlab, as per Chapter III. 
6.3.4. Quantitative PCR 
 
Quantitative PCR (qPCR) was performed on P9-P11PS for a number of pluripotency marker and lineage-
specific markers; thresholds for these markers were set according to the standards previously 
established by the UKSCB (Table 6.1). The primers and probes were from ThermoFisher Scientific; the 
RT-qPCR was performed by the same conditions described in Chapter IV. Three separate wells from the 
6-well plates were used as technical replicates. The same RNA samples were used for RNA-Seq analysis. 
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Table 6.1. Typical Ct Value Ranges for hPSCs, Day 7 EBs and Day 14 EBs 
The expected Ct value ranges for the different cell types and different gene types measured by RT-qPCR. 
Global refers to the gene expression globally in all cell types, whereas Day 7 and Day 14 EBs refers to 
the pre-differentiated and differentiated embryoid body gene expression, respectively. This table was 
designed according to the quality control paperwork managed by the UKSCB.   
Typical Ct Values Range 
Type Gene Assay ID Global hPSCs Day 7 EBs Day 14 EBs 
Housekeeping 
ACTB Hs01060665_g1 15-18 15-16 16.5-17.5 17.18 
GAPDH Hs02758991_g1 17-20 17-18.5 18.5-20 19-20 
Self-renewal 
NANOG Hs04399610_g1 22-34 22-26 30.5-34 30-33 
OCT4 Hs04260367_gH 16-33 16.5-18.5 26-33 27-32 
SOX2 Hs01053049_s1 19-24 19.5-21.5 21-24 21-25 
Ectoderm 
HES5 Hs01387463_g1 20-31 30-36 20.5-25 22-27 
NEUROD1 Hs01922995_s1 22-36 31-36 23-30 22-29 
PAX6 Hs00240871_m1 20-33 26.5-33 20-27 21-29 
Endoderm 
CXCR4 Hs00607978_s1 24-33 28-33 24-24 24-27 
FOXA2 Hs00232764_m1 25-39 25-29 35-38 32-39 
GATA6 Hs00232018_m1 28-36 29-36 28-36 29-35 
Mesoderm 
DCN Hs00754870_s1 28-39 34-39 31-36 28-34 
NCAM1 Hs00941830_m1 N/A N/A N/A N/A 
PECAM Hs00169777_m1 32-36 32-36 32-36 33-36 
VIM Hs00185584_m1 17-22 18-20 18-20 17-20 
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6.3.5. Immunofluorescence and Micronuclei Counts 
 
Coverslips were placed into the wells of each 6-well plate; feeders or Matrigel™ was placed on the 
coverslip followed by the hESCs cultures. Following one week in culture, the coverslips were washed 
with PBS and ice-cold methanol acetone 1:1 (v/v) was added for 5 min. The coverslips were then 
removed with forceps and washed for 5min three times in PBS. Immunofluorescence was performed 
for the lamins (A, C, B1 and B2) in conjunction with the pluripotency marker Nanog on both of the cell 
lines across passages P9-P11PS. Cellular distribution of lamin proteins was performed as per Chapter 
IV. The same dilutions as used previously for the lamin antibodies were employed in 1% (v/v) fetal calf 
serum (FCS) in PBS; for Nanog IF a chicken anti-Nanog from Abcam, UK was used at 1:200 (v/v) with the 
secondary antibody goat anti-chicken (Abcam) at 1:50 (v/v). For micronuclei scoring, 1000 cells were 
counted, and the number of micronuclei recorded. 
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TruSeq® Stranded mRNA RNA-Seq (Illumina, UK) was performed on the two cell lines on passages P9-
11PS using the low samples (LS) protocol by Dr Martin Fritzsche (Department of Bioinformatics, NIBSC). 
The Illumina NextSeq 500 Sequencer was used. The same RNA samples were used to produce cDNA for 
the RT-qPCR described above. Three separate wells from the 6-well plates of the cell cultures were used 
to provide three biological replicates. This was performed for all 12 different samples, except 
“masterShef2 Matrigel™ P9PS”, where only one replicate was available due to the lack of cell growth at 
that timepoint. Dr Mark Preston (Department of Bioinformatics, NIBSC) performed the data 
normalisation and statistical analysis for the RNA-Seq samples. 
6.3.6.1. RNA-Seq Data Analysis 
 
The Illumina NextSeq 500 Sequencer was used to generate 75bp reads from the three biological 
replicates of each sample. Reads were mapped to the human reference genome GRCh37 using the 
TUXEDO software package. The Cuffdiff software was used to identify significant changes in transcript 
expression levels. Genes were filtered at the ≥log5 fold change threshold and pathways enrichment 
was analysed using the Cytoscape software (Shannon et al. 2003) with Reactome FI (Wu et al. 2010). 
6.3.6.2. RNA-Seq QC 
 
To ensure the RNA-Seq was producing accurate results, a QC report was produced. The quality of calls 
on most platforms will degrade as the run progresses, so it is common to see base calls falling into the 
orange area towards the end of a read. The high quality of the base call value scores are in green. See 
Appendix V for the raw FastQC files. 
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The UKSCB reported that an in-house generated iPSC, known as NIBSC-5, developed pentasomal X 
aneuploidy at passage 10 (Appendix I). Dr Jennifer Man kindly provided us a sample from the original 
fibroblast cell line, MRC-9 at passage 9. The MRC-9 sample was from before it was reprogrammed to 
an iPSC, whereas the iPSC sample was from passage 20. A ddPCR™ experiment was performed to 
monitor the difference in the ratio of AMEX to ALB between the two samples. From Figure 6.1, we 
observe that the MRC-9 had two copies of AMELX, as would be expected for a female sample, whereas 
the NIBSC-5 was indeed aneuploid for chromosome X, but with an average ratio of 1.85, equivalent to 



























Figure 6.1. Scatter Plot of MRC9 and NIBSC-5 Ratio 
The ratio of AMELX to ALB was calculated from MRC9 and NIBSC-5 cells. Data was extracted from the 
Quantasoft software. AMELX was labelled with FAM and ALB –VIC. Two-tailed t-test was calculated; 
significant difference is shown with an asterisk (*). An F-test was used to calculate the whether there 
was any significant difference between the variances of the two samples. The F-test showed no 
significant difference in variances; the t-test showed significant difference between samples.  
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From previously analysed results, we found that G-banding often produced inaccurate results, due to 
the poor resolution, therefore it may not be appropriate for the sensitive and high-throughput 
characterisation of hPSCs. We found in iPSC cell line NIBSC-5 pentasomal X had been reported via G-
banding, however during our analysis by observing the ratio of AMELX to ALB via ddPCR™ the results 
were not accurate and indicative of mosaicism. For this reason, this last study was designed to grow 
two cell lines in parallel and using our different assays to characterise the genomic instability of hPSCs.  
Embryonic stem cell line mShef2 was sent from the distribution vials for G-banding by the UK Stem Cell 
Bank at passage 32 and found complete monosomy for chromosome X (Appendix III). In addition, when 
the cell line was grown once more under different conditions NutriStem and Laminin-521™ at P28 and 
Essential 8™ and Laminin-511 at P28 they displayed 100% and 85% monosomy X, respectively 
(Appendix IV). Interestingly, when the mShef2 samples were grown on Essential 8™ and Laminin-511™ 
(Chapter V) for prolonged periods of time (P41), the G-banding results had shown the return of a 
complete diploid karyotype (46, XX; Appendix III). The clinical-grade cell line equivalent of mShef2, 
known here as masterShef2, displayed a normal karyotype according to personal correspondence with 
the UKSCB and from the records at the Human Pluripotent Stem Cell Registry, however due to the short 
time in culture these aberrations may not have become apparent at the time of G-banding. For this 
reason, we investigated the two cell lines in parallel combining all of the techniques developed in this 
PhD project. 
6.4.1. Initial ddPCR™ Runs 
 
Initially, to confirm that the mShef2 cell line the UKSCB was reporting as aneuploid for chromosome X 
was indeed fully aneuploid, a ddPCR™ run was performed to compare the ratio of AMELX to ALB (as 
seen in Chapter II). Late passage cells were supplied from the distribution bank vials provided by Sofia 
Spyrou from the UKSCB. The mShef2 cells are usually grown on HDFs, however in this case they were 
also grown on Matrigel™, therefore it was possible to compare the two samples side-by-side, along 
with the feeder cells the mShef2 cells were grown on. The HDF feeder cells have an XY karyotype, 
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therefore only one chromosome X would be present. Using the AMELY detection assay on the ddPCR™, 
the contribution of feeders could also be observed. 
To look at how much material or how many cells the HDFs contribute to each well of the stem cells in 
culture, the ratio of AMELX to AMELY was observed in a ddPCR™ run with the same samples from Figure 
6.3. The results confirmed that the HDFs had a ratio of 1 (Figure 6.2), as one copy of AMELX and one 
copy of AMELY are present, due to the XY karyotype. Additionally, the contribution of feeders in the 
mShef2 culture was 0.5%, whereas in the mShef2 and Matrigel™ sample, no AMELY was detected. 
Interestingly, a sample, where cells are manually picked from colonies, was provided from the UKSCB 
and was used to demonstrate how much carryover of HDFs occurs during the manual passage of hESC. 
Although not statistically significant, we observed a reduced carryover of the HDFs using manual cutting 
techniques; 0.3% of HDFs were detected in the ddPCR™ results.  
 

























Figure 6.2. ddPCR™ Results for HDF Detection in Late Passage mShef2 Cells 
ddPCR™ was performed on the HDFs, mShef2 cell line grown on both HDFs and Matrigel™ and on cells 
manually cut from HDFs during passage. mShef2 cells were at passage P43. The ratio of AMELX to 
AMELY observed in all of the samples. The asterisk symbols (***) signify the extremely statistically 
significant observed (p<0.001) using a one-tailed t-test. No statistical analysis was performed on the 
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The ddPCR™ results demonstrated that the ratio of AMELX to ALB was 0.53 in mShef2 samples grown 
on both HDFs and Matrigel™ and in the HDF feeder cells and in addition, these samples were extremely 
statistically significant with a two-tailed t-test (Figure 6.3; p<0.001). This suggests complete monosomy 
for chromosome X in these samples. 




















Figure 6.3. ddPCR™ Results for Aneuploidy Detection in Late Passage mShef2 Cells  
ddPCR was performed on the mShef2 cell line grown on both HDFs and Matrigel™ and on the HDF cells 
to observe the ratio of AMELX to ALB versus the control. mShef2 cells were at passage P43, the control 
was the same as per Chapter II, a stock of female lymphoblastoid DNA was used. The asterisk symbols 
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6.4.2. MasterShef2 and mShef2 ddPCR™ Results 
 
 
The two embryonic stem cell lines masterShef2 and mShef2 were thawed at the same time and cultured 
in parallel to monitor the change in the genomic stability over time. The samples were referred to their 
passage number post-seed i.e. passage n post-seed (PnPS), n is the passage number. The first sample 
available for ddPCR™ was P2PS; a ddPCR™ run was performed for each following passage until P11PS; 
at P11PS, due to sample surplus two separate pellets of the two cell lines grown on HDFs were analysed. 
At P4PS, both cell lines were placed onto two different matrices, HDFs and Matrigel™, to study the 
effects of feeders and feeder-free conditions on genomic instability.  
From Figure 6.4, we can observe the change in ratio of AMELX to ALB over time. A significant difference 
of ratio relative to the control was detected in the masterShef2 HDF samples at P4PS, P5PS, P6PS, P7PS 
and P9PS with approximately 6-60% increases in AMELX. Interestingly, the 58.33% increase detected at 
P9PS was not carried over to P10PS or P11PS. From the result, mShef2 displayed less incidence of 
significant difference to the control. P6PS in mShef2 HDF showed a 6.41 % decrease in AMELX and an 
7.5% and 25.2% increase at P7PS and P11Ps in sample 1, respectively. MasterShef2 Matrigel™ showed 
a significant difference at P5PS, P10PS and P11PS in sample 1, where an increase of 8.14% and 6.64% 
was observed at P5PS and P11PS in sample 1 and a decrease of 41.29% at P10PS. For mShef2 grown on 
Matrigel™ at P11PS in sample 1 a 44.81% decrease was observed. 
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Figure 6.4. ddPCR™ Results for masterShef2 and mShef2 
The two embryonic stem cell lines mastershef2 and mShef2 were grown in parallel over 11 passages. 
The two cell lines were grown on HDFs and Matrigel™ from P5PS. Statistical significance was calculated 
using a two-sample t-test and is shown using asterisks. The control was the same as per Chapter II, a 
stock of female lymphoblastoid DNA was used. The asterisk symbols (*, ** and ***) signify the 
statistically significant, very statistical significance and extremely statistical significance, respectively, 
using a one-tailed t-test.  
 
 
6.4.3. Gene Positioning 
 
Fluorescence in-situ hybridisation was performed to analyse interphase gene positioning on the two 
embryonic stem cells masterShef2 and mShef2 from passages P3PS to P11PS for the genes AMELX and 
ALB. Additionally, from P5PS the cells were grown on both HDFs and Matrigel™. In order to compare 
the two cell lines and the conditions accurately over time the interphase gene positioning results were 
divided into two parts; the first compares the two cell lines mastershef2 vs mShef2, whereas the second 
compares each cell line grown on HDFs and Matrigel™.  
6.4.3.1. MasterShef2 vs mShef2 
 
This study was performed to compare the two cell lines’ gene positioning across each passage. From 
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Panel A mastershef2 HDF had shown an interior positioning of ALB, whereas mShef2 HDF displayed a 
more intermediate positioning; a significant difference between the two samples in Shell 1 was 
observed. ALB positioning had stayed interior in P4PS in masterShef2 HDF and intermediate in mShef2 
HDF (Figure 6.5 Panel C).  
For AMELX positioning, a peripheral positioning was observed in masterShef2 HDF P3PS and a more 
intermediate positioning was observed in mShef2 HDF P3PS; a significant difference between the two 
samples in Shell 1 was observed (Figure 6.5 Panel B). For P4PS, masterShef2 HDF displayed a more 
bimodal distribution of AMELX positioning in the cell nuclei, whereas in mShef2 HDF it was more central 
(Figure 6.5 Panel D). 
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Figure 6.5. Fluorescence in-situ Hybridisation Results in P3PS-P4PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs for P3PS and P4PS. 
A two-sample t-test was performed between each sample to P3PS to their corresponding shell and 
gene to observe any difference in positioning over time. A two-sample t-test was also performed 
between the two embryonic stem cell samples to observe any difference in positioning between the 
two cell lines. The asterisk symbol (*) signifies statistical difference observed over time, whereas an 
asterisk with a line above shows the statistical significance between the two samples. Standard error of 















                                                              Chapter VI: The Genomic Health of Human Pluripotent Stem Cells 
Marianne P Henry  Page | 188  
 
From the results displayed in Figure 6.6 Panel A, masterShef2 HDF shifted to a bimodal distribution of 
ALB positioning in the nuclei with a large amount of gene signal from the intermediate and interior 
shell; mShef2 HDF, on the other hand, shifted to an interior positioning, compared to the previous 
passage, were intermediate positioning of ALB was observed. Their counterparts grown on Matrigel™ 
displayed bimodal distribution toward the periphery and Shell 4 for masterShef2 and mShef2 on 
Matrigel™, respectively (Figure 6.6 Panel B). 
For AMELX positioning, a bimodal peripheral positioning was observed in masterShef2 HDF P5PS and a 
peripheral organisation was displayed in mShef2 HDF P5PS (Figure 6.6 Panel C).  For P5PS samples 
grown on Matrigel™, masterShef2 displayed an intermediate positioning of AMELX, whereas in mShef2 
displayed a random distribution mainly in intermediate shells of the nuclei (Figure 6.6 Panel D). 
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Figure 6.6. Fluorescence in-situ Hybridisation Results in P5PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P5PS. A two-sample t-test was performed between each sample to P3PS to their corresponding shell 
and gene to observe any difference in positioning over time. A two-sample t-test was also performed 
between the two embryonic stem cell samples to observe any difference in positioning between the 
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From the results displayed in Figure 6.7 Panel A, a peripheral positioning of ALB was observed in both 
masterShef2 and mShef2 HDF samples P6PS, however for the Matrigel™ counterparts a more 
intermediate positioning was observed for the two samples with significant differences observed in 
Shells 1, 2 and 4 (Figure 6.7 Panel B).  
For AMELX positioning, a bimodal positioning was displayed in both masterShef2 HDF and mShef2 HDF 
at P6PS (Figure 6.7 Panel C).  For P6PS samples grown on Matrigel™, masterShef2 displayed a bimodal 
distribution of AMELX at the periphery and in the intermediate shells of the nuclei, whereas mShef2 
displayed intermediate positioning (Figure 6.7 Panel D). 
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Figure 6.7. Fluorescence in-situ Hybridisation Results in P6PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P6PS. A two-sample t-test was performed between each sample to P3PS to their corresponding shell 
and gene to observe any difference in positioning over time. A two-sample t-test was also performed 
between the two embryonic stem cell samples to observe any difference in positioning between the 
two cell lines. The asterisk symbol (*) signifies statistical difference observed over time, whereas an 
asterisk with a line above shows the statistical significance between the two samples. Standard error of 
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At P7PS, masterShef2 HDF displayed an intermediate positioning of ALB, whereas mShef2 HDF – 
peripheral; significant different was observed between the two samples in Shell 2 (Figure 6.8 Panel A). 
Interestingly, the significant difference in Shell 2 remained between masterShef2 and mShef2 
Matrigel™ samples; however, both samples displayed a more random positioning of ALB compared to 
when they were grown on HDFs (Figure 6.8 Panel B).  
AMELX positioning, on the other hand, was peripheral for masterShef2 HDF and bimodal, mainly 
peripheral for mShef2 HDF; significant difference was observed between the two cell lines in Shell 2 
(Figure 6.8 Panel C). For AMELX positioning in the two cell lines grown on Matrigel™, only mShef2 
results were available and displayed a peripheral positioning (Figure 6.8 Panel D). 
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Figure 6.8. Fluorescence in-situ Hybridisation Results in P7PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P7PS. A two-sample t-test was performed between each sample to P3PS to their corresponding shell 
and gene to observe any difference in positioning over time. A two-sample t-test was also performed 
between the two embryonic stem cell samples to observe any difference in positioning between the 
two cell lines. The asterisk symbol (*) signifies statistical difference observed over time, whereas an 
asterisk with a line above shows the statistical significance between the two samples. Due to lack of 
sample of masterShef2 Matrigel™ at P7PS, no FISH was performed (Panel D). Standard error of mean is 
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At P8PS, ALB positioning was intermediate and bimodal for masterShef2 and mShef2 HDF, respectively 
(Figure 6.9 Panel A), whereas for Matrigel™ intermediate positioning was displayed (Figure 6.9 Panel 
B). For AMELX positioning, interior positioning was displayed in masterShef2 HDF nuclei and peripheral 
for mShef2 HDF nuclei; significant difference was observed between the two samples in Shells 1, 2 and 
5 (Figure 6.9 Panel C). For the samples grown on Matrigel™, masterShef2 expressed interior positioning 
and mShef2- intermediate positioning (Figure 6.9 Panel D). 
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Figure 6.9. Fluorescence in-situ Hybridisation Results in P8PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P8PS. A two-sample t-test was performed between each samp8le to P3PS to their corresponding shell 
and gene to observe any difference in positioning over time. A two-sample t-test was also performed 
between the two embryonic stem cell samples to observe any difference in positioning between the 
two cell lines. The asterisk symbol (*) signifies statistical difference observed over time, whereas an 
asterisk with a line above shows the statistical significance between the two samples. Standard error of 







                                                              Chapter VI: The Genomic Health of Human Pluripotent Stem Cells 
Marianne P Henry  Page | 196  
 
 
At P9PS, ALB positioning was bimodal and central for masterShef2 and mShef2 HDF, respectively (Figure 
6.10 Panel A), whereas for Matrigel™ peripheral and intermedia positioning was displayed in 
masterShef2 and mShef2 samples, repectively (Figure 6.10 PanelB). For AMELX positioning, bimodal 
peripheral positioning was displayed in masterShef2 HDF nuclei and bimodal for mShef2 HDF nuclei; 
significant difference was observed between the two samples in Shell 1 (Figure 6.10 Panel C). For the 
samples grown on Matrigel™, masterShef2 and mShef2 nuclei exhibited random positioning (Figure 
6.10 Panel D).  
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Figure 6.10. Fluorescence in-situ Hybridisation Results in P9PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P9PS. A two-sample t-test was performed between each sample to P3PS to their corresponding shell 
and gene to observe any difference in positioning over time. A two-sample t-test was also performed 
between the two embryonic stem cell samples to observe any difference in positioning between the 
two cell lines. The asterisk symbol (*) signifies statistical difference observed over time, whereas an 
asterisk with a line above shows the statistical significance between the two samples. Standard error of 
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ALB positioning in masterShef2 and mShef2 HDF samples were peripheral (Figure 6.11 Panel A), 
whereas in the Matrigel™ condition masterShef2 was peripheral once more, however mShef2 showed 
a shift to a more interior positioning (Figure 6.11 Panel B). For AMELX positioning, masterShef2 HDF 
had a peripheral positioning and mShef2 HDF – bimodal (Figure 6.11 Panel C), however in the Matrigel™ 
condition, masterShef2 exhibited bimodal positioning, whereas mShef2 was intermediate; a very 
significant difference was observed between the two samples in Shell 1 (Figure 6.11 Panel D).  
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Figure 6.11. Fluorescence in-situ Hybridisation Results in P10PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P10PS. A two-sample t-test was performed between each sample to P3PS to their corresponding shell 
and gene to observe any difference in positioning over time. A two-sample t-test was also performed 
between the two embryonic stem cell samples to observe any difference in positioning between the 
two cell lines. The asterisk symbol (*) signifies statistical difference observed over time, whereas an 
asterisk with a line above shows the statistical significance between the two samples. Standard error of 
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6.4.3.2. The Effects of HDFs Versus Matrigel™ on Gene Positioning 
 
To compare the effects of different basement membranes on the gene positioning of hESCs, the two 
embryonic stem cell lines mastershef2 and mShef2 were plotted side-by-side with the two different 
conditions i.e. HDFs and Matrigel™. Statistical significance was calculated using two-sample t-tests 
between conditions for each cell line. 
For ALB positioning in masterShef2 HDF and Matrigel™ bimodal intermediate and intermediate 
positioning was displayed, respectively, with no significant difference detected (Figure 6.12 Panel A), 
whereas for the mShef2 HDF and Matrigel™ conditions interior and bimodal positioning, respectively, 
was observed with significant differences in Shells 2 and 5 (Figure 6.12 Panel B). On the other hand, 
AMELX positioning showed bimodal peripheral and intermediate positioning in masterShef2 HDF and 
interior in masterShef2 Matrigel™ with significant difference detected in Shell 1 (Figure 6.12 Panel C). 
In mShef2, the HDF samples were peripheral, whereas in Matrigel™ it was intermediate (Figure 6.12 
Panel D). 
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Figure 6.12. Fluorescence in-situ Hybridisation Results in P5PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P5PS. A two-sample t-test was performed for each cell line between the different conditions to observe 
any difference between the two basement membranes. The asterisk symbol (*) signifies statistical 
difference observed over time, whereas an asterisk with a line above shows the statistical significance 
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For ALB positioning, masterShef2 HDF and Matrigel™ displayed peripheral and intermediate 
positioning, respectively (Figure 6.12 Panel A). Significant differences over time (compared to P3PS 
corresponding samples) were detected in Shell 2 and 5 for masterShef2 HDF and Shells 2, 3 and 5 for 
masterShef2 Matrigel. For mShef2, ALB positioning in the HDF conditions was peripheral and for 
Matrigel™ - intermediate; significant difference was observed in Shell 1 and very significant difference 
in Shell 2 (Figure 6.12 Panel B).   
For AMELX positioning, peripheral and bimodal central and peripheral positioning was observed in 
masterShef2 HDF and Matrigel™, respectively. Additionally, a statistically significant difference was 
observed using a two-sample t-test between the two conditions for Shell 2 and a very statistically 
significant difference in Shell 4 (Figure 6.12 Panel C). In mShef2 HDF and Matrigel samples a peripheral 
and intermediate positioning of AMELX was revealed with significant difference in Shell 1 (Figure 6.12 
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Figure 6.13. Fluorescence in-situ Hybridisation Results in P6PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P6PS. A two-sample t-test was performed for each cell line between the different conditions to observe 
any difference between the two basement membranes. The asterisk symbol (*) signifies statistical 
difference observed over time, whereas an asterisk with a line above shows the statistical significance 
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In masterShef2 HDF and Matrigel™ samples at P7PS, an intermediate and bimodal central positioning 
of ALB was observed, respectively. For mastershef2 HDF significant difference over time (compared to 
P3PS corresponding samples) were detected in Shells 3 and 5 (Figure 6.14 Panel A). For mShef2, ALB 
positioning in the HDF condition was peripheral and for Matrigel™ - intermediate; a very significant 
difference was observed in Shell 1 (Figure 6.14 Panel B). For AMELX, masterShef2 HDF, mShef2 HDF 
and mShef2 Matrigel™ all displayed peripheral positioning (Figure 6.14 Panel C and D). 
 
masterShef2 P7PS ALB








































































Figure 6.14. Fluorescence in-situ Hybridisation Results in P7PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and Matrigel™ for 
P7PS. A two-sample t-test was performed for each cell line between the different conditions to observe 
any difference between the two basement membranes. The asterisk symbol (*) signifies statistical 
difference observed over time, whereas an asterisk with a line above shows the statistical significance 
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In masterShef2 HDF and Matrigel™ samples at P8PS, an intermediate and central positioning of ALB 
was observed, respectively. For mastershef2 Matrigel™ significant difference over time (compared to 
P3PS corresponding samples) were detected in Shell 4 (Figure 6.15 Panel A). For mShef2, ALB 
positioning in the HDF condition was bimodal peripheral and central, whereas for Matrigel™ it was 
peripheral (Figure 6.15 Panel B). For AMELX, masterShef2 HDF and Matrigel™ the nuclei displayed 
central positioning (Figure 6.15 Panel C). Using two-sample t-tests significant difference was observed 
over time (compared to P3PS corresponding samples) in masterShef2 HDF in Shell 1 , whereas in 
masterShef2 Matrigel™ significant idfference was detected in Shells 2 and 4. 
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Figure 6.15. Fluorescence in-situ Hybridisation Results in P8PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and 
Matrigel™ for P8PS. A two-sample t-test was performed for each cell line between the different 
conditions to observe any difference between the two basement membranes. The asterisk 
symbol (*) signifies statistical difference observed over time, whereas an asterisk with a line 
above shows the statistical significance between the two conditions.  Standard error of mean is 
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For ALB positioning, masterShef2 HDF demonstrated bimodal peripheral and intermediate positioning 
with significant difference over time (compared to masterShef2 HDF P3PS) in Shell 3, whereas in 
masterShef2 Matrigel™ peripheral positioning was observed with significant difference in Shell 2 
observed over time when compared to masterShef2 Matrigel™ P3PS (Figure 6.16 Panel A). In mShef2 
HDF and Matrigel™ nuclei, intermedia positioning was observed with significant differences between 
the cell line grown on different basement membranes in Shells 1, 3 and 4 (Figure 6.16 Panel B). 
For AMELX positioning, masterShef2 HDF showed bimodal peripheral and interior positioning, whereas 
for Matrigel™ is was intermediate; significant difference between the two conditions was observed in 
Shells 1 and 3 using a two-sample t-test (Figure 6.16 Panel C). Interestingly, random positioning was 
observed in mShef2 HDF and Matrigel™ (Figure 6.16 Panel D), significant difference was observed 
between the two conditions in Shell 1 (Figure 6.16 Panel D). 
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Figure 6.16. Fluorescence in-situ Hybridisation Results in P9PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and 
Matrigel™ for P9PS. A two-sample t-test was performed for each cell line between the different 
conditions to observe any difference between the two basement membranes. The asterisk 
symbol (*) signifies statistical difference observed over time, whereas an asterisk with a line 
above shows the statistical significance between the two conditions.  Standard error of mean is 
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In ALB positioning of masterShef2 HDF and Matrigel™ intermediate positioning was observed in the 
P10PS samples (Figure 6.17 Panel A). The masterShef2 HDF nuclei demonstrated significant differences 
in Shells 3 and 5 when compared to masterShef2 HDF P3PS nuclei, whereas in masterShef2 Matrigel™ 
this was observed in Shells 2 and 5. On the other hand, mShef2 HDF and Matrigel™ showed bimodal 
positioning and interior positioning, respectively (Figure 6.17 Panel B). 
For AMELX positioning, masterShef2 HDF and masterShef2 Matrigel™ exhibited peripheral and bimodal 
intermediate positioning, respectively (Figure 6.17 Panel C). In comparison, mShef2 HDF and Matrigel™ 
nuclei showed bimodal peripheral and central positioning and intermediate positioning, respectively 
(Figure 6.17 Panel D). 
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Figure 6.17. Fluorescence in-situ Hybridisation Results in P10PS 
FISH was performed for ALB and AMELX on masterShef2 and mShef2 grown on HDFs and 
Matrigel™ for P10PS. A two-sample t-test was performed for each cell line between the different 
conditions to observe any difference between the two basement membranes. The asterisk 
symbol (*) signifies statistical difference observed over time, whereas an asterisk with a line 
above shows the statistical significance between the two conditions. Standard error of mean is 
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6.4.4. Nuclear Morphology Analysis 
 
 
Nuclear morphology was analysed using Fiji (Image J), as per Chapter II to look at the association of 
genomic instability, gene positioning, nuclear area and circularity. In Figure 6.18, masterShef2 HDF 
positioning for ALB (Panel A) and AMELX (Panel B) is shown. The average nuclear area is increasing from 
P4PS to P8PS, and then reduces to P10PS, whereas nuclei circularity stayed relatively stable across all 
of the passages. In addition, the pattern of ALB followed a relatively similar pattern through the 
passages. The ALB positioning graph from P3PS to P4PS stayed the same and then started changing to 
a more bimodal shape in P5PS. This was followed by a peripheral organisation for the next two passages. 
In P8PS, the shape of the graph shifted to bimodal distribution once more untill P10PS, where the 
distribution was more intermediate. 
For AMELX positioning (Figure 6.18 Panel B), the gene positioning flucatuated more than the ALB graph 
(Panel A). The distribution of AMELX started peripheral, followed by different bimodal distributions as 
the cells progressed over time. Interstingly, the an increase in the bimodal distrubtion of both AMELX 
and ALB was observed at P9PS when a 60% increase of AMELX was observed.  
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Figure 6.18. MasterShef2 HDF Nuclear Morphology, Genomic Stability and Gene Positioning 
Results from all of the different assays were combined in the graphs above throughout all passages; 
gene positioning is shown in blue, the average nuclear area in a solid black line, average nuclear 
circularity in a black dashed line and the genomic instability, shown in AMELX to ALB ratio, is 
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In Figure 6.19, masterShef2 Matrigel™ positioning for ALB (Panel A) and AMELX (Panel B) is shown. The 
nuclei area is increasing from P4PS to P5PS and from P8PS to P9PS, and reduces P5PS to P6PS and P9PS 
to P10PS.  On the other hand the nuclei circularity increases P5PS to P7PS and is then stable throughout 
the rest of the study. 
For ALB positioning (Figure 6.19 Panel A), the gene positioning distribution displayed little consistency 
in pattern throughout the eight passages with a mainly intermediate distribution of the ALB gene.  
For AMELX positioning (Figure 6.19 Panel B), the gene positioning fluctuated more than the ALB graph 
once again. The distribution of AMELX included bimodal distrubtion, with a  large amount of the nuclei 
demonstrating peripheral or intermedaite organisation. An increase in the bimodal distribution can be 
observed at P10PS when a drop in 40% of AMELX was reported from the ddPCR™ results (Figure 6.19). 
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Figure 6.19. MasterShef2 Matrigel™ Nuclear Morphology, Genomic Stability and Gene Positioning  
Results from all of the different assay were combined in the graphs above throughout all of 
passages; gene positioning is shown in blue, the average nuclei area in a solid black line, average 
nuclei circularity in a black dashed line and the genomic instability, shown in AMELX to ALB ratio, 
is represented in a dashed blue line. Panel A shows the ALB positioning, where Panel B shows the 
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In Figure 6.20, mShef2 HDF positioning for ALB (Panel A) and AMELX (Panel B) is shown. The nuclei area 
is very inconsistent throughout the different passages with a gradual increase up to P9PS and then a 
drop again in P10PS.  On the other hand the nuclei circularity remained relatively constant. 
For ALB positioning (Figure 6.20 Panel A), the gene positioning distribution displayed a semi-consistent 
pattern at the beginning of the culture, where the positioning was intermediate. However, as the 
culture progressed peripheral organisation and then finally bimodal distribution appeared.  
The AMELX positioning (Figure 6.20 Panel B) too displayed altered gene positioning throughout the 
culture time. The nuclei originally displayed intermediate organisation of AMELX and then slowly 
progressed to internal, peripheral and finally, bimodal.  
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Figure 6.20. mShef2 HDF Nuclear Morphology, Genomic Stability and Gene Positioning 
Results from all of the different assay were combined in the graphs above throughout all of 
passages; gene positioning is shown in pink, the average nuclei area in a solid black line, average 
nuclei circularity in a black dashed line and the genomic instability, shown in AMELX to ALB ratio, 
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In Figure 6.21 a drop in the nuclear area from P5PS to P6PS has been observed, followed by a gradual 
increase in nuclear size until P8PS. After this the nuclear area had once again dropped untill P10PS. 
During this time the nuclear circularity fluctuated upto P7PS, after which it remained stable throughout 
the study.  
The ALB positioning had once again displayed relative stability across the different passage with a 
mainly intermediate positioning in the nuclei, whereas AMELX positioning remained stable until P9Ps, 
whereafter a bimodal distribution was obseved.  
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Figure 6.21. mShef2 Matrigel™ Nuclear Morphology, Genomic Stability and Gene Positioning 
Results from all of the different assay were combined in the graphs above throughout all of 
passages; gene positioning is shown in pink, the average nuclei area in a solid black line, average 
nuclei circularity in a black dashed line and the genomic instability, shown in AMELX to ALB ratio, 
is represented in a dashed pink line. Panel A shows the ALB positioning, where Panel B shows the 
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In addition, images of the embryonic stem cell colonies were taken to observe any potential 
differentiation that may have occurred, as seen in Figure 6.22 Image B with the white arrow. When the 
cells were grown on HDFs, we could observe the feeder cells surround the hESC colonies (Figure 6.22 
Image A Blue Arrow) and interestingly, when cells were grown on Matrigel™ these cells were creating 
a type of niche by differentiating at the edge of the colonies into cells similar to feeders in morphology 
(Figure 6.22 Image B Blue Arrow). 
  
A B 
Figure 6.22. Embryonic Stem Cell Colony Images 
Example images were taken during the cell culture of masterShef2 and mShef2 cell lines. Image A shows 
masterShef2 cell colonies surrounded by human dermal fibroblasts (HDFS), whereas Image B shows 
mShef2 grown on Matrigel™. Both cell lines shown in the images above are at P7PS. Scale bar is shown. 
The blue arrows point to the feeder cells surrounding the hESC colonies, whereas the white arrow 
highlights the hESC cells with poor morphology. 
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6.4.5. FISH Summary 
 
To summarise the FISH results, Figure 6.23 displayed all of the ALB (Panel A) and AMELX (Panel B) results 
throughout the eight passages in both of the embryonic stem cell lines grown on both HDFs and 
Matrigel™. Between samples a very similar pattern of ALB distribution was observed, especially 
between the samples from the same cell line i.e. mShef2 HDF and mShef2 Matrigel™. On the other 
hand, the AMELX organisation in the nuclei of the different samples was more diverse, although once 
more, the samples from the same cell line grown on different conditions were more similar than 
between the two cell lines. Additionally, Table 6.2, Table 6.3, Table 6.4 and Table 6.5 list a summary of 
all of the ddPCR™, FISH and nuclear morphology analysis. 
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Figure 6.23. Summary of all FISH Results in the Embryonic Stem Cells 
The line graph displays the masterShef2 HDF (blue solid line), masterShef2 Matrigel™ (blue jagged line) 
mShef2 HDF (pink solid line) and mShef2 Matrigel™ (pink jagged line) gene positioning of ALB and 
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Passage Cell Line Condition 
ddPCR™ 
AMELX/ALB Ratio 






masterShef2 HDF 1.04 Periphery Interior 53 0.75 
mShef2 HDF 1..00 Intermediate Intermediate 143.9 0.8 
P4PS 
masterShef2 HDF 1.06 Periphery and Intermediate Interior 194.4 0.79 








mShef2 0.96 Periphery Interior 267.7 0.70 
masterShef2 
Matrigel™ 
1.08 Intermediate Periphery and Interior 157.5 0.56 
mShef2 1.02 Intermediate Intermediate 326.1 0.34 
Table 6.2. MasterShef2 and mShef2 Study Combined Results 
The table shows all of the results from this study, including the ddPCR™ AMELX to ALB ratios, the FISH gene positioning data, nuclear area and nuclear 
circularity in P3PS-P5PS. 
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Table 6.3. MasterShef2 and mShef2 Study Combined Results 
The table shows all of the results from this study, including the ddPCR™ AMELX to ALB ratios, the FISH gene positioning data, nuclei area and nuclei circularity 
in P6PS-P7PS. 
Passage Cell Line Condition 
ddPCR™ 
AMELX/ALB Ratio 








1.06 Periphery and Intermediate Periphery 259 0.67 
mShef2 0.94 Periphery and Intermediate Periphery 331.5 0.74 
masterShef2 
Matrigel™ 
1.03 Periphery and Intermediate Intermediate 305.4 0.60 




1.06 Periphery Intermediate 317 0.75 
mShef2 1.07 Periphery and Interior Periphery 362.7 0.79 
masterShef2 
Matrigel™ 
-  Intermediate 180.8 0.85 
mShef2 1.01 Periphery Random 201.5 0.73 
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Table 6.4. MasterShef2 and mShef2 Study Combined Results 
The table shows all of the results from this study, including the ddPCR™ AMELX to ALB ratios, the FISH gene positioning data, nuclei area and nuclei 
circularity in P8PS-P9PS. 
Passage Cell Line Condition 
ddPCR™ 
AMELX/ALB Ratio 








1.04 Intermediate Intermediate 297.7 0.79 






1.02 Periphery and Interior Intermediate 164.1 0.83 
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Table 6.5. MasterShef2 and mShef2 Study Combined Results 
The table shows all of the results from this study, including the ddPCR™ AMELX to ALB ratios, the FISH gene positioning data, nuclei area and nuclei circularity 
in P10PS. 
Passage Cell Line Condition 
ddPCR™ 
AMELX/ALB Ratio 








1.0 Periphery Intermediate 231.7 0.8 






0.59 Periphery and Intermediate Periphery 248.7 0.79 
mShef2 1.04 Intermediate Interior 211.9 0.77 
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6.4.6. Micronuclei Counts 
 
In order to look at the level of genomic instability in the hPSCs, the number of micronuclei per 1000 
nuclei was counted on the microscope for each of the two embryonic stem cells, masterShef2 and 
mShef2. This was performed for both of the cells grown on HDFs and on Matrigel™ from passage P9PS 
to P11PS. An example image is shown in Figure 6.24. 
 
Figure 6.24. Micronucleus Representative Image 
An image of a micronucleus formed out a nucleus is shown above with a white arrow. The nuclei were 
stained with DAPI and imaged with the Leica microscope; the scale bar is displayed. 
 
 
From the micronuclei counts (Figure 6.25), varying numbers of micronuclei between samples were 
observed. No significant difference was observed between the samples at P9PS using a two-sample t-
test.  In addition, at P9PS between 5-15% of micronuclei was observed in each of the cell lines, whereas 
at the next passages P10PS and P11PS, reduced to approximately 1.5-6%. For masterShef2 Matrigel™ 
and mShef2 Matrigel™ this was statistically significant (p= 0.0208) and statistically very significant (p= 
0.0065), respectively, in comparison to the P9PS number of micronuclei (a two-sample t-test was used). 
Furthermore, mShef2 HDF and mShef2 Matrigel™ displayed statistically significant number of 
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At P11PS, masterShef2 Matrigel™ micronuclei was 1.73% and was statistically significant to its 
counterpart at P9PS at 10.37% micronuclei per 1000 nuclei (p= 0.0132). MasterShef2 Matrigel™ at 

















































Figure 6.25. Number of Micronuclei in the Human Embryonic Stem Cells 
The number of micronuclei per 1000 nuclei are displayed for each embryonic stem cell line grown on 
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6.4.7. Indirect Immunofluorescence 
 
 
MasterShef2 and mShef2 were grown on coverslips and indirect immunofluorescence was performed 
for lamin proteins in P9PS to P11PS in conjunction with the pluripotency marker, Nanog, to confirm the 
cells were still stem cells and that they did not differentiate. The cell nuclei stained for Nanog within 











Figure 6.26. Immunofluorescence Staining of Human Pluripotent Stem Cells with Nanog 
A human pluripotent stem cell colony is visualised using the Leica microscope. The cell nuclei are 
counterstained with DAPI in blue and Nanog protein in Magenta. A scale bar is shown. 
DAPI Nanog Merged 
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6.4.7.1. A-Type Lamins 
 
 
Due to the large number of cells growing in a single colony, the distribution of lamins were analysed 
dependent on whether the nuclei were within a colony or outside a colony. 
Lamins A and C were not detected in the embryonic stem cells growing deep within the colonies; but 
Nanog expression was detected in these cells (Figure 6.27). However, when lone cells were imaged 
outside their colonies, both lamins A and C started appearing in low levels throughout the whole nuclei, 
whilst Nanog expression was reduced. Interestingly, lamin A and C staining appeared strongly in the 
nucleoli (Figure 6.28). In contrast, some cells outside the colonies still expressed Nanog, despite the 
appearance of lamin A and C expression throughout the nucleoplasm (Figure 6.29).  
On the other hand, a small number of cells outside the embryonic stem cell colonies expressed lamins 
A and C in speckles, rather than an homogenous veil as seen in Figure 6.29, in the cell nuclei with strong 
Nanog staining within and outside the nuclei (Figure 6.30), however some cells did not express Nanog 
protein staining outside the colonies with lamin A and C speckle staining (Figure 6.31). These speckles 
were seen throughout both of the cell line when the nuclei was outside the main cell colonies and were 
more numerous for lamin C staining, than lamin A, although some speckles were still visible (Figure 6.30 
and Figure 6.31).  
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Figure 6.27. A-Type lamin Staining Within Embryonic Stem Cell Colonies 
Cell nuclei were stained with DAPI in blue, lamin A in green, lamin C in red and Nanog in magenta. The 
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 DAPI Lamin A 
Lamin C Nanog 
Merged 
Figure 6.28. A-Type lamin Staining Outside Embryonic Stem Cell Colonies without Nanog Staining 
Cell nuclei were stained with DAPI in blue, lamin A in green, lamin C in red and Nanog in magenta. The 
A-type lamins stained throughout the cell nucleus, whereas Nanog staining was very faint in the cell 
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Figure 6.29. A-Type lamin Staining Outside Embryonic Stem Cell Colonies with Nanog Staining 
Cell nuclei were stained with DAPI in blue, Lamin A in green, Lamin C in red and Nanog in magenta. 
Lamin A nuclear staining was very faintly observed, whereas lamin C staining was observed throughout 






DAPI Lamin A 
Lamin C Nanog 
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Figure 6.30. A-Type lamin Staining Outside Embryonic Stem Cell Colonies With lamin A and C 
Speckles and Strong Nanog Staining 
Cell nuclei were stained with DAPI in blue, Lamin A in green, Lamin C in red and Nanog in magenta. Lamin 
A staining was observed as strong spots, along with some staining throughout the nucleus, whereas 
lamin C staining only displayed strong spots. Nanog staining was observed outside and inside the 





DAPI Lamin A 
Lamin C Nanog 
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Figure 6.31. A-Type lamin Staining Outside Embryonic Stem Cell Colonies With lamin A and C 
Speckles and Weak Nanog Staining 
Cell nuclei were stained with DAPI in blue, Lamin A in green, Lamin C in red and Nanog in magenta. A-
type lamin staining was observed as strong spots throughout the nucleus, whereas Nanog stained 






DAPI Lamin A 
Lamin C Nanog 
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6.4.7.2. B-Type Lamins 
 
 
Similar to A-type lamins staining pattern analysis, the B-type lamin staining pattern analysis was also 
performed by observing the staining within and outside the embryonic stem cell colonies. 
Lamins B1 and B2 were expressed as rims in the stem cell colonies with Nanog staining within the nuclei 
(Figure 6.32). Although most of the samples displayed this staining pattern, some samples, such as 
masterShef2 grown on HDF at P10PS, expressed very weak rims for Lamin B2 until eventually the rim 
completely disappeared at P11PS (Figure 6.33). Despite Lamin B2 staining disappearing over time, the 
pluripotency marker Nanog staining remained. Outside the stem cell colonies, both lamins B1 and B2 
expressed speckled aggregates in the cell nuclei.  
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Figure 6.32. B-Type Lamin Staining Within Embryonic Stem Cell Colonies  
Cell nuclei were stained with DAPI in blue, Lamin B1 in green, Lamin B2 in red and Nanog in magenta. 
B-type lamins were observed as rims around the cell nuclei, whereas Nanog mainly stained as speckles 






Nanog Lamin B2 
Lamin B1 DAPI 
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Nanog Lamin B2 
Lamin B1 DAPI 
Figure 6.33. B-Type Lamin Staining Within Embryonic Stem Cell Colonies Lacking Lamin B2 Staining 
Cell nuclei were stained with DAPI in blue, Lamin B1 in green, Lamin B2 in red and Nanog in magenta. 
Lamin B1 was observed as rims around the cell nucleus, whereas lamin B2 staining was not observed 
Nanog staining was strongly observed within and outside the cell nucleus. The scale bar is shown. 
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6.4.8. RT-qPCR for Gene Expression 
 
Using the RT-qPCR assay from the UKSCB, a range of different markers were analysed for gene 
expression changes over time and in the different cell lines. Thresholds were set in the graphs for the 
minimum amount of gene expression of pluripotency markers required by the cells to be categorised 
as hPSCs; these thresholds were set by the UKSCB. This is shown as a yellow dashed line in Figure 6.34. 
All of the cell lines under the different cell culture conditions passed the quality control threshold values 
to meet the hPSC requirement, except mShef2 HDF P11PS for SOX2 expression. 
Differentiation markers for all three of the lineages i.e. mesoderm, endoderm and ectoderm were 
measured by RT-qPCR. These genes are highly expressed only in differentiated cells and should not 
reach above a certain threshold for cells that are to still be considered as hPSCs. This threshold is shown 
as a red jagged line in Figure 6. 35. All of the cell lines in all of the cell culture conditions passed this 
quality control threshold values to be classified as hPSCs.  
In addition, although no threshold values were identified for the lamin gene expression levels in hPSCs, 
as this was not a routine RT-qPCR at the UKSCB, all of the samples expressed similar levels of lamin 
genes. However, it was noted that a sharp drop was detected in masterShef2 HDF P10PS sample, 
consistent with the immunofluorescence data.  
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Figure 6.34. Quantitative PCR for Pluripotency and Lamin Genes 
The graph shows the gene expression values, relative to GAPDH for pluripotency and lamin genes. Cell 
lines masterShef2 and mShef2 were grown on HDFs or Matrigel™. The yellow jagged lines show the 
minimum threshold required by the cells to be categorised as hPSCs. The error bars are the standard 
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Figure 6. 35. Quantitative PCR for Lineage-specific Genes 
The graph shows the gene expression values, relative to GAPDH for endoderm, mesoderm and 
ectoderm lineages. Cell lines masterShef2 and mShef2 were grown on HDFs or Matrigel™. The red 
jagged lines show the maximum threshold the cells are permitted to reach to be categorised as hPSCs. 
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6.4.10. Quality Control 
 
To assess the overall quality of the RNA-Seq run, all of the samples were analysed by quality control 
checks on raw sequence data coming from high throughput sequencing pipelines. The per base 
sequence quality determined that all of our samples were above 32, demonstrating that the run was of 
good quality. All of the raw FASTQC files are shown in Appendix V. 
6.4.11. RNA-Seq Network Analysis 
 
To detect which genes and pathways were differentially expressed, comparisons between RNA-Seq 
data sets were made by setting log 5-fold change as the threshold value. The analysis was grouped into 
three parts – the comparison of different cell culture conditions, the comparison of the different cell 
lines used in this study, and the effect of passage number on each of the cell lines in their respective 
growth conditions. 
The comparison between masterShef HDF samples versus masterShef2 MatrigelTM revealed 167 genes 
with different expression (156 up-regulated; 11 down-regulated). Network analyses using Cytoscape 
(Shannon et al. 2003) with ReactomeFI (Wu et al. 2010) were used to classify highly interacting groups 
of genes (modules) and to identify the associated pathways from the RNA-Seq datasets. Cytoscape with 
ReactomeFI were used to identify pathways to which differentially expressed (DE) genes belong to. 
Comparing mastershef2 HDF samples versus mastershef2 MatrigelTM demonstrated that twenty-three 
pathways were significantly enriched in the dataset of 167 overexpressed genes in mastershef2 
MatrigelTM. Interestingly, the extracellular matrix organisation, vitamin digestion and absorption and 
retinoid metabolism and transport pathways were amongst these enriched pathways (Table 6.6). All of 
the pathways identified had a p-value and false discovery rate (FDR) <0.05. The full list of differentially 
expressed genes are shown in Appendix VII.
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Table 6.6. Network Pathways Enriched in MasterShef2 HDF versus MasterShef2 Matrigel™ Samples  
Genes were analysed based on their log5FC thresholds. The network enrichment was determined via Cytoscape analysis with ReactomeFI. the 
enriched pathways are shown below with the total number of genes up-regulated in response to the different growth conditions in the 
masterShef2 cell line. The P-value and the false discovery rate (FDR) are shown. The nodes identify specific genes/proteins from our log5FC 
threshold datasets that are present in the enriched networks. 
 Protein from 
Network 
P-Value FDR Nodes 
Extracellular matrix 
organisation 
12 7.18E-07 2.97E-04 
VTN, HAPLN1, FGB, FGA, FGG, PECAM1, ITGA8, COL15A1, PLG, 
TTR, LUM, COL3A1 
Vitamin digestion and 
absorption 
3 1.90E-03 0.0247 APOB, APOA1, APOA4 
Retinoid metabolism and 
transport 
8 6.21E-09 7.18E-07 RBP4, APOB, APOA2, APOA1, APOA4, TTR, APOC3, APOC2 
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On the other hand, in mShef2 HDF samples versus mShef2 MatrigelTM samples 84 genes demonstrated 
different expression (30 up-regulated; 54 down-regulated). The upregulated genes identified twenty-
three pathways that were significantly enriched in the mShef2 MatrigelTM samples (Table 6.7), whereas 
the down-regulated genes identified six pathways that were significantly reduced in the mShef2 
MatrigelTM samples (Table 6.8). Amongst the down-regulated pathways were the WNT ligand 
biogenesis and trafficking, cancer and basal cell carcinoma pathways. For the up-regulated pathways 
the fibrinolysis pathway, plasminogen activating cascade and FOXA1 transcription factor network 
pathways were identified. All of the pathways identified had a p-value and FDR <0.05. The full list of 
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Table 6.7. Network Pathways Enriched in mShef2 HDF versus mShef2 Matrigel™ Samples  
Genes were analysed based on their log5FC thresholds. The network enrichment was determined via Cytoscape analysis with ReactomeFI. the enriched 
pathways are shown below with the total number of genes down-regulated in response to the different growth conditions in the mShef2 cell line. The P-
value and the false discovery rate (FDR) are shown. The nodes identify specific genes/proteins from our log5FC threshold datasets that are present in the 
enriched networks. 
 Protein from 
Network 
P-Value FDR Nodes 
WNT ligand biogenesis and 
trafficking 
2 7.60E-04 0.0122 WNT8B, WNT7B 
Pathways in cancer 4 2.89E-03 0.0364 WNT8B, MMP1, WNT7B, PAX8 
Basal cell carcinoma 2 3.31E-03 0.0364 WNT8B, WNT7B 
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Table 6.8. Network Pathways Enriched in mShef2 HDF versus mShef2 Matrigel™ Samples  
Genes were analysed based on their log5FC thresholds. The network enrichment was determined via Cytoscape analysis with ReactomeFI. The enriched 
pathways are shown below with the total number of genes upregulated in response to the different growth conditions in the mShef2 cell line. The P-
value and the false discovery rate (FDR) are shown. The nodes identify specific genes/proteins from our log5FC threshold datasets that are present in 
the enriched networks. 
 Protein from 
Network 
P-Value FDR Nodes 
Fibrinolysis pathway 3 8.27E-06 6.21E-04 FGB, FGA, FGG 
Plasminogen activating 
cascade 
2 3.35E-04 3.35E-03 FGB, FGA 
FOXA1 transcription factor 
network 
2 6.86E-03 0.0431 C4BPB, INS 
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In addition, cell lines masterShef2 and mShef2 were compared based on their cell culture conditions 
i.e. HDF or Matrigel™. Comparing mastershef2 HDF versus mShef2 HDF, 28 genes with ≥5-log fold 
change expression (16 up-regulated; 12 down-regulated) were detected. Using the Cytoscape network 
analysis software no pathways were identified between these two samples. 
In contrast, mastershef2 MatrigelTM versus mShef2 MatrigelTM showed differential expression of 135 
genes (114 up-regulated; 21 down-regulated). Once again, the upregulated genes in the masterShef2 
MatrigelTM samples identified the extracellular matrix organisation, retinoid metabolism and 
plasminogen activating cascade pathways amongst the enriched pathways (Table 6.9). The full list of 
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Table 6.9. Network Pathways Enriched in MasterShef2 HDF versus MasterShef2 Matrigel™ Samples  
Genes were analysed based on their log5FC thresholds. The network enrichment was determined via Cytoscape analysis with ReactomeFI. the 
enriched pathways are shown below with the total number of genes up-regulated in response to the different growth conditions in the 
masterShef2 cell line. The P-value and the false discovery rate (FDR) are shown. The nodes identify specific genes/proteins from our log5FC 
threshold datasets that are present in the enriched networks. 
 Protein from 
Network 
P-Value FDR Nodes 
Extracellular matrix 
organisation 
12 7.18E-07 2.97E-04 
VTN, HAPLN1, FGB, FGA, FGG, PECAM1, ITGA8, COL15A1, PLG, 
TTR, LUM, COL3A1 
Plasminogen activating 
cascade 
3 7.90E-05 1.90E-03 FGB, FGA, PLG 
Retinoid metabolism and 
transport 
8 6.21E-09 7.18E-07 RBP4, APOB, APOA2, APOA1, APOA4, TTR, APOC3, APOC2 
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To consider the effect of the time in culture on the gene expression in human pluripotent stem cells, 
each of the cell lines at passage 9 post-seed were compared to their respective cell line and cell 
culture condition at passage 11 post-seed. For example, masterShef2 HDF at P9PS was compared to 
masterShef2 HDF at P11PS. This resulted in ≤10 genes differentially expressed between all of the 
different combinations and no pathway enrichment was identified. 
Finally, Venn diagrams were designed to look at the overlap of genes up- and down-regulated in the 
different cell lines and conditions over time (Figure 6.36). All of the gene transcripts analysed at the set 
threshold had shown an overlap with the different cell line or condition in our study, however when 
observing the effect of time on the cell samples no overlap in the gene transcripts was observed (Figure 
6.36 E). The list of genes for all of the different conditions in the Venn diagrams are listen in Appendix 
VII. 
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Figure 6.36. Venn Diagrams for Transcripts With ≥Log5FC in the hPSCs  
Venn diagrams demonstrating the number of genes up- or down-regulated in the cell lines masterShef2 
and mShef2 in the different cell culture conditions i.e. HDFs or Matrigel™ are shown. A shows the 
number of genes downregulated in each of the cell lines masterShef2 and mShef2 and also the overlap 
between the groups, B - the number of genes upregulated in each of the two cell line and the overlap 
between the groups, C - the number of genes downregulated in the cell lines grown on HDFs or 
Matrigel™, D – the number of genes upregulated in the cell lines grown on HDFs or Matrigel™ and E 
shows the number of genes downregulated in all of the cell lines and different conditions over time. 
The full list of genes differentially expressed are shown in Appendix VII. 
The Effects of Different Conditions on masterShef2 and mShef2 Cell Lines 
The Common Effects on Different Cell Lines 
The Effects of Time/Passage on Different Cell Lines in Different Conditions 
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The ddPCR™ results from Figure 6.4 indicate the genomic instability of the hPSCs over time. Due the 
small amount of DNA required to perform the ddPCR™ experiments, it has been possible to observe 
the ratio of AMELX to ALB for each passage in the cells and also for each of the cell culture conditions. 
This is the first study that has been able to observe the changes in genomic stability so sensitively. In 
addition, this part of the study had demonstrated the amount of genomic instability that occurs in the 
hPSC genomes with each passage. 
Here, we have shown that although some cell populations can appear to be fully aneuploid from results 
provided from karyotyping via G-banding, in reality that may not be, as G-banding only looking at a very 
small proportion of the cell population. Our results, on the other hand, provide a capture of the whole 
cell population, making it a more accurate method for total cell population analyses. In addition, G-
banding only looks at the presence or absence of aberrations in dividing cells from the metaphase 
spreads formed from the supplementation of mitosis blocking agents, such as colcemid or nocodazole. 
If aneuploid cells indeed have a growth advantage in culture (Maitra et al., 2005; Amps et al., 2011; 
Avery et al., 2013), then presumably they are more actively dividing than the diploid cells. On one hand, 
if these cells were blocked in mitosis and never formed future daughter cells, then this would result in 
an over-representation of aneuploidies in the G-banding results and potentially give a false indication 
of the number of aneuploidies in the total cells population.  
Interestingly, the results from this chapter have also demonstrated the diversity of the genomic stability 
in hPSCs and their ability to lose and regain gene copy numbers in a short period of time. For example, 
in  Figure 6.4 we show masterShef2 HDF P9PS with a large rise in the amount of AMELX at P9PS, despite 
it being not significantly different to the control at the passage before. However, at P10PS this rise had 
gone back down to a level that was not significantly different to the control once again. This was not 
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exclusive to any particular cell line or condition, once again indicating that hPSC have the ability to gain 
or lose gene copy numbers very quickly. Furthermore, this discovery may also lead us to believe that 
perhaps when hPSCs are classified as aneuploid using G-banding, they may recover in the following 
passages. Additionally, findings displayed in Figure 6.4, where masterShef2 and mShef2 at P11PS DNA 
was extracted from two separate wells have highlighted again the genomic stability diversity in hPSCs. 
We hypothesise this is due to the fact that hPSC grow in colonies making them very different and 
therefore, separate to each other.  
6.5.2. Fluorescence in-situ Hybridisation, Nuclear Morphology and Genomic Instability 
 
The data described in section 6.4.3. have demonstrated the level of chromatin plasticity in the hPSC cell 
nuclei. Like the ddPCR results, hPSC gene loci location shifted at each passage and in many of the cell 
nuclei gene positioning showed bimodal positioning. For example, in masterShef2 HDF at P9PS, AMELX 
positioning seemed to be both internal and peripheral. We put forward two theories that can explain 
this characteristic in hPSC. One theory is that this is due to cell mosaicism in the population, where one 
population of cells have a diploid gene copy number, whereas the other has an aneuploid number of a 
particular gene or chromosome. This would result in two different gene positionings and therefore the 
overall image of the gene positioning would look bimodal on a graph. This theory is supported from our 
results in Chapter II, where a change in gene positioning of different cell lines with different karyotypes 
has been observed and also from another group that has been looking at gene positioning for the 
prognosis of different cancers (Meaburn et al., 2009, 2016; Leshner et al., 2016). They believe that with 
the appearance of different sub-types of cancer is it possible to anticipate a patient’s response to 
treatment, dependent on the chromosome organisation. The second theory is that the hPSC chromatin 
is highly flexible and therefore the gene positioning can shift very easily dependent on the environment. 
This theory is supported by the previous studies performed on reviewing the amount of the histone 
modifications between somatic and naïve cells (Meshorer and Misteli, 2006; Meshorer et al., 2006; 
Morris, Kelly, Chotalia and Pombo, 2010; Mattout, Biran and Meshorer, 2011).  
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From our results in section 6.4.4. we have not identified a particular predisposition in gene positioning 
of hPSCs, due a specific cell culture condition or passage. This has also been similarly identified in 
Chapter V. In addition, no correlation between nuclear circularity, area, gene positioning or genome 
instability has been observed in the hPSCs, suggesting that perhaps the hPSCs are indeed flexible or 
plastic in their genome stability, morphology and organisation.  
Additionally, because of the high genomic instability presence in the hPSCs, it was no surprise that the 
number of micronuclei present in the hPSCs was also high. However, no correlation of the number of 
micronuclei at the last three passages and the genome instability as measured via indirect 
immunofluorescence was observed. Further analysis with more data from more passages would be 
required to make a definite conclusion. In addition, it is worth noting that unlike the method above, the 
traditional method for measuring genomic instability is by the addition of cytochalasin B and observing 
the number of micronuclei in binucleated cells (Sinitsky and Druzhinin, 2014). 
To our knowledge, no study has yet been conducted that observed the change in gene positioning so 
closely for each passage and for the different conditions studied in parallel. Our results have been novel 
for using the different assays from our study in parallel to research the gene positioning and genomic 
instability in hPSCs. 
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6.5.3. RT-qPCR and Immunofluorescence 
 
In order to make sure that the hPSCs we were studying were indeed still stem cell-like, RT-qPCR was 
performed for the commonly used pluripotency markers and lineage-specific markers. Using these 
markers, we have determined that the hPSCs used in this study were indeed still expressing the genes 
required to classify the cells as hPSCs. However, although almost all the cells had passed the threshold 
values set, some variation between the samples were observed. Only one sample mShef2 HDF at P11PS 
did not pass the minimum threshold level of SOX2 expression, as no FISH was performed for that 
sample, no data are available to observe any potential changes in the gene positioning. As gene 
expression is an indicator of whether cells are differentiated or naïve, and therefore, their gene 
positioning in the nucleus, this variation could affect the gene positioning we studied. However, due to 
the high number of nuclei analysed in this study, it is highly unlikely that would have impacted the gene 
positioning. In addition, the differential protein expression is clear from the IF data, where cells outside 
the colonies started differentiating and expressing A-type lamins and potentially also changing in the 
expression with other differentiation-associated genes. This mixed population of RNA extracted from 
each well of the cell culture dish would explain the small variation in the RT-qPCR differentiation-
associated gene expression. 
When using indirect immunofluorescence to analyse the different staining patterns of lamin proteins 
in nuclei, A-type lamins were not present in the hPSCs that grew within the colonies in cell culture. 
However, cells that were further away from the colonies expressed for A-type lamins suggesting that 
the cells were beginning to differentiate. As Nanog staining was also performed in parallel with the 
lamin protein staining, we were able to observe whether the differentiation state was still naive. 
Interestingly, despite Nanog staining being present in the nuclei, A-type lamins staining was also 
present. This suggests that A-type lamins may be a better marker for determining the differentiation 
state of hPSCs (Constantinescu et al., 2006). In addition, although it has been previously studied that 
undifferentiated nuclei do not express A-type lamins, the gene expression is still present in these cells. 
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Furthermore, it is worth noting that the pattern expression of A-type lamin outside the hPSC colonies 
was different in terms of sometimes displaying a homogenous veil and sometimes displaying speckles 
within the nuclei. This suggests that when differentiation occurred at the edges of the colonies or 
outside the colonies the cells differentiated into different types of cells, therefore displayed different 
A-type lamin staining patterns. Often studies do not look at the A-type lamins A and C separately; here, 
we have demonstrated that both the staining and expression can vary despite the two proteins 
originating from the same gene LMNA.  
Additionally, lamin A protein formation has been suggested to regulate chromatin protein dynamics 
(Melcer et al., 2012) and also affect the physical plasticity of the stem cell nucleus with differentiation 
(Pajerowski et al., 2007). This would once again support the idea of lamin A as a better differentiation 
marker of hPSCs and also suggest another explanation as to why the hPSC nuclei is so vulnerable to 
damage. 
For B-type lamin analysis using IF we observed a sudden loss of lamin B2 staining in some of the samples 
analysed. Although this was not present in all of the biological replicates analysed i.e. the coverslips in 
the hPSC wells, nor in all of the biological replicates for the RT-qPCR, there was still a notable drop in 
lamin B2. As lamin B2 loss has recently been linked to the appearance of aneuploidies in colorectal 
carcinoma cells (Ranade et al., 2017), it is of particular interest in hPSCs. It is worth mentioning that 
despite the loss of lamin B2 in these samples, Nanog protein was still strongly expressed in the hPSC 
samples, suggesting that lamin B2 loss does not affect the pluripotency. 
We suggest that lamin B2 could be a contributor to the genomic instability well-established in hPSCs. 
Our results from Chapter IV support this hypothesis, as reduced levels of lamin B2 was also observed in 
the aneuploid cell lines in comparison to the diploid lymphoblastoid cell lines. Further research with 
more cell lines across more passages is required to study the effect of lamin B2 on hPSCs. One possibility 
could be by using new technology, such as CRISPR-Cas9 to study the effect of lamin B2 loss on hPSCs, 
however this may not be possible due to the importance of B-type lamins for life. In this case, siRNA 
could be used to knockdown the gene and monitor the effect it has on genomic instability of hPSCs. 
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6.5.4. RNA-Seq Network Analysis in hPSCs 
 
 
When analysing the RNA-Seq data for the pathway enrichment in different cell culture conditions 
between the HDFs and Matrigel™, we saw an upregulation in the pathways associated with extracellular 
matrix organisation, vitamin digestion and absorption and retinoid metabolism and transport in the 
masterShef2 Matrigel™ samples. Embryonic stem cells are often grown on feeder layers, and it has 
been established that human dermal fibroblasts secrete growth factors (GFs), despite being mitotically 
inactive, that help maintain the hPSC culture (Jin, 2007; Moogk et al., 2010; Abdian et al., 2015). 
However, when ESCs are removed from feeder layers we have noticed the stem cell colonies tended to 
form feeder cell-like layer around them. We hypothesise this was to help maintain their niche and their 
stem cell-like properties in culture. This has been previously reported by other groups (Moogk et al., 
2010; Abdian et al., 2015) and our RNA-Seq data showing the enrichment in extracellular matrix 
organisation in Matrigel™ samples supports this theory (Table 6.6, Table 6.8 and Table 6.9). 
Furthermore, the enrichment of vitamin digestion and absorption pathway is of particular interest. In 
recent years, vitamin C has been identified as a key regulator of stem cell biology, specifically its role in 
the maintenance of pluripotency, self-renewal and differentiation in the stem cell culture (D’Aniello et 
al., 2017). The presence of vitamin C has been shown to stimulate  the extracellular matrix (ECM) 
secretion of collagen glycosaminoglycan, and has been associated with improved somatic cell 
reprogramming (D’Aniello et al., 2017). More importantly, has been shown to impact the epigenetic 
signature of hPSCs by counteracting H3K9 and H3K36 DNA methylation (Comes et al., 2013; D’Aniello 
et al., 2017), which would suggest its crucial role in the chromatin organisation of hPSCs.  
The natural and synthetic analogues of retinol/vitamin A are also known as retinoids and new evidence 
suggests that this metabolite has a key role in the regulation of stem cell self-renewal, especially as an 
extracellular function (Khillan, 2014). Similarly, the fibrinolysis and plasminogen activating cascade 
pathway (Table 6.8) have also shown a significant role in the self-renewal of stem cells (Heissig et al., 
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2007, 2009; Ruf, 2016). These data along with our RNA-Seq data would suggest that the pathways 
activated in the feeder-free Matrigel™ samples required the extra vitamins and GFs in the ECM to be 
able to support and maintain the cells’ pluripotency, especially with the significant overlap of 
upregulated gene transcripts we have observed in Figure 6.36 B.  
With our gene positioning data demonstrating the remarkable mobility of chromatin in the hPSCs and 
the upregulation of extracellular matrix organisation and vitamin digestion and absorption pathways in 
the feeder-free conditions, this would again support the vital role growth factors from HDF secretion 
or from the niche the stem cells on the feeder-free conditions themselves create play in the 
maintenance of pluripotency. We would theorise that this environment around the stem cells are key 
regulators in the plasticity of the hPSC nuclei. Further investigation in this area is required to observe 
the function of growth factors and vitamins on the hPSC nucleus. 
6.5.5. Detection of Mosaicism in Human Pluripotent Stem Cells 
 
From our results, we have observed that ddPCR™ is a very promising tool for the sensitive detection of 
aneuploidy mosaicism in human pluripotent stem cells (Figure 6.1). When comparing directly to the 
NIBSC -5 karyology results (Appendix III), it is clear how biased it is to only look at 20-30 metaphase 
spreads to determine the cells’ karyotype. Although ddPCR™ cannot detect the precise number of 
chromosomal aneuploidies in a mosaic culture, it provides the ability to look at the whole cell 
population from a very small sample and detect abnormalities that appear over time. This is a very 
important characteristic of ddPCR™, due to its potential in terms of stem cell therapeutic use in the 
future and the regulatory requirements for their use. Additionally, it is unknown whether the aneuploid 
cells in a whole population are still actively dividing and give rise to new cells or whether they are 
blocked in mitosis. If these cells are blocked in mitosis, then the level of aneuploidy would not change 
and eventually these cells would disappear without having affected the hPSC genome. Furthermore, if 
the pentasomal X cells are giving rise to new cells, it is unclear whether they are dividing at a rate 
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different to the diploid cells in the population. Previous reports have shown hPSCs to accumulate 
aneuploidies that give them a growth advantage in culture (Avery et al., 2013) . 
It must be noted, however, that the karyology results from the NIBSC-5 cells were from passage 10, 
whereas the sample we tested on the ddPCR™ was from a later passage of 20. It is a possibility that 
some changes may have occurred between passages 10-20. Despite this all, out results would suggest 
lower level mosaicism in the NIBSC-5 cells rather than 75% chromosome X aneuploidy, as the 
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7.1. General Discussion 
 
The aim of this project was to develop a sensitive and high-throughput screen for the detection of 
chromosome aneuploidies in human pluripotent stem cells, as well as characterise gene loci positioning 
in aneuploid nuclei. Human pluripotent stem cells have long been known to develop chromosomal 
aberrations in culture via whole chromosome gains and/or losses, particularly for chromosomes 12, 17, 
20 and X (Draper et al., 2004; Baker et al., 2007; Harrison, Baker and Andrews, 2007; Amps et al., 2011). 
However, no method has yet been developed to sensitively detect these aneuploidies or characterise 
their role in the nucleus and the hPSC population. The aim was to look at the effect of different cell 
culture conditions on general genomic health of hPSCs and observe potential global gene expression 
changes utilising pathway analysis. 
 
7.1.1. Aneuploidy Detection via Droplet Digital Polymerase Chain Reaction 
 
Currently, karyotyping cells via G-banding is the gold standard and a requirement for cells intended for 
therapeutic use. Although cost effective, the method is labour-intensive and requires trained 
cytogeneticists for the analysis. In addition, G-banding resolution is typically 10Mb with a sensitivity of 
10% aneuploidy detection and typical turnover time of five weeks; these factors drastically discourage 
its use. 
Several different approaches were undertaken to determine the most appropriate and sensitive 
method to detect the abnormalities via Droplet Digital PCR™ (ddPCR™). Initially, a model experiment 
was performed for genes AMELX and AMELY located on chromosome X and Y, respectively. DNA from 
diploid male and female lymphoblastoid cell lines was used in a titration experiment to model how the 
pluripotent stem cells would behave when mosaic cultures would start appearing. Our results had 
demonstrated the sensitive detection of up to 1% of aneuploidy in a background diploid cells. 
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We demonstrated improved droplet segregation in the 2D plots of the ddPCR™ software when treating 
the DNA with enzymes or sonicating the DNA. Although the enzymatic treatment did not affect the 
overall ratio of the two amplicons, sonication significantly increased the number of positive droplets in 
the results. We hypothesised that the fragmented DNA allows efficient binding of the primers to the 
DNA sequences and thus, improves their amplification. This has been consistent with previous findings 
using enzymes or sonication as a pre-treatment of the DNA intended for ddPCR use (Yukl et al., 2014; 
McMahon et al., 2017; Vitomirov et al., 2017). In addition, we initially observed a bias in the level of 
fluorescent signal from the FAM channel when using the AMELX and AMELY model in the male cell 
lines. This proved to be a cell culture artefact in the male cells, where potentially the Y chromosome is 
lost (Pierre and Hoagland, 1972), resulting in a strong FAM channel. We had shown this with the use of 
the same male blood samples as the cell culture samples and demonstrated a closer ratio of AMELX 
and AMELY to one. Because of this slightly higher AMELX to AMELY ratio, the same control sample was 
run in each ddPCR experiment performed and was used to normalise the rest of the samples. 
Most importantly, our study demonstrated the inefficiency of G-banding versus ddPCR (Chapter V). In 
this manner, the optimisation of the ddPCR assay set-up in Chapter I demonstrated the ability to detect 
1% aneuploidy in a background of diploid DNA, a level of sensitivity that has not been reported for other 
methodologies. Furthermore, the sensitivity of the assay allowed the monitoring of small percentage 
changes in the level of AMELX with regards to the reference gene, ALB for an extended amount of time 
in culture. This would, therefore allow the sensitive detection of low-level aneuploidy population 
emergence in culture. This previously been impossible with other assays, such as G-banding, aCGH and 
KaryoLite BoBs™, due to both the amount of DNA required to carry out such analysis and the lack of 
sensitivity. Our study demonstrated the amount of genomic alteration hPSCs appear to go through with 
each passage, something that had not been performed before. In the future, panels around unstable 
areas of the genome, such as multiple locations on chromosome 12, 17, 20 and X could be set-up to 
monitor the genomic instability of hPSCs. Such assays have already been developed for qPCR (STEMCELL 
TECHNOLOGIES, 2018), however not for the more sensitive ddPCR™. 
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7.1.2. Aneuploidy Positioning via Fluorescence In-situ Hybridisation 
 
 
The nucleus is a highly organised organelle with chromosome territories occupying specific discrete 
areas in the nucleus with intermingling tendencies (Volpi et al., 2000; Branco and Pombo, 2006). In 
lymphoblastoid cell lines, results from the reference gene ALB (HSA4) demonstrated positioning across 
all aneuploid cell lines consistent with previous studies using somatic cells (Boyle et al., 2001; Mehta, 
et al., Unpublished; Bikkul, et al., Manuscript in Preparation). This consistency with other studies 
demonstrated the robustness and accuracy of our results. 
On the other hand, AMELX (HSAX) demonstrated more significant differences when compared between 
different chromosome X aneuploid lymphoblastoid cell lines. Once again, this had been previously been 
observed with other research groups containing different types of aneuploidies (Petrova et al., 2007; 
Shete et al., 2014). Interestingly, despite the changes in positioning a conserved radial distribution was 
still observed in our data, which was similar to other studies (Cremer et al., 2003; Wiblin et al., 2005; 
Sengupta et al., 2007; Shete et al., 2014).  
Unlike the results in the lymphoblastoid cell lines, the stem cell lines showed great variation in the 
positioning of both ALB and AMELX genes. This was not exclusive to one particular cell culture condition 
(Chapter V) or passage number (Chapter VI).  As previously mentioned, we suggest that this 
phenomenon is a particular attribute of hPSCs, where cells are still in a naïve state and have not 
terminally differentiated, therefore, their chromatin is highly flexible and can shift readily dependent 
on the transcription requirement. This is supported by the lack of heterochromatin and the amount of 
histone modifications in the cells (Meshorer and Misteli, 2006; Meshorer et al., 2006; Morris, Kelly, 
Chotalia and Pombo, 2010; Mattout, Biran and Meshorer, 2011). Furthermore, our results from Chapter 
VI demonstrated that this flexibility remained over 10 passages in two different sub-types of the same 
cell line with very little variation to the global gene transcription and despite the changes in the genomic 
instability. Previous studies have established that aneuploid nuclei often display significant changes to 
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their gene expression profile (Upender et al., 2004; Grade et al., 2006). Our study has not identified 
such changes, however as our study was dealing with presumed mosaic cell cultures, rather than whole 
aneuploid populations, this may be the reason for the small changes in the transcript levels. Further 
work could incorporate the data from this study and identify the global gene expression changes in 
hPSCs with whole chromosome aneuploidies. Single-cell RNA-Seq could be one potential method for 
the design of such studies. 
In addition, our study was designed with the use of media and matrices that are commercially available, 
however many are not chemically defined, nor xeno-free. For research to move forward in the potential 
clinical use of hPSCs, the effect of specific molecules needs to be more extensively studied. Our data 
has shown different responses of cells in the different conditions with regards to their pluripotency 
markers. Therefore, the cell culture conditions could have a great effect on the therapeutic potential 
of hPSCs. 
Interestingly, unlike the lymphoblastoid cell lines that showed significant differences in both nuclear 
size and nuclear circularity, in hPSC no correlation was observed. This was true for the different cell 
lines, the cells grown in different conditions and also across different passages. One explanation for 
this, as supported by our qPCR and IF staining findings, could be that within each cell culture colony 
small populations of the hESC cells differentiate into different lineages. Thus, this mixed population of 
cells may potentially skew the area and circularity data. One potential suggestion for future work that 
cells could first be stained via IF for multiple different pluripotency markers, their pluripotency 
confirmed and only then images be taken for cell morphology analysis. 
Furthermore, in order to better understand the genome organisation of human pluripotent stem cells, 
chromosome territories could be positioned for chromosome 4 and X to observe whether genes, ALB 
and AMELX are within or outside these territories. In addition, whether the chromosome territories are 
also as flexible as the gene organisation within nuclei. 
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7.1.3. Aneuploidy and Lamins 
 
 
Lamins have long been implicated in the normal functioning of the cells and their disruption has been 
linked with several diseases. Our study was designed to observe the protein staining pattern and 
expression, as well as the gene expression of both A-type ad B-type lamins. Interestingly, very little 
staining of A-type lamins was observed in the lymphoblastoid cell lines, however in the hESCs the 
staining patterns were more variable. We observed no A-type lamin staining in hESCs that were grown 
in the colonies, however A-type lamin faint staining appeared with further distance away from these 
colonies. We hypothesise that the differentiation abilities of the hESCs allow these cells to differentiate 
into a wide range of different cell types and results in the heterogenous staining we observed in Chapter 
VI. This concept is supported by the colony differentiation we observed in culture (Images in Appendix 
VI) and from our varied nuclear size and shape (Chapter VI and Appendix IV). This has been consistent 
with previous findings that suggest A-type lamins to have a role in the regulation of chromatin dynamics 
(Melcer et al., 2012) as well as the physical plasticity of the stem cell nucleus (Pajerowski et al., 2007). 
In comparison to A-type lamin expression, B-type lamins demonstrated much more reduced levels in 
the protein expression in aneuploid lymphoblastoid cell lines versus diploid cell lines. Similarly, their 
staining patterns showed significant differences between the cell lines, especially in DD0567 (XXX) and 
their gene expression levels for lamin B2 were significantly different in DD0710 (XXY) and DD1473 
(XXXX) versus the female diploid control cell line. Interestingly, in the hESCs staining patterns as rims 
were observed inside and outside the hESC colonies, however some samples displayed the complete 
loss of lamin B2 in both the gene expression and protein staining in the nucleus. This is of particular 
importance as recent research has demonstrated that the loss of lamin B2 is associated with the 
formation of aneuploidies in culture (Ranade et al., 2017). In order to make a clear link between the 
two, further research is required. Previously, it was established that B-type lamin complete knock-out 
can cause embryonic lethality (Vergnes et al., 2004). Therefore, we propose further research on the 
stable knockdown of the gene, rather than transient. Alternatively, the use of CRISPR-Cas9 could 
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improve research and finally, prove whether lamin B2 reduction indeed is a direct cause of aneuploidy 
formation in cells. 
Finally, we had performed RNA-Seq on several different cell lines across different conditions alongside 
our different assays to monitor the global gene expression differences. Although the RNA-Seq results 
were consistent with previous views of HDFs being required for the production of GFs and the creation 
of stem cell microenvironments, very little research had demonstrated this as clearly as our data. 
Further analysis of our data needs to be performed to monitor the transcription levels of each 
chromosome across the different cell lines and conditions. This would provide us with a valuable insight 
into the potential changes in the transcriptomics of hESCs during genomic instability.   
7.1.4. Conclusions 
  
We have successfully established a sensitive and high-throughput method for the detection of low-level 
aneuploidies in a majority diploid population. The sensitivity of our ddPCR™ assay, to our knowledge, is 
the most sensitive to date with the detection limit of up to 1% aneuploidies in a diploid population. In 
addition, our study not only optimised the use of ddPCR™, but also performed multiple studies on 
several different hPSC lines and the cell lines grown in different conditions. The robustness of our assay 
can be applied to other genes for the sensitive detection of common aneuploidies and the use of a 
control with each run increases the consistency of the results allowing us to compare different ddPCR™ 
runs. 
Furthermore, we have performed the first study that had used multiple platforms to monitor the effects 
of different cell lines, conditions and passage on the genomic health of human pluripotent stem cells. 
The data from our gene positioning have demonstrated the genomic plasticity of the hPSCs, alongside 
the appearance of genomic instability in the cells. We theorise, that it is this flexibility in genome 
organisation that gives hPSCs their pluripotent capabilities and makes them susceptible to genomic 
aberrations, thus a concern for therapeutic use in clinics. 
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Finally, our results demonstrate the following key findings: 
• Droplet Digital PCR™ can successfully detect up 1% of aneuploidies in a background of diploid 
cells 
• Chromosome X aneuploidies in lymphoblastoid cell lines can cause significant alterations to 
nuclear organisation 
• Human pluripotent stem cells demonstrate a very high level of genomic stability with the ability 
to lose and regain gene copy numbers in very short periods of time, however these 
abnormalities do not change their gene positioning significantly 
• Using fluorescence in-situ hybridisation, we demonstrated that chromatin organisation in 
human pluripotent stem cells is highly flexible, regardless of the presence or absence of feeder 
cells and of passage number 
• The association of lamin B2 loss with aneuploidy formation in human embryonic stem cells 
• Pathways, associated with the creation of stem cell microenvironments and the enrichment of 
vitamin digestion and absorption, are upregulated in human embryonic stem cells grown in 
feeder-free conditions  
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Appendix II: Data Analysis 
Nuclear Area Analysis of H9 Cells Grown Under Different Conditions 
 
Human embryonic stem cell line H9 was grown in different media and matrices and the nuclear area 
was compared across the different conditions using Tukey’s Multiple Comparison Test. The table below 
summarises the results, significant different between samples are shown as asterisks (*) when p<0.05, 
** when p<0.001 and *** when p<0.0001. 
Tukey's Multiple Comparison Test Significant? P < 
0.05? 
Summary 
TeSR2 matrigel P3PS vs TeSR2 521 P9PS Yes * 
TeSR2 matrigel P3PS vs NutriStem matrigel P6PS Yes *** 
TeSR2 matrigel P3PS vs NutriStem 521 P6PS No ns 
TeSR2 matrigel P3PS vs NutriStem 511 P10PS No ns 
TeSR2 matrigel P3PS vs E8 matrigel P7PS Yes *** 
TeSR2 matrigel P3PS vs E8 521 P6PS No ns 
TeSR2 matrigel P3PS vs E8 511 P7PS Yes *** 
TeSR2 matrigel P3PS vs E8 vitronectin P3PS No ns 
TeSR2 521 P9PS vs NutriStem matrigel P6PS Yes *** 
TeSR2 521 P9PS vs NutriStem 521 P6PS Yes *** 
TeSR2 521 P9PS vs NutriStem 511 P10PS No ns 
TeSR2 521 P9PS vs E8 matrigel P7PS No ns 
TeSR2 521 P9PS vs E8 521 P6PS Yes *** 
TeSR2 521 P9PS vs E8 511 P7PS Yes *** 
TeSR2 521 P9PS vs E8 vitronectin P3PS No ns 
NutriStem matrigel P6PS vs NutriStem 521 P6PS Yes ** 
NutriStem matrigel P6PS vs NutriStem 511 P10PS Yes *** 
NutriStem matrigel P6PS vs E8 matrigel P7PS Yes *** 
NutriStem matrigel P6PS vs E8 521 P6PS Yes *** 
NutriStem matrigel P6PS vs E8 511 P7PS No ns 
NutriStem matrigel P6PS vs E8 vitronectin P3PS Yes *** 
NutriStem 521 P6PS vs NutriStem 511 P10PS Yes *** 
NutriStem 521 P6PS vs E8 matrigel P7PS Yes *** 
NutriStem 521 P6PS vs E8 521 P6PS No ns 
NutriStem 521 P6PS vs E8 511 P7PS Yes *** 
NutriStem 521 P6PS vs E8 vitronectin P3PS Yes ** 
NutriStem 511 P10PS vs E8 matrigel P7PS Yes * 
NutriStem 511 P10PS vs E8 521 P6PS Yes *** 
NutriStem 511 P10PS vs E8 511 P7PS Yes *** 
NutriStem 511 P10PS vs E8 vitronectin P3PS No ns 
E8 matrigel P7PS vs E8 521 P6PS Yes *** 
E8 matrigel P7PS vs E8 511 P7PS Yes *** 
E8 matrigel P7PS vs E8 vitronectin P3PS Yes *** 
E8 521 P6PS vs E8 511 P7PS Yes *** 
E8 521 P6PS vs E8 vitronectin P3PS Yes * 
E8 511 P7PS vs E8 vitronectin P3PS Yes *** 
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Nuclear Circularity of H9 Cells Grown Under Different Conditions 
 
Human embryonic stem cell line H9 was grown in different media and matrices and the nuclear 
circularity was compared across the different conditions using Tukey’s Multiple Comparison Test. The 
table below summarises the results, significant different between samples are shown as asterisks (*) 
when p<0.05, ** when p<0.001 and *** when p<0.0001. 
 
Tukey's Multiple Comparison Test Significant? P < 0.05? Summary 
TeSR2 matrigel P3PS vs TeSR2 521 P9PS Yes *** 
TeSR2 matrigel P3PS vs NutriStem matrigel P6PS No ns 
TeSR2 matrigel P3PS vs NutriStem 521 P6PS No ns 
TeSR2 matrigel P3PS vs NutriStem 511 P10PS No ns 
TeSR2 matrigel P3PS vs E8 matrigel P7PS Yes *** 
TeSR2 matrigel P3PS vs E8 521 P6PS Yes *** 
TeSR2 matrigel P3PS vs E8 511 P7PS Yes *** 
TeSR2 matrigel P3PS vs E8 vitronectin P3PS No ns 
TeSR2 521 P9PS vs NutriStem matrigel P6PS Yes *** 
TeSR2 521 P9PS vs NutriStem 521 P6PS Yes *** 
TeSR2 521 P9PS vs NutriStem 511 P10PS Yes *** 
TeSR2 521 P9PS vs E8 matrigel P7PS Yes *** 
TeSR2 521 P9PS vs E8 521 P6PS Yes *** 
TeSR2 521 P9PS vs E8 511 P7PS No ns 
TeSR2 521 P9PS vs E8 vitronectin P3PS Yes *** 
NutriStem matrigel P6PS vs NutriStem 521 P6PS Yes * 
NutriStem matrigel P6PS vs NutriStem 511 P10PS Yes * 
NutriStem matrigel P6PS vs E8 matrigel P7PS Yes *** 
NutriStem matrigel P6PS vs E8 521 P6PS Yes *** 
NutriStem matrigel P6PS vs E8 511 P7PS Yes *** 
NutriStem matrigel P6PS vs E8 vitronectin P3PS Yes *** 
NutriStem 521 P6PS vs NutriStem 511 P10PS No ns 
NutriStem 521 P6PS vs E8 matrigel P7PS Yes ** 
NutriStem 521 P6PS vs E8 521 P6PS Yes *** 
NutriStem 521 P6PS vs E8 511 P7PS Yes *** 
NutriStem 521 P6PS vs E8 vitronectin P3PS No ns 
NutriStem 511 P10PS vs E8 matrigel P7PS Yes ** 
NutriStem 511 P10PS vs E8 521 P6PS Yes *** 
NutriStem 511 P10PS vs E8 511 P7PS Yes *** 
NutriStem 511 P10PS vs E8 vitronectin P3PS No ns 
E8 matrigel P7PS vs E8 521 P6PS No ns 
E8 matrigel P7PS vs E8 511 P7PS Yes *** 
E8 matrigel P7PS vs E8 vitronectin P3PS No ns 
E8 521 P6PS vs E8 511 P7PS Yes ** 
E8 521 P6PS vs E8 vitronectin P3PS Yes ** 
E8 511 P7PS vs E8 vitronectin P3PS Yes *** 
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Appendix III: Karyology 
 
NIBSC-5 
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Appendix IV: Data Analysis 
 
MasterShef2 HDF Nuclear Area 
 
One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 8 
F 178.2 
R square 0.4988 
    
 
Tukey's Multiple Comparison Test Mean Diff. q Significant? P < 0.05? Summary 
P3PS vs P4PS -141.4 21.75 Yes *** 
P3PS vs P5PS -72.64 10.57 Yes *** 
P3PS vs P6PS -205.8 32.22 Yes *** 
P3PS vs P7PS -264.1 24.44 Yes *** 
P3PS vs P8PS -244.7 37.05 Yes *** 
P3PS vs P9PS -281.7 37.65 Yes *** 
P3PS vs P10PS -178.7 23.31 Yes *** 
P4PS vs P5PS 68.78 9.965 Yes *** 
P4PS vs P6PS -64.40 10.03 Yes *** 
P4PS vs P7PS -122.6 11.33 Yes *** 
P4PS vs P8PS -103.3 15.57 Yes *** 
P4PS vs P9PS -140.3 18.68 Yes *** 
P4PS vs P10PS -37.26 4.844 Yes * 
P5PS vs P6PS -133.2 19.60 Yes *** 
P5PS vs P7PS -191.4 17.32 Yes *** 
P5PS vs P8PS -172.1 24.59 Yes *** 
P5PS vs P9PS -209.1 26.69 Yes *** 
P5PS vs P10PS -106.0 13.24 Yes *** 
P6PS vs P7PS -58.25 5.415 Yes ** 
P6PS vs P8PS -38.92 5.966 Yes *** 
P6PS vs P9PS -75.87 10.24 Yes *** 
P6PS vs P10PS 27.14 3.573 No ns 
P7PS vs P8PS 19.32 1.775 No ns 
P7PS vs P9PS -17.62 1.540 No ns 
P7PS vs P10PS 85.39 7.386 Yes *** 
P8PS vs P9PS -36.95 4.862 Yes * 
P8PS vs P10PS 66.06 8.492 Yes *** 
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masterShef2 HDF Nuclear Circularity 
 
One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 8 
F 48.88 
R square 0.2273 
 
 
Tukey's Multiple Comparison 
Test Mean Diff. q 
Significant? P < 
0.05? Summary 
P3PS vs P4PS -0.04698 5.599 Yes ** 
P3PS vs P5PS 0.05971 7.984 Yes *** 
P3PS vs P6PS 0.07359 10.58 Yes *** 
P3PS vs P7PS -0.008717 0.7412 No ns 
P3PS vs P8PS -0.04669 6.494 Yes *** 
P3PS vs P9PS -0.08080 9.921 Yes *** 
P3PS vs P10PS -0.04996 5.988 Yes *** 
P4PS vs P5PS 0.1067 12.18 Yes *** 
P4PS vs P6PS 0.1206 14.50 Yes *** 
P4PS vs P7PS 0.03827 3.034 No ns 
P4PS vs P8PS 0.0002949 0.03464 No ns 
P4PS vs P9PS -0.03381 3.622 No ns 
P4PS vs P10PS -0.002975 0.3129 No ns 
P5PS vs P6PS 0.01388 1.877 No ns 
P5PS vs P7PS -0.06843 5.689 Yes ** 
P5PS vs P8PS -0.1064 13.97 Yes *** 
P5PS vs P9PS -0.1405 16.48 Yes *** 
P5PS vs P10PS -0.1097 12.58 Yes *** 
P6PS vs P7PS -0.08231 7.031 Yes *** 
P6PS vs P8PS -0.1203 16.94 Yes *** 
P6PS vs P9PS -0.1544 19.14 Yes *** 
P6PS vs P10PS -0.1235 14.94 Yes *** 
P7PS vs P8PS -0.03797 3.205 No ns 
P7PS vs P9PS -0.07208 5.789 Yes ** 
P7PS vs P10PS -0.04124 3.278 No ns 
P8PS vs P9PS -0.03411 4.124 No ns 
P8PS vs P10PS -0.003270 0.3862 No ns 
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masterShef2 Matrigel™ Nuclear Area 
 
One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 6 
F 77.54 
R square 0.3039 
 
Tukey's Multiple Comparison 
Test Mean Diff. q 
Significant? P < 
0.05? Summary 
P5PS vs P6PS -147.9 21.06 Yes *** 
P5PS vs P7PS -23.29 1.987 No ns 
P5PS vs P8PS -7.372 0.9653 No ns 
P5PS vs P9PS -159.3 18.39 Yes *** 
P5PS vs P10PS -91.21 11.96 Yes *** 
P6PS vs P7PS 124.7 10.84 Yes *** 
P6PS vs P8PS 140.6 19.27 Yes *** 
P6PS vs P9PS -11.39 1.362 No ns 
P6PS vs P10PS 56.74 7.791 Yes *** 
P7PS vs P8PS 15.92 1.340 No ns 
P7PS vs P9PS -136.0 10.82 Yes *** 
P7PS vs P10PS -67.92 5.719 Yes ** 
P8PS vs P9PS -152.0 17.11 Yes *** 
P8PS vs P10PS -83.84 10.65 Yes *** 
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masterShef2 Matrigel™ Nuclear Circularity 
 
One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 6 
F 120.6 
R square 0.4044 
 
 
Tukey's Multiple Comparison 
Test Mean Diff. q Significant? P < 0.05? Summary 
P5PS vs P6PS -0.03790 3.775 No ns 
P5PS vs P7PS -0.2883 17.21 Yes *** 
P5PS vs P8PS -0.2655 24.33 Yes *** 
P5PS vs P9PS -0.2682 21.67 Yes *** 
P5PS vs P10PS -0.2237 20.53 Yes *** 
P6PS vs P7PS -0.2504 15.24 Yes *** 
P6PS vs P8PS -0.2276 21.84 Yes *** 
P6PS vs P9PS -0.2303 19.27 Yes *** 
P6PS vs P10PS -0.1858 17.86 Yes *** 
P7PS vs P8PS 0.02278 1.341 No ns 
P7PS vs P9PS 0.02011 1.120 No ns 
P7PS vs P10PS 0.06458 3.806 No ns 
P8PS vs P9PS -0.002672 0.2105 No ns 
P8PS vs P10PS 0.04180 3.716 No ns 
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mShef2 HDF Nuclear Area 
 
One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 8 
F 77.91 
R square 0.3466 
 
Tukey's Multiple Comparison Test Mean Diff. q Significant? P < 0.05? Summary 
P3PS vs P4PS -116.6 12.50 Yes *** 
P3PS vs P5PS -123.8 10.69 Yes *** 
P3PS vs P6PS -187.5 16.95 Yes *** 
P3PS vs P7PS -218.7 22.96 Yes *** 
P3PS vs P8PS -176.7 16.50 Yes *** 
P3PS vs P9PS -236.5 26.48 Yes *** 
P3PS vs P10PS -22.21 2.088 No ns 
P4PS vs P5PS -7.196 0.5996 No ns 
P4PS vs P6PS -70.93 6.170 Yes *** 
P4PS vs P7PS -102.1 10.18 Yes *** 
P4PS vs P8PS -60.07 5.384 Yes ** 
P4PS vs P9PS -119.9 12.67 Yes *** 
P4PS vs P10PS 94.39 8.512 Yes *** 
P5PS vs P6PS -63.74 4.759 Yes * 
P5PS vs P7PS -94.93 7.811 Yes *** 
P5PS vs P8PS -52.88 4.036 No ns 
P5PS vs P9PS -112.8 9.641 Yes *** 
P5PS vs P10PS 101.6 7.788 Yes *** 
P6PS vs P7PS -31.19 2.676 No ns 
P6PS vs P8PS 10.86 0.8592 No ns 
P6PS vs P9PS -49.01 4.384 Yes * 
P6PS vs P10PS 165.3 13.14 Yes *** 
P7PS vs P8PS 42.06 3.714 No ns 
P7PS vs P9PS -17.82 1.844 No ns 
P7PS vs P10PS 196.5 17.46 Yes *** 
P8PS vs P9PS -59.87 5.529 Yes ** 
P8PS vs P10PS 154.5 12.58 Yes *** 
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Tukey's Multiple Comparison Test Mean Diff. q Significant? P < 0.05? Summary 
P3PS vs P4PS 0.3599 36.89 Yes *** 
P3PS vs P5PS 0.09850 8.129 Yes *** 
P3PS vs P6PS 0.05801 5.013 Yes * 
P3PS vs P7PS 0.005608 0.5628 No ns 
P3PS vs P8PS 0.06370 5.687 Yes ** 
P3PS vs P9PS 0.02345 2.510 No ns 
P3PS vs P10PS -0.04498 4.042 No ns 
P4PS vs P5PS -0.2614 20.83 Yes *** 
P4PS vs P6PS -0.3019 25.11 Yes *** 
P4PS vs P7PS -0.3543 33.78 Yes *** 
P4PS vs P8PS -0.2962 25.38 Yes *** 
P4PS vs P9PS -0.3365 33.99 Yes *** 
P4PS vs P10PS -0.4049 34.91 Yes *** 
P5PS vs P6PS -0.04049 2.891 No ns 
P5PS vs P7PS -0.09289 7.308 Yes *** 
P5PS vs P8PS -0.03480 2.540 No ns 
P5PS vs P9PS -0.07505 6.136 Yes *** 
P5PS vs P10PS -0.1435 10.52 Yes *** 
P6PS vs P7PS -0.05240 4.298 No ns 
P6PS vs P8PS 0.005692 0.4305 No ns 
P6PS vs P9PS -0.03455 2.955 No ns 
P6PS vs P10PS -0.1030 7.826 Yes *** 
P7PS vs P8PS 0.05809 4.905 Yes * 
P7PS vs P9PS 0.01785 1.766 No ns 
P7PS vs P10PS -0.05059 4.297 No ns 
P8PS vs P9PS -0.04024 3.553 No ns 
P8PS vs P10PS -0.1087 8.466 Yes *** 




One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 8 
F 142.5 
R square 0.4925 
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Tukey's Multiple Comparison Test Mean Diff. q Significant? P < 0.05? Summary 
P5PS vs P6PS 208.2 20.71 Yes *** 
P5PS vs P7PS 124.6 15.77 Yes *** 
P5PS vs P8PS -128.7 15.32 Yes *** 
P5PS vs P9PS -112.4 14.44 Yes *** 
P5PS vs P10PS 114.3 15.12 Yes *** 
P6PS vs P7PS -83.59 8.083 Yes *** 
P6PS vs P8PS -337.0 31.40 Yes *** 
P6PS vs P9PS -320.6 31.28 Yes *** 
P6PS vs P10PS -93.94 9.317 Yes *** 
P7PS vs P8PS -253.4 28.97 Yes *** 
P7PS vs P9PS -237.1 29.09 Yes *** 
P7PS vs P10PS -10.35 1.305 No ns 
P8PS vs P9PS 16.32 1.889 No ns 
P8PS vs P10PS 243.0 28.80 Yes *** 
P9PS vs P10PS 226.7 29.00 Yes *** 
 
  
One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 6 
F 219.3 
R square 0.5243 
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mShef2 Matrigel™ Nuclear Circularity 
 
One-way analysis of variance   
P value < 0.0001 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
Number of groups 6 
F 278.4 
R square 0.5834 
 
 
Tukey's Multiple Comparison Test Mean Diff. q Significant? P < 0.05? Summary 
P5PS vs P6PS -0.4903 36.90 Yes *** 
P5PS vs P7PS -0.3926 37.61 Yes *** 
P5PS vs P8PS -0.2315 20.80 Yes *** 
P5PS vs P9PS -0.3829 37.23 Yes *** 
P5PS vs P10PS -0.4325 43.30 Yes *** 
P6PS vs P7PS 0.09770 7.150 Yes *** 
P6PS vs P8PS 0.2589 18.23 Yes *** 
P6PS vs P9PS 0.1074 7.928 Yes *** 
P6PS vs P10PS 0.05779 4.337 Yes * 
P7PS vs P8PS 0.1612 13.92 Yes *** 
P7PS vs P9PS 0.009695 0.9004 No ns 
P7PS vs P10PS -0.03991 3.807 No ns 
P8PS vs P9PS -0.1515 13.24 Yes *** 
P8PS vs P10PS -0.2011 18.00 Yes *** 
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Appendix V: FASTQC Files 
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P5PS 
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P5PS 
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P6PS 
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P6PS 
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P7PS 
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P7PS 
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P8PS 
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P8PS 
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P9PS 
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P9PS 
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P10PS 
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P10PS 
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Appendix VII: List of Genes Generated from the RNA-Seq Analysis 
 
Upregulated genes in hESCs cultured on HDFs: 
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masterShef2 (125 genes) 
IFI44L RAMP1 SAMD5 
MLC1 WNT11 APOA2 
OSR1 TBX4 P2RY6 
RALYL SH3TC1 COLEC11 
FIBIN LINC00645 CLEC14A 
CD34 HOXB3 C1orf61 
FLI1 PI15 LRRN4 
SCN3A MEP1A PGM5 
ALB FMO1 CPED1 
PLG APOC2, APOC4 HPX 
DIO3 SMLR1 EGFLAM 
SERPINC1 DIO1 GRIA2 
COL3A1 APOB TBX20 
FSTL5 C7 SULT2A1 
FAM163A HAVCR1 CLEC1B 
CXCL14 ITIH2 MIR143, MIR143HG 
EPAS1 TTR SYT10 
ASGR2 ANXA8 PRDM6 
GSTA1 ALX4 ANXA8L1 
CNTN5 RGS13 FSHR 
CDH10 FOXF1 GATA6-AS1 
HSD17B2 ESAM VTN 
PITX2 PLA2G12B NPY 
SLC40A1 AGT PDE7B 
HOXC10 LINC00461, MIR9-2 GSTA2 
APOA1 RBP4 HAPLN1 
MEOX2 FENDRR COL15A1 
LUM HOXB6 CD93 
HOXA10, HOXA9 PDZRN4 HOPX 
HMGCS2 SLC17A8 SOAT2 
ACSL5 KYNU APOA4 
CTSE ADRB3 THBD 
GUCY1A3 SLCO2B1 FOXA1 
HKDC1 CDH5 CSGALNACT1 
KISS1 ATP10B MGP 
G0S2 LRP1B GFAP 
C2orf80 GBP4 GJB1 
TF CREB3L3  
HOXD11 ITGA8  
LINC01158 F2  
GABRP KCNQ5  
PECAM1 HGF  
ADAMTS9 FEZF2  
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Downregulated genes in hESCs cultured on HDFs: 
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Upregulated genes in the different cell lines masterShef2 and mShef2: 




















Matrigel™ (81 genes) 
FGA TMEM132C LINC00925 COL19A1 POU3F3 
IFI44L CILP SERPINC1 LPL NFIX 
CYP26B1 FABP1 SLC17A8 MEP1A CFI 
LINC00461, MIR9-2 MAP6 TFAP2B FMO1 C1orf61 
AGT EMX2 FSTL5 SFTA1P AHSG 
SFRP4 C2orf80 ATP10B APOC2, APOC4 KISS1 
MLC1 HTR1A SERPINA7 SMLR1 DCN 
OLIG3 WNT8B GPM6A LIPC TECRL 
LOC440896 ZIC1 CNTN5 DIO1 SLC18A3 
ZNF732 ITGBL1 PAX8 POU3F2  
PXDNL GRIA2 CDH10 S100B  
RBP4 ELMOD1 NPAS3 TTR  
SCN4B OTX1 HOXC10 MGP  
FGG MIR143, MIR143HG LOC145845 FGB  
SCN3A DMRTA2 POSTN SPARCL1  
NPTX1 APOC3 PTX3 WNT7B  
PLG AFP SERPINA1 SCN1A  
A2M COMP DPYSL5 GFAP  
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Downregulated genes in the different cell lines masterShef2 and mShef2: 
















Matrigel™ (109 genes) 
FOXF1 SLC6A19 PITX2 LCN15 HOXA11-AS HAPLN1 ARHGDIB 
SYTL5 GYPE SLC40A1 WISP1 CDKN2B-AS1 MAGEA4 ZNF662 
FGA NLRP7 H19, MIR675 AHSG AADACL3 LINC01559 HOXB5 
RHAG MYCT1 APOA1 LRRN4 AFP LINC00607 LINC01139 
XCL1 COL3A1 SAMSN1 HOXD11 MYL3 LOC101927901 PKP1 
ZNF596 PLVAP OIT3 TF PRDM6 COLEC10 GSTA2 
TLR4 HOXD9 NPNT CRHBP RGS1 HOPX HAND1 
DPPA5 RNASE1 HGF EGFLAM ADGRF4 TRPM2 PRR9 
CPA2 FAM163A LINC01108 MEPE DNMT3L TFF1 TNNT2 
FIBIN CBLN2 ABHD12B TBX20 FSHR ACTC1 SLC28A3 
RBP4 MYL4 SERPINA1 GATA4 TBX4 APOA4 DNM3OS 
ZAP70 SYNPO GGT5 FRMPD4 HOXB7 DUSP27 HOXD10 
PTPN20 GBP4 IGF2, INS, INS-IGF2 ITGA11 GPAT2 ANXA8 AQP1 
FMOD TCHH KCTD16 SLN GATA6-AS1 LOC101927915  
ENTPD3 IGF1 P2RY6 TCF21 VTN FGB  
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Passage Affected Genes: 
 
masterShef2 HDF and Matrigel™ (1 gene) 
TTR 
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